%PDF-1.6 % 39 0 obj <> endobj 54 0 obj <>/Filter/FlateDecode/ID[<81F2F404A2008144801D205C526EC146>]/Index[39 29]/Info 38 0 R/Length 79/Prev 212242/Root 40 0 R/Size 68/Type/XRef/W[1 2 1]>>stream hbbd``b`$CAD Hu @T+D ) 1 aHqWJ  endstream endobj startxref 0 %%EOF 67 0 obj <>stream hb```a``23Z@ (1 n^,Ge`>L300:03(1] aXtUMׂPsH1_; }`aP endstream endobj 40 0 obj <> endobj 41 0 obj <>/ProcSet[/PDF/Text/ImageB]/XObject<>>>/Rotate 0/Type/Page>> endobj 42 0 obj <>stream hެMO0 p~$4iL&m!MՔHmR 1~=n c &c[8|!]')q^zD>q Q]AzA\\٢q(qm &ED+;5wqW>.5 <"uZ"KdJt:ԦT^ pv%*_>}ˤqwB@ղfwG>2L 65ސT=h*lJEV9c.gLo-vUU`LOljɾnnc<4G7to4kZ. ޳KNr.o"mS?,mj>stream HWn7}Wl5A N 6 mo!+)F ;.w)n V,r.gΜˆhZ+|?RW*cYWoP"+RoWbz5RFRUXsuqכճO2 i UQqgICHf](D%\"H0wh~v0IsB"?/߮mڗOiՋμ|yu`;kDȽj?r? BuNCpĝE`HT5h6!D0"YAXfwpu!Bs/m%=(]=$GST2Z.e9톾kUQW56,&>+xG!8nMHXբ6Yʠl)4)Oµ3Pu%#.i L,QyVxxYBTDcZXF}IsQtn5/l"Q(z4y9Vbs^\0BCh!OHGłz `:rO^')鉈]?qIM `O}w[Bdz#.Ig8ZJoT;bqTƟ\O\Tv؁dy,m%B zX0[b*3\7Se't/.luvӷf6i<2VOH+6Va"pL rU (nJd".ٵ}sL`z?E`&ǹ~mKR$>stream HWnF}W1/Mv$ bC*IP]^%ߞdgg̜Hid:{lɫ@|hHXpklyp΂Mll_h)br5>E{/(`).[fyO[M))y"p%WwnSϪibtc \Ţ_=;YDTqϖL"Ӊ)c"&wݩ%lGw4+^gCRMw`~/+ ݢ\#ػ(G JSDl"ܤ:ik:(kFL Δg]=e.w[ʼn)H( ^7 KZ)ʯX oUQ\he+}ZlcQg;gBX"_jmFBaꡋyZtgSOd!Ή@KZT\0E1[߈\)WA 5S>k}C7sp74HhEYg5J|G*4L! 2Ab'p<:$dki:xQ#ԏ]Z&CPqѥT/zF!Ye훮n@An>FIcCa9>F^=X(HvO4=<ժm솫tـHm}vt  s@z_6Y<{w1E_rVe|oR;}rD:!{7V' G4}("K}Lb㧷;ك("n{+_ endstream endobj 45 0 obj <>stream HWnF }W1p@S}h+{UhW ]KM#i8}ECrxxxȡ2 b,hqzw՟x}=# 2)W/ }NAoݡ,}S<Ah??EY0ʣ٢XBU(nzŔ/W9(_X\%"`N0"=tvR X[JPЄfC s΍3EB~,W07Jӷ \ÕcYj|!:'VNwePjn` [2\;7"qYlSJ7 37.B}qh(Alk$\Z6"oچ=vU78LA:T}jQƤ+.0ܣu6P퓚ޗJ=Եͽ8q,iX JA)("Wp6u]0"M~Tc7k #:OXgy٠OY5-Zh9)Cxи,TzگZ}0.-妍 (ץDrܣUv+=Ms6ǚ0veth\}S@Du;诶&aYJrĉ+e Kƴ"DAʖ$WF8pJ6Oz_a%lYdf#h.pq=ma7@|[WOˡ}qX7;4NBiE|8MLWVآ w]+fcxH`M*p %jP ~|__ ;X$XV/y]B fgVopZP6{%94PA`/j(1U -p[%l oɓ*(#z(p?T\ PB^BqWP?G~Iq ;Ǥ! ,n B<$7qz`Q2 vYT&)E6q#EBӷ%YoʅaaKOi_Zz8Ss_igSv 4KrqrU.TRtq(D±~ym_^ '͝剟y\~G !c缯15 endstream endobj 46 0 obj <>stream HWnF+Lx<x4@ 4jW-,RTT}/99t!ygpa, \lwx#F[ O?8sK"\pXSy;>HithCݧ_>i݆|%O(33HI<QdFF Yl7NG*%J+GrpV(T@ctsA'N]Sav&։!.3k>i)P`[ُ5HOou<Äs##ܫ;տl k I>5]W#@= B ޞbL)0p(}+ q o?DT!Q=d*T{8YU0!CH]ne)%ǧ enue|՝#kRU|}",M۲(jT Ζs <'coG4zF 0[[?xGј 9tphI<]b!H@ K<[ViUx,%$n~q_7Ӛ"VA33lеuDKn, ֡Ӏs[~躿3x D]4% XL`v軩3̼%aU5b##:)q{HlJK0ưԃ9r5ß2LF0D!aO"z5!R1wGEK27Tl\ 3Ú}5 ,35.Z$0\Wh<475_X" 50XۉK\61Ng9dIHE=G*Dv#>5AF)̼.z?bA|)_>D,;7_xE(10 ߍL+F bi/ٞHd-GYV-~*~8ٯ4`d5/WBم(g|fA\A ,uoh f/+t4_۲)r=P^fwNqˡ~"*cfI?]##CjQK=db(R$xĹ"H<3@:x~GSɐI-y!P媣r-/ugF0LGL= wł0-58Ş!q@mw]V-ƞ{/";"Iٻ\W(#Q†Ndӕ$ lܽk# k^֔='=(Pf5uEmI?m>stream HW[F~_ ē9s&Mh -Ekk d$9a{xn6[`g;w޽Cqf @jE ?ՄK h)E>\]۶+vū竏+J8Ѭ5K fn<]u&'ko8j3o߾6wxN 5w4&sg_F}>#,dkL9Y0-^ou?t5FNpe:.̢%5b ^kO\+'W+DPQSShvxϜSjc=xWIjl<ňb}}"582kj ܴӾ "P"5I% ?U{`aIkD CyϰӖ,H(cu m뚞j<}Uݱ6<e1AfqD51RO7fӖe\3_ m }`EjO3o9QhvC K<P7Y 8<&4/|B(Uއ #s;T[GPD &}\.ՃWߋشq aQ³&C̒z2ɝG-xspTKUsX< Hgh(_;M =eCAl3?)#t쓛иP-/M'eN0i$OZyGj?*7~Xr i|_2\'؍f{+7[ų)Mn3)>-@;"_B-{'Xv(naӰkH2^RzDŽoQ̓-#nU#un}-,_!3~I^9KytB@Xz?]&Emݷ60t}{d:+eܓ62a`ƟbqW.n77⃥?]9䦤+떜EUv+"CBhZ#V%!C"h¥ucuߵ_=B}\|uqGyu4 )r>sҩ=xZfZ!ӛeuh˱n*6SCcG)| TRǶ/l Sy"[i$Ax_%n!E5CKtc\zSs1Z9ۮΏUIiՒXشsOB| endstream endobj 48 0 obj <>stream HWK61b.ߤ CC}!@i[-܅;D"ٛoMg0DLJ F(VlwE.wLKaNyߙT{dC1"h;G{K J ޚ5CɃx4C!ŨpvxP*P{-D>gR99kM L>DQyyx Z/&B<.:rqXܥ%jL ^޵>xIT̷ˤW:f}}x_n(>~|68_1-IJX4EhyL9W!,k;cv 30;Bp"I/ڦ&g Vu4t=ܺd:+"eh5?t"+ ."3dž?:c@m: EU %w1Y8kGoƢ~ͱm?'j^{#ϊp_G,i+̾M2U.Q3zp}}=ٜfѐdv4uF{ueT*I[ٴC&2. =!.uվn]u=ջ|p0t0 h^IfHR΍ToPx *٦eע Wx6)(^ݾw+ZrS Ԝ oOJb? TpA0_a-qjg8CT@Y~5$OfW]L>1òqpܨbJŕܶN5v(9"ڙz \ _^XSҺ94@\pʀc^˸?U}u5vɤttUguUA0_c{L$6;v/ɔHXeY!~Vq ]L$P#@Ll!cG$3n@'E2bXͦk(Z"lCdU|`v,*d۬;D0nC{1"<ʙ Iej:-z@[flAVk!֮}@GWNJUR^*VA]Imm&o):i-N[. 9~Bi++q #)5=8D^Bg,b/11XY3 l^#^f 3lLZ@Jh"8GcoPLAV1y1ZA8F3d vUݗ%S00r9Tv,t`+M⁄:#TgVbK.ˎ8Y mwi6ZrRW0mYi׸k k%"/h5š>stream HWɒ6WhWE0僝rp#q$&pdi A@VbfDk8.LJW4~;)J~p31ш*N . ҅F#Ɗ|0\ ͝C.H(+#yyyb:>~ZR KXG )}5&C%qR2.y'Sq{P%eAXY<}L@:dAߗUg$:lNwt.%o~kuo|'?>o3)&6Ls=Ge}7F&d y!!֖*[L}C~ɂ O"4p&å i1wHdeMw(Jq/ar/ل0naNn-ɽH|u "络ˍDtT%VUs?:ebe(A֎]cK+HAjbP ~g}<^8AH(YЖ4X: Oc?Qм4Iw{V 2mBkL鸭纩PRJV"Of,E:UK7s=lk02|7._ g㿡9KMR3יA%|1/_dsyՊYᣖ~h>GbTı˺z`9s$* tT%:>swuGRA[h)yߒcA;/Ğk_ ^~#{N{ /2x@ rK4A ZCݡ\_vᯩ]2bW +k28G~j B6U渙jO!-kPch bKaX?ݘ*uH;A1ظ1[B֮<^ƶǍ-M^\"~1r}@|eC5m/RnZ:_hZ~B|ZYcH*uhƻ{b1Bb 8I|45ƽRSgÇ/N0U!Y@K?!>9AC.5's:w7#ڥnn }bM NsqHb=q+؇F&3U/0Ɯa@p@,C e|MYVzh&z$u)&sܤ5h8x[Y@G|dG\Z,`=x endstream endobj 50 0 obj <>stream HWM6W9@4mQ@ZY2$P$e&=y"g3o޼}~.c?aH{'#.UaxF!.{['߻//C(]JHj( J#ePL&>fϊă3^2w~ؽ튗=H9IG9GջR`q ReSPSDԯ< 3[lR!5\c,HŭGkC1!sߺfF"D?HH WL=z$x*W1z _0-Rbb:'@irq;KX;ȥ ͱ:^uulUPI '>%TFZF) h  {fddA3Z}v*t/ c$PT;.|  =l[$tx8[s(ν@z60$,*| B֦dO iY~R}ơXpnFn]A9kl@u@t.]&ȡ|q.uGQf4] H!]{YP\3^LpiWHAD ƤfraX\cs͢\ X9 31fߝލ=ût hmdrWyfxksM}J=< ˷+W9ְvq,,wFw<${0\Uj -#\{b0ҳ0k2a*yx}ER6xvP!۱/dcM@te5瘒V ]ul;k,1j[f@rg[}[e@C w! s$E:K|8qalֆC=e¨$vtd6J[7x4c2pr_󥎻*5k>]7Mݢ0rZX@ B78}Q9<5`}"Ri~Цܥs-r|Tm=e':5]σ&_DzlY endstream endobj 51 0 obj <>stream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endstr endstream endobj 52 0 obj <>stream Hd͊zy8 >sRhF^#y QG#Oç==o/ϧ;c_mӷKv|~_oo~y>}~W=|z>{O݇q~?>Ï?o+~ߒ~;%zΏx߽w;>lp?(O?{wٸ^ PZUuTGu^5P5FjFDMԤU PjVjUmFmک]uPuNNE]E5|| _#_k55|| _#_k55|| _#_k55|| _#_k5Z||-_+_kZ||-_+_kZ||-_+_kZ||-_+_ku:||_'_uu:||_'_uu:||_'_uu:||_'_uz||=_/_z||=_/_z||=_/_z||=_/_ || ߀o77 || ߀o77 || ߀o77 || ߀o77 KG#(~? ?G#(~? ?G#(~? ?G#(~? ?z $߄o77MM&|| $߄o77MM&|| $߄o77MM&|| $߄o77MM&||3,ߌo77f||3,ߌo77f||3,ߌo77f||3,ߌo77f|| "߂oȷ[--|| "߂oȷ[--|| "߂oȷ[--|| "߂oȷ[--||+*ߊoŷʷ[V||+*ߊoŷʷ[V||+*ߊoŷʷ[V||+*ߊoŷʷ[V|| &߆o÷ɷmm6|| &߆o÷ɷmm6|| &߆o÷ɷmm6|| &߆o÷ɷmm6|ۯ\t;]~~߅ww;]~~߅ww;]~~߅ww;]~~߅w߁w;;|C߁w;;|C߁w;;|C߁w;;|C߉w;;NN|'S߉w;;NN|'S߉w;;NN|'S߉w;;NN|'S ߅w]..|K ߅w]..|K ߅w]..|K ߅w]..|?|x>/Filter/JBIG2Decode/Height 1752/ImageMask true/Length 22307/Name/X/Subtype/Image/Type/XObject/Width 1240>>stream 6ΆxRHGX/2}.88<\@x܌䳞_>xO!uɾ r8ی$:)GNhfX$e.G94VA(2[ADK:o1ye (Np9`}yz㛄^Ű6v5I\qu/f&)vJ|@Fϊ$9G=e-.NPq7P !Z+S͙}k.=_cF]*r<+rnS̙"-BM,+Ui4r~jhcd0:u}\ VSV(1]6 ^{\t:tkSo\lt Y1#ܴ KD;7uS^#jL# y]*\xD+ vxLGEcɣ?[WLN۟OݸHWS6.6HmB"}>'ւ* HJǎ-eU-:c\WRT$)R8HVtj?fH({҃\>Aп!}xCǢH&I1n?W8YM!ki&ްg~PJ3ME\8~N\M w%DQrJ> ӘHϻ7&BߦH)dI֛VnV5iЉN3Yk:|>POj!t_&|K&7p إv1Yr2템D)kW|C,݈wwE>O #U@՝mQ}\Y`= >I޸F7ک)`yVX/bZ]JMkTتeCqRA#X(`q6EA!2qVVX<"/KucUg`o9#%6> 'N8稨 &u™wGw Ox~vFx(Z;eӷb@J0OouU״׈}$%LF6"}@[1M)bE(f遼ڈ:)߱2y77fPNUW7jRt/N=bVߥH)qZ ϸ1D vفPYLʻfj@qCv{ =K-m8.'%|h`Dc%rjVlX6x.>ue/.lTZ3eV3,%cW`U$IglGKZoQBYfP槲dž)r5@>>1Bwe 4Ue~d11lkx_|Y0|8kam#?L,6]d$pte[:waQG팉8JYYĹY )=7_^@AKjOH49B~Nu4WCӣ2hu0lڣw#7 '౉#Su#wݑ(;}4:SJšA_sVR]>1ôQE7ޘ+ȸ.p!Ըzc@vre(p%^! q*m__],L\jݓT 4e>tn%Hk9e1Ot&5W<c鷤'L?q^s@Nn "m\ #>PDg $C|5Ld=ૃU@ E:Dpk|6Sžq=R["MqF0$FgxU\rhXuWD gi?4.>'(.6l2rKK0+CuԸrc54=CR !z)E #k=J!,Fn2Վ[&t2 f`H(}`oU΀˜1ηG$팕R4_4#9zuF Ou2/ T7UE{lvJ-oGgX3{C!5V-+jʘtfK0sHQ 5/՘0C~O1OiEA:nL r4( \ӅO'Ss "爂K6PnwaqN99j fj fpOشe )R#}bp)h7Lg55JFc( ѷDtD*N[Q W=iHiHA"(BA`{qFD^a,CG<"9ڸLV{O=( HV2 !ei{\&>^BR(dqÿ|̺Лs |Xiwn05Tvc6Wț17e_~:{)_T7zLV>S*~BVӐ.=M:x,M{O[Fuc!ݜDx GGo7 !QZ6iq:rt!EM`T %^ڿz k HJ%wJ 7lڐG\X10D)*) TםRG^]ϼ꒥{1Hh'dC+/?| 2GAlH|$ޖmIuw>c0eo<l#<:-.`{B;-?mKˉ^X!׊#I6{ y]#ЍFH*Hw~5#HbFl9q;)ajTMyt)FהF:m0 tJ-\x{Xt;)k;6p[cb~%AE6賺Åז Dm֕&"o/( M{ZyrylU?%*h&_8 $oL.U%N_E ׆:=3"䡟 w{˟ r0Ypno/KZw6mKf8\Y:]0bH/?[)(Ļ`.6Ri1u(@OvPerڮ*qbEH׵h3Tm&bje#wr sM&F \S.k5%rHw1tn-ΡtzeFc ^\@kCWvIüxj&^- ~bf*bnt+> h&ŜDz_&@Zxzhnm.Z}spq;(Էcp[E[ AaYU>v?͙@OJ4^ըlscUʙI,x Dl;vHT^E)wDyoas|^H&T 7yۨvP+SO"ȵļv0InyGr3 <"f%b1my jl>H]N_@I͕kV*9M*xe;mSEt`jWA$e!K8'Hj\0yhi(vE=P\%jt<,8w^]垕;8͠ύ B!5DE6hY 6k0;V=/a*EU . ӟw`EmH^:SMf^OM*-!!ta"%6/J2Wa7{ZYI\Ufܓmޛ2(Ճe>M31yUaB2\KG^6bR, i^by\U)4AV T+uc<.i@ՄϦ` J0+K!ң?,U۸z䙡jp؋_ Ry|h8W2Ş)1ҽЙ9-*Jʽ5e-XƐJFDc'3m80y $1إƝ6s.Oϯe-S~GpǓɝ 53иAR~ ӀT:QZJ>IbEtk?[ @nh'Qb4rAu++۝AbRS}20D7 W`ѫiqc~|[C/sͥTS;()="-hj-;;oݚDVXmojIƳExN`+xV3›kE[w]h 3qPxINZKoqd=wtC Ex+A`rKk2 qİ($t(Z)'sb@|ݥyoiCDAqD2EXlT!)R`j[v_\|A[*J}6pF, ~ĀoBQ:L+1 -'+};!+o$6>ƦN,Rd)M2K,.o?$5ވqe![1j=qYj$PO(D0ړdtb} EE$@G!5^f:=Xw@AX5ȡ@,eWnu(")8!h rx)B>$Mw:7#Ofzp|gK.2Ғ3:i$,l1đJ؈8cʹ5OuG%wO(5 𠌟++#TSE>:եW7^a}Y1#^s_T[L&z&v(@[x s50/5_)b4 49|.vo1!d#wo|ߢEqlbW A"Ǿe1܆ n?KՒU fPw;aT;D\J-XQ#526&6QX]g^`VbU>XC''*g}:wd[U-L>_zy6ֱw &T)i$^̭8j WSz}Gi'E)rK+vA:8"/]k@Ǘڗ,SyG',?]uc J 1_]!ճU^#KxQqh1_zGa0'<M&P}嶋ɃW lIRSR ghhO8 yJh;-iqK.1fW#<˯F ]^ jjF{RH!WeAMwaؓ 9O3w%?ު| A 0I_kǎLXo>27 D<Ȁo3.U\Wu=,Es5H%kH/ݩ_E~$] Y t3xsgn=fQoȓ>g9ڤ&Q Lث W9*ذfh*DQurFQMV"-HUcu =seRKҷ?  yK(0p,#'$7-K\}3 (+u/_h .YN怦/lTRJ9&.S[cGjȵs37+֢!m# nRg<^}+rq>%wqJ@4VS>|BiCUum7uTuw+ArX1YG%ůLɊUxM?D#F% X!%\we(>?®~ekA@{v g i`&WGn'&j`nP;9hՖW[* `m<&%㔳j7IOtZv E0+|ΐSf{r@,|QyVZ<9WN;ʫB$HRK8իdFͨM2T9Ѯ놈izL7W'Åq䁐^;&.4|܁<}e"xdS@v$m߈켌ͥSàp3v%[6ؤ֤P&[A$Ƭ ҈1hw>@>|  z?\>څ՞$7 wptlEcqLvqh્$?oGM=b_gyP-4pT_~s w@a4e=\< wQۅSes>tkm9̔WM^ٸq}<}EPqgD 4*.dZBz"'T$"~6CE}0Gܥ$F;qTkH.{d 쑀9ٲ\F[KSxEtNO.׏N3+JRc?05  tkgD$3@~=F3Ͱm)šEeQ A+$c!D>A y۞u}{$)68 ҳq̰- ?W)ZZ(yާQwEH \VwSuTґ`-G.RфW⮆z y,"05|AnyOیLY7($\XP21bx6@:HvMI؀TvZȪ 6O\mb0'Pp@)HbL 4=7K" EX 4GfwǦjZs&y vf 31iQI`ktOUI.%~pdZkCO4bT ft/PJ>RKpqiON-*G1 ba9tv0rp&Pò`~&3v^4b3*>|1!??lD:XLh# . fʼM/;mdGcot> 4cd[b.X-pŶÂ126 3X(ax '$zjhtÃPؤ;k3;kM7)`bVq p $,H5 [,ʛeHt:jِ%J%@(vS7›mm=G2+ Row3OSi5oCC g-lc*68P !vHѡ$|aI)iX#Իyԩ,aiiI$ЍXr`d:(-Q.?Ns[Si祣{~sBvs~Y+g'6P+4R[HY s'I i֠JWTfYʲ} m'2{9:`@Z]}_쉿ӎH- <Ԣ&_X.#,-X~'Bncqݖ@ʊzmj*4RlVt@;ܿ{2 @-L@.^5#-kf%(RךY{֥Zx,o;4h)r+7}mp>` RV*ci= oR*~KKW|ppO3Pj KDqZm W--9jm3#?=#~E)^M"Zf>9dW%eBn@&{;tIhʋedd3 h1tA/;}=j[$.yh.RIIXO4-0po锪so}CHئA´E l voսd7r")ןibFk5wWMTC߱twmڍ#\ ,jeўX8!pT]gQclI8k4kS{G|)魄٩y% >U!x~fsl@tPV )"ߨՐh'.^oo7~9'q˗NUH|PHO t[Ukk~noGTo@$Sg VLrY`W7w ˜,?fУKWa8(G4}=PoW?ֵm9#"Yh믚͠EL!oO UCbkucsݮ AqH΅,,6L V2Ŭ΂hj қ!Npȋu7f3NAA9BJ8N.%psHg_Ft€,C\I Ćp*@JaV[(Zp/`rӎQYX7#dlE$^u+5^ji1#4TߚX`%"&~xʎp$G*9(l wCXA瀁 Rֹ7SGlnyְ?QmԶ~ɩ%cDygKf-2q:w#cY*m8{ͬ,-1dHc2ӝ$3nUKY{b -Hn+I)]MsrH=BOHCوSå`ʻ\Voz9:ۭ}aeV2:2A 2+R|Kbۢ-f7IM+ݜT~i]HBp)Ρ"ɳ+3ޛdWEyNgTzlgr \7XśFê&3K=@޲bQ 6 _7Xawٔw_& O.z^ +RU({)?WO]ʭ m~3F6F-N9XqJ}[Bfת </}\RV~p1[gwI"_}'|outP,a2Vt-)eq \B㧠0<3 iRByvy3lpj%a ?C`sN9-<Ϫ=ҊU]P^%RCQ  8QßDk߮!H=gC7#H tHirz,2{贸ǭ@~('EKXZgS/ar9$n,eD1%GEAEUKk~(u7rˈkڣAC@C4Co= Ԡ1W_`&ڴ["QyR& cNy+YcXGZ.G08NnTlDTOc9@&s\TgL, }@py0$q[0HHww͌˸N2&2ɇn& T[z5j1)ة-9P:zl6Ow!|dWR^v\ܴ%l4Kݎ&Q)R5P1muijpf a:(A{㔨| c]=޽5 OQHotk{ΐ+7ZR+T-$K p.5O:S̈́N*2҃2%V>|nZS-;79o]tQ*rP9bPQeb;xwпC%.9l .N݌(7s`F{,7/ RMIi fKK?҇ F KOBOX}¯ʽe6W6jqeYGCm.s-V9[M !ohah b6K4SJ3 h9"Xi%E)Շ]ФCF%a7iW/_:췊J Wt%h8Negɷm0jDď'p_StG}}IQl/R"K~ž7pY*:=&)資Ϟd񷗺t 'nf*%z6 tUNաaGLv`N1O }>AI?*9]:Y’B$do&e~5ġ"Yq I6NLK_h&HfC\)G|"a,{Z㒎KO~H">$U0ޙkm߻ܢ2;ƴq(Q@UO@̡&O><i\*0-47tԟ>h %f0J9{Ldo,ur0Cn";OPcHrM)pX&t (p1 Kb?YBbjΨBCٳkȘ 3jPlzQ#Tz1 |f 5Lȣ0 } Si>}0r褫E2#KN9ܻ\qXu77 wzj4 pW2kTB; `VNgWʘ2.׳1"Q 5)zpl ׸L_6 bAZe!uEIvH`[dL1\:Kk2 *+ ȷ:3Z :̣WrgCn`rf6(JGI, Cax~wx[tYFh^3TH.I2gs{8k& e@]Q;ٮr6rOm9a jRWhӦXB*G|̘vScʛ[b‹=P X@pV"U6ujBB+`[ZQbLH_z%bzn4]TfYT>x 9jA9V?UfQ42! wN54E%q)׹梦FR%:4oޥ h/wح$`L"1b Rg@Ra7}Cqk¿CL0}V>96,'ms;̅;YuOpm4P NM32.(\fDA#+6hw.(O˂ ykT- ? by&s-\_ؔ(r 竲ڍar*+pBT!={;* m~E-S{5XHBcj33qt!§8MUrusy ekI3◀s$`BF/5žh_.741 x#%FY}?73]~c,Y]NBỶ&03\cKXp0 jᏴ)x6tbߖիnS:ꢖN/a+#pټ_/%zP_wcMKE!3}mzW][< տy˝ΘE:wCjGƈ.?="ui"oiލ:26g毠w;| a ݭłIנj)9Qi<WySRHB"lqn(ѧ3~$OS |lUC.VK 2tT_*h:c`!XwYc~:S70@   %:xh C4 #˜w>4r@ "WfQ/{~Mˇ .CҴx,iK3x8R$$@it}@T^sl*Y!$T d;3b36(U?Ȼ^a uOU|IyM閆k5;xTVŤVrqq]7DâfW<8]|@s=e=ZdR#-WFK r'-k S K/ųX2M*V-uNT/?kB8;0?(b&'%^j\/噛&s&6Umg7E /uO" Gd sS=bpp.&ؘqs.{#ּUP.+ {0jj~L܀[!B n,E40䱝$EXůP'\"iC*iO"9늉)0sud™\~1U4Me s70xVR_-T6Oо용O; ]VʜgzM&s䒜 CQ58So.U LqGc Rb\uF!>h/>msU~Zn1H3ZIj H% WyY2k#;[g*1uC vL}^AUEFF=Gj(QhĒD+Da_v֎װȯfOCnFGm8c/G6NNP#@7ĈK^?q-_2䠙M|![aceypIZͤ+,2HxYHðiѡJr[-tѸ#JߌP[Z_,p=}C"H]d<z6*u(zzc .PoBan#*"fͰ5!*[Zjw3I$`&3煟{#FE ZwW=ث]^L,Wݺe@5n^?D\[^K$Ol(N?sAUuQ6[YQ3'n/XvSqc SvPp/QGlәp|~T K-}lT{HρcaR}dyCD6j^*Nq`#ŻM -Tzf=+|';'AfD<Ź ΣMFp1ͥ~@|*E32|i I5%drB<]33eSX a{\ncl<5 f083aJfggm}"{#AKUP:Qģ} ?d:}sFl, ʉclRđǸ^nG y[sAړ /TrH \0Klyia0`"N>Pk]r7V-7t~|b -6i.{d` &؜ ȦS01Ν5YMN0RY}[1q7eK)X?*jRx߅X>kˊ-qO ,.|~|f]JF))Xǥ &p;FXh_ovMZɡH_ˆ zT=m]Z [Dʃq-3/5ɬZ` ~LڜDW]mjkbp&vr3tOQ>?Gw7VQ:֓&yhz2ȸ+`Ѳh<%hd&" j7%<"X"#M"iMp/ ߁R"腸ˏd1b;A5i}(w 7:p9î"*YlC\|l|np FY)79[u/PeAU^6߲yg^dijWQc~݁|s`٤N3-AY&Zn0RDD[um'*70DD-d9PȝbE[pjHo8P&7n@▗^X4>!F \I>ǹqAMqZ !Xby=TUj 8xYTڴ^UĂ)!p <l{!oFU;/Ajń4h:DcxY:v ʧgu!2+by0 8UpOL[`/]]` !g؇t:c;%fbx^ Gmތ;m|<*%%fΫԵ؁ʯ],| ~iH[z ӡœ1>W@C=Vr ?tqdQ1uLjR}mN-J'W3Ie -_Q"k(2CJ6S;en?얐i+4Vx=^]ت /syAN&NPៀEis'pOCPT@}$]Յy"{Iׅj|\B&O1֠o"Y#iѐksZT>sk"_WמϊnHCŨKt64 >NzX#y+;g;Da16φ( pfDRQ(qvWue߆ j)5/=[QVي!`  w:Gy`勓1b2bdE)E}ݳS{lJ󫼼G$!QݘX?]YIPǽ;kB{XfpvocH04w!I仇w =ľyu>Ma^ wusHU NFIH;E#=dykLϑTyѕgwF9opp`~ȓG\B; R;:PO5eEP4gg8JH*zW7geB]0?յVV7DIN+P|rw^0Dú~C̘} ?n,L,>n@(1 M[Nm(%GKj7fafh \jF|ߧtr_!bOh15SFqHBHGȄ4E |c9i~h[ ?ks2|ԙpKRd~7]὚<7!b]6-ܾ`JV_ QR }hmT;jӜIkҩLF0Y]{g'(, b &9 Ѥ>6gi >ueI%B-lZEm5K]k  Xm$xV朶OxVD ' 5oajDO3;rUߞS>K ~_˄AD &{lY!`a}/屴]s%nGKi+~uC^vO\{$5~MJ͔.]{-ŁX\J#}Kb"xGrui1=q<zϫGMɽq?Ar+?,Ϩq1"Q_?@IW%,y6c*Pdu38v*PlQFRT=l{aDG}@㥒8eI9@"3`".,787v/5kR#ہKUIÙ& y|,V>Et:/9QcƤА;Y7(dD"7Gv88^z[)jO'R;y:r{Ux)eSr"PcK~iEL'E<,!U3V2_H![4vu8@k^IU>_$T;JlTE69fP5mf+oa"֋9T;ENk xkuxopx') s:1Mw<xk_R΃E#E>[Q<+=dg|Noa5TWEh~r=rlAkh+YYN ̱;z1Ni{9yXs#hE^-U& !tv<F6 J.Թ@[8#x5fGAKe}FB9$ھj""fA Aq+gi+nY8Űw1kOAH47cP9g7oFH٣dc1b$ٶV:7F== ,w|,FJbc8?qzcqh̏*?[rXpd2 f?} KrW؜'8`Aw9Mry*Y'*&e>]F';bGZvO.{ Ťt/2jy5ᚤD /L8Jwnκ==0.ě !T\X?䪛ȑg#'>h9S}fTlV1$28w~\|f׹t;s+;q[XT* 7*&vy/>41ZXiDŽ!~CY2!'WYv#t{CpGwaNk[0-xn &֗HD-tu/(T^peL0ᦨ5E7BR6;KNW Sxf4E$G0۟ J~]|5x[9Ĕl,\#u@SKjgLN?Փ!dĖ_ռp qr6rA-l!`ao<*+rP c u< e^LHF]+)v*Y5gllxͥaDb;Q(Af}^$u)ǚu4wQsp ٵ dIdi&yZϋ<Ԓ?,4n3Mȵ6ic2eL7`D6 -XcPv+ v >YuFW8O7?xR[ZNR&0D8H[<ᡯ`yQ/!vg j<ᾦV,w3%_HRM}I-MiNjI\/BU] 2c/ 0BM}Gr9\bwg$w/4e'{B%?Jrx3M؎Fn37Ô8spcvtJPa\?*2`T!P΁OLDP![O&V̛8~tvX6F^?Ŷaw%9j*,0Bf&2WޟzwfC1BQv'~Rv_ԿPsi^Y]q[%^ /rj L| Q2qF%F8WVrj粆3G'[ҙnzq Q?} X;^#hs:KQy>GP9 BOP 2)|9z(:ŏd;U>: T\Srbn'8Ƭ 6 `ͦhT@4ar kVW vx-^ tg+"^vtDe]o<^<^!)S>ɜs?{qx˾cj(x"Uγ{' X0id6ڽT*0Ye&Gz3DMB"K3I&i/q'5-kH-R4ґhI}l9j}W.I̲2CLǶk .XBKj K*SB'l({35E*ƅz`ŋ9sYجs0WE=7WDn?3`  !">\чP/6_fw5V5bce8L{Կ A'P$vVf% .sak$$6c$u ^cQio1:~vYEY)>]dS|MeӍTb8e:8f3/xTFO_2aIwmv)3HznDhfâ`[J+-}duD Oп"O񞒛R* k`p?V!LR Ƥ_FwTGԥ:,nYyHܓg"uVxFwTH\&0՝ b/ToE>G6U[ \|>/ProcSet[/PDF/Text/ImageB/ImageC]/XObject<>>>/Rotate 0/Type/Page>> endobj 2 0 obj <>stream q 595.1999969 0 0 840.9600067 0 0 cm /Im0 Do Q q 595.1999969 0 0 840.9600067 0 0 cm /Im1 Do Q q 13.4400024 0 0 11.5200043 225.1199951 59.0399933 cm /Im2 Do Q BT /Suspect <>BDC 0.188 g /T1_0 1 Tf 0.0261 Tc 3 Tr 8.8 0 0 8.8 62.3 771.12 Tm (930 )Tj EMC ET BT /T1_0 1 Tf 0.0274 Tc 7.9001 0 0 7.9001 252.45 770.65 Tm (M.B. )Tj 0.0133 Tc 2.797 0 Td (ALLEN, )Tj 0.0023 Tc 4.19 0 Td (K. )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0188 Tc 7.9001 0 0 7.9001 320.1302 770.65 Tm (PROWSE )Tj EMC /Suspect <>BDC /T1_1 1 Tf 0.005 Tc 9 0 0 9 62.34 746.17 Tm (Table )Tj EMC ET BT /T1_1 1 Tf -0.035 Tc 8.1087 0 0 9 89.5 746.17 Tm (1. )Tj 0 Tc 9 0 0 9 99.76 746.17 Tm (-)Tj ET BT /Suspect <>BDC /T1_1 1 Tf -0.0069 Tc 9 0 0 9 109.309 746.17 Tm (Clinical )Tj EMC ET BT /T1_1 1 Tf 0.0127 Tc 9 0 0 9 141.511 746.17 Tm (details )Tj -0.012 Tc 3.361 0 Td (of )Tj 0.0026 Tc 1.231 0 Td (the )Tj -0.0231 Tc 1.816 0 Td (five )Tj -0.0078 Tc 1.957 0 Td (patients )Tj -0.0046 Tc 3.912 0 Td (with )Tj -0.0064 Tc 2.168 0 Td (bacteraem)Tj 0.063 0.067 0.063 rg 0 Tc 4.747 0 Td (i)Tj 0.188 g 0.221 0 Td (c )Tj /T1_2 1 Tf 0.0211 Tc 8.6 0 0 8.6 324.88 746.17 Tm (haemophilus )Tj /T1_1 1 Tf -0.0011 Tc 9 0 0 9 378.55 746.17 Tm (pneumonia )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0222 Tc 8.8 0 0 8.8 62.36 722.17 Tm (Patient )Tj EMC ET BT /T1_0 1 Tf 0.0003 Tc 8.8 0 0 8.8 90.7576 722.17 Tm (No. )Tj 0 Tc 9 0 0 9 168.65 721.68 Tm (1 )Tj 9.3 0 0 9.3 238.03 721.68 Tm (2 )Tj 0.0041 Tc 8.8 0 0 8.8 62.24 702.48 Tm (Sex )Tj /T1_1 1 Tf 0 Tc 9.1 0 0 9.1 167.78 702 Tm (F )Tj 7.701 -0.052 Td (F )Tj /T1_0 1 Tf 0.0431 Tc 8.8 0 0 8.8 61.9 682.8 Tm (Age )Tj 0.05 Tc 8.8142 0 0 8.8 167.48 682.33 Tm (46 )Tj -0.035 Tc 8.6772 0 0 8.8 237.97 681.85 Tm (69 )Tj 0.0175 Tc 8.8 0 0 8.8 61.76 663.12 Tm (Symptoms )Tj 0.019 Tc 11.959 -0.108 Td (Breathless )Tj 0.0207 Tc 8.012 0 Td (Cough )Tj 0.0411 Tc -7.958 -1.092 Td (Rt )Tj 0.0148 Tc 1.369 0 Td (pleuritic )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0094 Tc 8.8 0 0 8.8 237.5488 652.56 Tm (Purulent )Tj EMC ET BT /T1_0 1 Tf 0.009 Tc 8.8 0 0 8.8 271.068 652.56 Tm (sp)Tj 0.286 0.286 0.282 rg 0 Tc 0.886 0 Td (u)Tj 0.188 g 0.0151 Tc 0.543 0 Td (tum )Tj 0.0366 Tc 8.7 0 0 8.7 167.53 642.48 Tm (pain )Tj 0.0122 Tc 8.8 0 0 8.8 61.76 623.29 Tm (Signs )Tj 0.0411 Tc 12.014 -0.056 Td (Rt )Tj 0.0068 Tc 1.369 0 Td (bronchial )Tj 0.0411 Tc 6.54 0 Td (Rt )Tj 0.0137 Tc 1.315 0 Td (bronchial )Tj 0.0068 Tc -9.218 -1.09 Td (breathing )Tj 7.909 -0.055 Td (breathing )Tj 0.0051 Tc -19.972 -2.182 Td (Initial )Tj 0.0195 Tc 2.79 0 Td (blood )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0152 Tc 8.8 0 0 8.8 167.7032 593.0356 Tm (160/90 )Tj EMC /Suspect <>BDC -0.035 Tc 9.6737 0 0 9.8 237.26 593.05 Tm (100/60 )Tj EMC ET BT /T1_0 1 Tf 0.0165 Tc 8.8 0 0 8.8 60.97 583.92 Tm (pressure )Tj 0.023 Tc -0.011 -2.236 Td (Chest )Tj 0 Tc 2.682 0 Td (X)Tj 0.063 0.067 0.063 rg 0.808 0 Td (-)Tj 0.188 g 0.0167 Tc 0.283 0 Td (ray )Tj 0.0411 Tc 8.288 -0.055 Td (Rt )Tj 0.0078 Tc 1.36 0 Td (lower )Tj 0.0317 Tc 2.673 0 Td (lobe )Tj 0.0411 Tc 3.876 0 Td (Rt )Tj 0.0078 Tc 1.36 0 Td (lower )Tj 0.0317 Tc 2.673 0 Td (lobe )Tj 0.0122 Tc -12.002 -1.145 Td (consolidation )Tj 0.0076 Tc 7.964 0 Td (consolidation )Tj 0.0204 Tc 0 -1.144 TD (and )Tj 0.0103 Tc 1.855 0 Td (effusion )Tj 0.016 Tc -21.864 -2.182 Td (Underlying )Tj 0.0104 Tc 5.072 0 Td (medical )Tj 0.05 Tc 8.7206 0 0 8.7 166.12 523.92 Tm (Nil )Tj -0.0108 Tc 8.8 0 0 8.8 236.2 523.92 Tm (Nil )Tj 0.0202 Tc -19.967 -1.036 Td (probl)Tj 0.286 0.286 0.282 rg 0 Tc 2.17 0 Td (e)Tj 0.188 g (m )Tj -2.176 -3.381 Td (F)Tj 0.286 0.286 0.282 rg 0.597 0 Td (i)Tj 0.188 g 0.0189 Tc 0.225 0 Td (nal )Tj 0.021 Tc 1.628 0 Td (outcome )Tj 0.0101 Tc 9.551 -0.056 Td (Well )Tj 7.964 0 Td (Well )Tj 0 Tc 10 0 0 10 60.01 439.44 Tm (b)Tj 0.286 0.286 0.282 rg 0.516 0 Td (e)Tj 0.188 g 0.0176 Tc 0.435 0 Td (ing )Tj 0.0016 Tc 1.77 0 Td (substituted )Tj 0.0074 Tc 4.851 0 Td (for )Tj 0.0048 Tc 1.633 0 Td (ampicillin )Tj -0.0162 Tc 4.617 0 Td (when )Tj -0.0028 Tc 2.675 0 Td (sensitivities )Tj ET BT /Suspect <>BDC /C0_0 1 Tf 0 Tc 4.3201 0 0 7.68 276.49 439.44 Tm <00620065007E0020>Tj EMC ET BT /T1_0 1 Tf 0.0087 Tc 10 0 0 10 59.9 428.89 Tm (came )Tj -0.0002 Tc 2.448 0 Td (available. )Tj 0.0124 Tc 4.518 0 Td (Patient )Tj -0.016 Tc 3.464 0 Td (No. )Tj 0 Tc 1.814 0 Td (2 )Tj 0.0172 Tc 1.157 0 Td (was )Tj /T1_1 1 Tf 0.05 Tc 11.2436 0 0 9.7 216.26 428.89 Tm (ill )Tj /T1_0 1 Tf 0.004 Tc 10 0 0 10 231.26 428.89 Tm (and )Tj 0.0002 Tc 2.064 0 Td (clinically )Tj 0.286 0.286 0.282 rg 0 Tc -19.204 -1.105 Td (s)Tj 0.188 g -0.01 Tc 0.397 0 Td (hocked )Tj 0.0284 Tc 3.063 0 Td (on )Tj -0.0021 Tc 1.2 0 Td (admission. )Tj 0.0063 Tc 4.565 0 Td (Despite )Tj -0.0086 Tc 3.309 0 Td (intravenous )Tj -0.035 Tc 9.9774 0 0 10 233.18 417.84 Tm (ampicil1in )Tj 0.004 Tc 10 0 0 10 275.42 417.84 Tm (and )Tj 0.0035 Tc -21.601 -1.056 Td (fluid )Tj 0.0065 Tc 2.218 0 Td (replacement )Tj -0.0054 Tc 5.315 0 Td (she )Tj -0.0072 Tc 1.683 0 Td (failed )Tj -0.0067 Tc 2.649 0 Td (to )Tj -0.0017 Tc 1.146 0 Td (improve, )Tj -0.007 Tc 3.935 0 Td (developing )Tj -0.0199 Tc 5.087 0 Td (an )Tj 0.0041 Tc -22.033 -1.103 Td (empyema )Tj -0.0094 Tc 4.57 0 Td (which )Tj 0.0045 Tc 3.024 0 Td (required )Tj 0.0034 Tc 3.971 0 Td (surgica)Tj 0.063 0.067 0.063 rg 0 Tc 2.934 0 Td (l )Tj 0.188 g -0.004 Tc 0.863 0 Td (drainage. )Tj 0 Tc 4.279 0 Td (A )Tj -0.0046 Tc 1.347 0 Td (beta\255)Tj 0.002 Tc -20.985 -1.104 Td (lactamase )Tj 0.0045 Tc 4.618 0 Td (producing )Tj /T1_2 1 Tf 0 Tc 9.4 0 0 9.4 149.65 385.21 Tm (H)Tj 0.286 0.286 0.282 rg 0.812 0 Td (. )Tj 0.188 g /T1_3 1 Tf -0.0257 Tc 10.7 0 0 10.7 162.59 385.21 Tm (inf/uenzae )Tj /T1_0 1 Tf -0.0068 Tc 10 0 0 10 210.23 385.21 Tm (was )Tj 0.0043 Tc 2.201 0 Td (isolated )Tj -0.0301 Tc 3.741 0 Td (from )Tj 0.0011 Tc -21.015 -1.056 Td (venous )Tj 0.0053 Tc 3.171 0 Td (blood, )Tj 0.0021 Tc 2.913 0 Td (sputum )Tj 0.004 Tc 3.316 0 Td (and )Tj 0.0152 Tc 1.832 0 Td (the )Tj 0.0007 Tc 1.54 0 Td (pus. )Tj 0.0077 Tc 2.004 0 Td (Oral )Tj 0.0054 Tc 2.112 0 Td (co-trimoxazole )Tj -0.0068 Tc -16.887 -1.104 Td (was )Tj 0.0085 Tc 1.907 0 Td (started )Tj 0.004 Tc 3.028 0 Td (and )Tj 0.0117 Tc 1.836 0 Td (produced )Tj 0 Tc 4.164 0 Td (a )Tj 0.0028 Tc 0.777 0 Td (rapid )Tj 0.0016 Tc 2.439 0 Td (clinical )Tj -0.0063 Tc 3.321 0 Td (response. )Tj 0.0209 Tc 9.9 0 0 9.9 151.63 334.33 Tm (Discussion )Tj 0.05 Tc 10.0747 0 0 10 67.65 309.84 Tm (We )Tj -0.0034 Tc 10 0 0 10 84.95 309.84 Tm (have )Tj 0.0045 Tc 2.208 0 Td (reported )Tj -0.0088 Tc 3.743 0 Td (the )Tj 0.0084 Tc 1.48 0 Td (clinical )Tj -0.0017 Tc 3.311 0 Td (features )Tj 0.05 Tc 10.0163 0 0 10 227.42 309.84 Tm (of )Tj -0.0121 Tc 10 0 0 10 238.93 309.84 Tm (five )Tj -0.0036 Tc 1.885 0 Td (patients )Tj 0.0015 Tc -19.923 -1.103 Td (with )Tj 0.0036 Tc 2.21 0 Td (bacteraemic )Tj /T1_3 1 Tf -0.0295 Tc 10.7 0 0 10.7 133.05 298.81 Tm (Haemophilus )Tj /T1_0 1 Tf 0.0041 Tc 10 0 0 10 191.06 298.81 Tm (pneumonia )Tj 0.0068 Tc 4.836 0 Td (over )Tj 0 Tc 2.16 0 Td (a )Tj -0.0083 Tc 0.863 0 Td (five\255)Tj 0.0201 Tc -21.11 -1.105 Td (year )Tj -0.0017 Tc 2.067 0 Td (period. )Tj 0.0477 Tc 3.061 0 Td (The )Tj 0.0062 Tc 1.928 0 Td (retrospective )Tj 0.0007 Tc 5.52 0 Td (nature )Tj 0.05 Tc 10.5727 0 0 10 212.06 287.76 Tm (of )Tj -0.0088 Tc 10 0 0 10 224.14 287.76 Tm (the )Tj 0.0048 Tc 1.476 0 Td (study )Tj -0.0064 Tc 2.502 0 Td (leaves )Tj 0.0049 Tc -20.55 -1.055 Td (several )Tj 0.0012 Tc 3.172 0 Td (aspects )Tj 0.0151 Tc 3.168 0 Td (open )Tj -0.0067 Tc 2.36 0 Td (to )Tj -0.0021 Tc 1.048 0 Td (criticism)Tj 0.286 0.286 0.282 rg 0 Tc 3.546 0 Td (, )Tj 0.188 g 0.003 Tc 0.536 0 Td (includ)Tj 0.286 0.286 0.282 rg 0 Tc 2.496 0 Td (i)Tj 0.188 g 0.0113 Tc 0.295 0 Td (ng )Tj -0.0088 Tc 1.343 0 Td (the )Tj -0.0051 Tc 1.488 0 Td (variation )Tj -0.035 Tc 9.9195 0 0 10 58.48 266.16 Tm (in )Tj -0.0051 Tc 10 0 0 10 71.03 266.16 Tm (numbers )Tj 0.05 Tc 10.5727 0 0 10 107.42 266.16 Tm (of )Tj -0.0028 Tc 10 0 0 10 118.57 266.16 Tm (blood )Tj -0.0031 Tc 2.725 0 Td [(cultures )-224(performed )]TJ 0.004 Tc 8.208 0 Td (and )Tj -0.0088 Tc 1.736 0 Td (the )Tj 0.0076 Tc 1.384 0 Td (amount )Tj 0.05 Tc 10.5727 0 0 10 58.46 255.13 Tm (of )Tj -0.0045 Tc 10 0 0 10 70.48 255.13 Tm (information )Tj 0.0013 Tc 5.047 0 Td (recorded )Tj -0.035 Tc 9.9195 0 0 10 159.76 255.13 Tm (in )Tj -0.0088 Tc 10 0 0 10 170.86 255.13 Tm (the )Tj 0.01 Tc 1.528 0 Td (case )Tj -0.0007 Tc 2.073 0 Td (notes. )Tj -0.0088 Tc 2.732 0 Td [(However, )-141(the )]TJ 0.0054 Tc -17.612 -1.104 Td (results )Tj 0.0105 Tc 3.312 0 Td (were )Tj -0.0141 Tc 2.582 0 Td (from )Tj 0.0327 Tc 2.593 0 Td (one )Tj 0.0088 Tc 2.114 0 Td (large )Tj 0.0013 Tc 2.695 0 Td (hospital )Tj -0.0145 Tc 3.504 0 Td (with )Tj 0 Tc 2.391 0 Td (a )Tj -0.0013 Tc 1.104 0 Td (central )Tj 0.0008 Tc -20.293 -1.057 Td (bacteriology )Tj 0.0041 Tc 5.751 0 Td (laboratory )Tj 0.028 Tc 4.798 0 Td (and )Tj 0.02 Tc 2.16 0 Td (are )Tj 0.05 Tc 10.0163 0 0 10 204.86 233.52 Tm (of )Tj 0.0076 Tc 10 0 0 10 220.24 233.52 Tm (interest )Tj 0.0028 Tc 3.657 0 Td (because )Tj 0.0118 Tc -19.881 -1.103 Td (little )Tj 0.0003 Tc 2.208 0 Td (information )Tj 0.0284 Tc 5.038 0 Td (on )Tj 0.0036 Tc 1.355 0 Td (bacteraemic )Tj /T1_3 1 Tf -0.034 Tc 10.7 0 0 10.7 195.93 222.49 Tm (Haemophilus )Tj /T1_0 1 Tf 0.0013 Tc 10 0 0 10 252.5 222.49 Tm (pneumo\255)Tj -0.0083 Tc -19.443 -1.056 Td (nia )Tj -0.0259 Tc 1.625 0 Td (is )Tj 0.007 Tc 1.006 0 Td (available )Tj -0.035 Tc 9.9195 0 0 10 124.72 211.93 Tm (in )Tj 0.0054 Tc 10 0 0 10 136.28 211.93 Tm (Britain )Tj -0.0122 Tc 3.196 0 Td ([4\). )Tj 0.0033 Tc -10.157 -1.104 Td (During )Tj -0.0088 Tc 3.315 0 Td (the )Tj 0.0124 Tc 1.62 0 Td (same )Tj 0.0096 Tc 2.464 0 Td (period )Tj 0 Tc 3.012 0 Td (a )Tj 0.0011 Tc 0.872 0 Td (total )Tj 0.05 Tc 10.5727 0 0 10 201.5 200.89 Tm (of )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0356 Tc 10 0 0 10 213.9 200.89 Tm (820 )Tj EMC ET BT /T1_0 1 Tf 0.0033 Tc 10 0 0 10 233.3 200.89 Tm (patients )Tj -0.0055 Tc 3.549 0 Td (were )Tj 0.0099 Tc -21.129 -1.104 Td (admitted )Tj 0.0015 Tc 3.945 0 Td (with )Tj 0.0053 Tc 2.631 0 Td (confirmed )Tj 0.05 Tc 10.0163 0 0 10 173.18 189.85 Tm (or )Tj 0.0024 Tc 10 0 0 10 190.1 189.85 Tm (probable )Tj 0.0032 Tc 4.309 0 Td (diagnosis )Tj 0.05 Tc 10.5727 0 0 10 279.26 189.85 Tm (of )Tj 0.0037 Tc 10 0 0 10 57.61 178.8 Tm (bacterial )Tj 0.0101 Tc 4.033 0 Td (pneumonia )Tj 0.05 Tc 10.0163 0 0 10 148.7 178.8 Tm (of )Tj -0.0094 Tc 10 0 0 10 163.19 178.8 Tm (which )Tj 0.0233 Tc 2.973 0 Td (49 )Tj -0.02 Tc 1.624 0 Td (\(6%\) )Tj -0.0055 Tc 2.555 0 Td (were )Tj 0.003 Tc 2.536 0 Td (due )Tj -0.0067 Tc 2.023 0 Td (to )Tj /T1_3 1 Tf -0.034 Tc 10.7 0 0 10.7 57.69 167.76 Tm (Haemophilus )Tj /T1_0 1 Tf -0.0099 Tc 10 0 0 10 115.54 167.76 Tm (spp. )Tj 0.0043 Tc 2.07 0 Td (isolated )Tj 0.0284 Tc 3.55 0 Td (on )Tj -0.0075 Tc 1.484 0 Td (sputum )Tj 0.003 Tc 3.364 0 Td (culture, )Tj 0 Tc 3.456 0 Td (a )Tj -0.001 Tc 0.911 0 Td (figure )Tj 0.0026 Tc -20.63 -1.055 Td (which )Tj 0.0053 Tc 2.967 0 Td (accords )Tj 0.0015 Tc 3.609 0 Td (with )Tj 0.0198 Tc 2.295 0 Td (other )Tj 0.0016 Tc 2.601 0 Td (reports )Tj 0.0042 Tc 3.337 0 Td ([5, )Tj -0.0012 Tc 1.596 0 Td (6]. )Tj -0.0022 Tc 1.64 0 Td (Bacteraemic )Tj /T1_3 1 Tf -0.0295 Tc 10.7 0 0 10.7 57.21 146.16 Tm (Haemophilus )Tj /T1_0 1 Tf 0.0041 Tc 10 0 0 10 115.22 146.16 Tm (pneumonia )Tj 0.0221 Tc 4.886 0 Td (is )Tj -0.0046 Tc 1.112 0 Td (uncommon )Tj 0.0143 Tc 4.897 0 Td (but )Tj -0.0259 Tc 1.719 0 Td (is )Tj -0.0057 Tc 1.066 0 Td (probably )Tj 0.0033 Tc -19.442 -1.103 Td (underestimated )Tj 0.0108 Tc 6.769 0 Td (because )Tj 0.05 Tc 10.5727 0 0 10 164.06 135.13 Tm (of )Tj 0.0085 Tc 10 0 0 10 179.06 135.13 Tm (prior )Tj -0.0018 Tc 2.628 0 Td (antibiotic )Tj 0.003 Tc 4.472 0 Td (treatment )Tj 0.0196 Tc -19.304 -1.105 Td (and/or )Tj 0.0025 Tc 2.831 0 Td (failure )Tj -0.0067 Tc 2.889 0 Td (to )Tj 0.001 Tc 1.06 0 Td (perform )Tj 0.0092 Tc 3.503 0 Td (blood )Tj 0.0037 Tc 2.581 0 Td (cultures)Tj 0.063 0.067 0.063 rg 0 Tc 3.205 0 Td (. )Tj 0.188 g 0.0063 Tc 0.448 0 Td (Relaxing )Tj -0.0088 Tc 3.939 0 Td (the )Tj 0.0015 Tc 1.433 0 Td (di\255)Tj -0.0008 Tc -21.889 -1.104 Td (agnostic )Tj 0.0106 Tc 3.6 0 Td (criteria )Tj 0.0176 Tc 3.131 0 Td (by )Tj 0.0048 Tc 1.335 0 Td (identifying )Tj 0 Tc 4.654 0 Td (a )Tj 0.003 Tc 0.78 0 Td (pure )Tj 0.0029 Tc 2.054 0 Td (growth )Tj 0.05 Tc 10.5727 0 0 10 243.74 113.04 Tm (of )Tj ET BT /Suspect <>BDC /T1_3 1 Tf 0.0071 Tc 10.7 0 0 10.7 254.97 113.04 Tm (Hamw\255)Tj EMC ET BT /T1_3 1 Tf -0.0091 Tc 10.7 0 0 10.7 56.0356 101.9976 Tm (philus )Tj /T1_0 1 Tf -0.0141 Tc 10 0 0 10 84.85 102 Tm (from )Tj 0.0016 Tc 2.313 0 Td (tracheal )Tj 0.0086 Tc 3.496 0 Td (aspirates )Tj 0.0047 Tc 3.897 0 Td (rather )Tj -0.0126 Tc 2.735 0 Td (than )Tj -0.0028 Tc 2.019 0 Td (blood )Tj -0.0031 Tc 2.629 0 Td (cultures )Tj 0.0065 Tc -19.918 -1.104 Td (increases )Tj 0.0152 Tc 4.23 0 Td (the )Tj 0.0141 Tc 1.777 0 Td (number )Tj 0.05 Tc 10.5727 0 0 10 152.54 90.96 Tm (of )Tj 0.0063 Tc 10 0 0 10 166.46 90.96 Tm (cases )Tj 0.0045 Tc 2.649 0 Td (reported )Tj 0.004 Tc 3.879 0 Td (and )Tj -0.0057 Tc 1.98 0 Td (probably )Tj 0 Tc 8.8 0 0 8.8 313.82 721.21 Tm (3 )Tj 8.898 0 Td (4 )Tj /T1_3 1 Tf 10 0 0 10 476.06 720.24 Tm (5 )Tj /T1_0 1 Tf 8.8 0 0 8.8 313.88 701.53 Tm (M )Tj /T1_1 1 Tf 9.4 0 0 9.4 391.96 701.05 Tm (M )Tj 9.1 0 0 9.1 475.94 701.05 Tm (F )Tj /T1_0 1 Tf 0.0064 Tc 8.8 0 0 8.8 313.83 681.85 Tm (73 )Tj 0.05 Tc 9.3623 0 0 8.8 392.06 681.85 Tm (74 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.035 Tc 9.8076 0 0 10.5 475.99 680.89 Tm (80 )Tj EMC ET BT /T1_0 1 Tf 0.0344 Tc 8.8 0 0 8.8 313.35 661.68 Tm (Cough )Tj 0.019 Tc 8.897 0 Td (Breathless )Tj 0.025 Tc 9.491 -0.053 Td (Breathless )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0172 Tc 8.8 0 0 8.8 313.8868 652.0968 Tm (Purulent )Tj EMC ET BT /T1_0 1 Tf 0.0055 Tc 8.8 0 0 8.8 347.406 652.0968 Tm (sputum )Tj 0.0172 Tc 5.082 0 Td (Purulent )Tj 0.0165 Tc 3.864 0 Td (sputum )Tj 0.0182 Tc -12.815 -3.382 Td (Crackles )Tj 0.05 Tc 8.8241 0 0 8.8 347.95 622.33 Tm (Lt )Tj 0.0175 Tc 8.8 0 0 8.8 359.52 622.33 Tm (upper )Tj 0.0182 Tc 3.644 0 Td (Crackles )Tj 0.0411 Tc 3.987 0 Td (Rt )Tj 0.0007 Tc 1.369 0 Td (base, )Tj 0.0182 Tc 4.243 -0.055 Td (Crackles )Tj 0.0109 Tc 3.939 0 Td (both )Tj 0.0113 Tc -22.425 -1.036 Td (zone )Tj -0.002 Tc 8.945 -0.056 Td (Lt )Tj 0.0161 Tc 1.258 0 Td (mid )Tj 0.0295 Tc 1.96 0 Td (zone )Tj 0.0205 Tc 6.443 -0.055 Td (bases )Tj 0.0411 Tc 2.558 0 Td (Rt )Tj 0.05 Tc 8.8241 0 0 8.8 510.19 611.76 Tm (Lt )Tj 0.007 Tc 8.8 0 0 8.8 313.43 592.56 Tm (Unrecordable )Tj ET BT /Suspect <>BDC /T1_2 1 Tf 0.0193 Tc 7.9001 0 0 7.9001 391.53 593.05 Tm (90{70 )Tj EMC /Suspect <>BDC /T1_0 1 Tf 0.0259 Tc 8.8 0 0 8.8 475.05 592.09 Tm (80/46 )Tj EMC ET BT /T1_0 1 Tf 0.0142 Tc 8.8 0 0 8.8 312.9364 563.2876 Tm (Apical )Tj 0.05 Tc 8.8241 0 0 8.8 340.27 563.29 Tm (Lt )Tj 0.0214 Tc 8.8 0 0 8.8 351.29 563.29 Tm (lower )Tj 0.0411 Tc 4.585 0 Td (Rt )Tj 0.0214 Tc 1.306 0 Td (lower )Tj 0.0136 Tc 2.727 0 Td (lobe )Tj 0.0164 Tc 5.567 -0.056 Td (Bilateral )Tj 0.0256 Tc 3.769 0 Td (patchy )Tj 0.0136 Tc -22.318 -1.09 Td (lobe )Tj 0.0122 Tc 2.125 0 Td (consolidation )Tj 0.0167 Tc 6.764 0 Td (consolidation )Tj 0.0213 Tc 9.491 -0.055 Td (consolidation )Tj 0.0432 Tc 0.006 -1.092 Td (Rt>Lt )Tj 0.0286 Tc -18.436 -2.182 Td (Mild )Tj 0.0131 Tc 2.394 0 Td (chronic )Tj 0.05 Tc 8.7206 0 0 8.7 390.76 523.44 Tm (Nil )Tj 0.0101 Tc 8.8 0 0 8.8 476.15 523.44 Tm (Urinary )Tj 0.021 Tc 3.435 0 Td (tract )Tj 0.0163 Tc -22.043 -1.09 Td (obstructive )Tj 0.0187 Tc 18.437 -0.056 Td (infections )Tj 0.0117 Tc -18.437 -1.035 Td (disease )Tj 0.005 -2.291 Td (Delayed )Tj 0.0202 Tc 3.758 0 Td (CXR )Tj 0.0283 Tc 5.134 0 Td (Well )Tj 0.0309 Tc 9.544 -0.055 Td (Died )Tj 0 Tc 2.284 0 Td (3 )Tj 0.0105 Tc 0.82 0 Td (days )Tj 0.0242 Tc 2.183 0 Td (later )Tj 0.0045 Tc -23.72 -1.036 Td (resolution )Tj 0.003 Tc 10 0 0 10 310.94 440.41 Tm (comes )Tj 0.007 Tc 2.928 0 Td (closer )Tj -0.0067 Tc 2.792 0 Td (to )Tj 0.0152 Tc 1.104 0 Td (the )Tj -0.0049 Tc 1.632 0 Td (true )Tj 0.0038 Tc 1.914 0 Td (incidence )Tj -0.0122 Tc 4.256 0 Td ([7]. )Tj 0.003 Tc -13.756 -1.104 Td (Previous )Tj 0.0016 Tc 3.987 0 Td (reports )Tj 0.05 Tc 10.5727 0 0 10 392.54 429.37 Tm (of )Tj 0.0036 Tc 10 0 0 10 405.61 429.37 Tm (bacteraemic )Tj /T1_3 1 Tf -0.0295 Tc 10.7 0 0 10.7 458.97 429.37 Tm (Haemophilus )Tj /T1_0 1 Tf 0.0093 Tc 10 0 0 10 517.46 429.37 Tm (pneu\255)Tj 0.0009 Tc -20.644 -1.104 Td (monia )Tj -0.0301 Tc 2.871 0 Td (from )Tj -0.007 Tc 2.271 0 Td (North )Tj 0.012 Tc 2.682 0 Td (America )Tj 0.0165 Tc 3.828 0 Td (suggest )Tj 0.0281 Tc 3.364 0 Td (an )Tj -0.0011 Tc 1.344 0 Td (association )Tj -0.0145 Tc 4.857 0 Td (with )Tj 0.008 Tc -21.273 -1.057 Td [(chronic )-383(chest )]TJ 0.0061 Tc 6.385 0 Td (disease, )Tj 0.0034 Tc 3.839 0 Td (alcoholism, )Tj 0.0001 Tc 5.377 0 Td (diabetes )Tj -0.0008 Tc 3.943 0 Td (mellitus, )Tj 0.0003 Tc -19.487 -1.104 Td (hypogammaglobulinaemia )Tj 0.004 Tc 11.271 0 Td (and )Tj 0.0011 Tc 2.066 0 Td (immunosuppression. )Tj /T1_1 1 Tf 0.05 Tc 12.2371 0 0 9.7 533.9 396.72 Tm (It )Tj /T1_0 1 Tf 0.0105 Tc 10 0 0 10 310.46 386.16 Tm (occurs )Tj 0.0032 Tc 3.036 0 Td (predominantly )Tj -0.035 Tc 9.9195 0 0 10 403.6 386.16 Tm (in )Tj 0.0152 Tc 10 0 0 10 415.18 386.16 Tm (the )Tj 0.0083 Tc 1.633 0 Td (right )Tj 0.0131 Tc 2.297 0 Td (lung, )Tj -0.016 Tc 2.455 0 Td (has )Tj -0.0088 Tc 1.775 0 Td (the )Tj -0.0126 Tc 1.632 0 Td (type )Tj 0 Tc 2.062 0 Td (B )Tj 0.0082 Tc -22.326 -1.104 Td (capsule )Tj -0.02 Tc 3.36 0 Td (and )Tj -0.0259 Tc 1.778 0 Td (is )Tj 0.0039 Tc 0.958 0 Td (associated )Tj -0.0145 Tc 4.473 0 Td (with )Tj 0 Tc 2.055 0 Td (a )Tj 0.016 Tc 0.78 0 Td (poor )Tj 0.0011 Tc 2.16 0 Td (prognosis )Tj -0.0198 Tc 4.246 0 Td ([2, )Tj 0.0069 Tc 1.356 0 Td (3, )Tj 0.0426 Tc 1.057 0 Td (7, )Tj -0.0199 Tc -22.183 -1.103 Td (8\). )Tj 0.0237 Tc 1.305 0 Td (The )Tj 0.0033 Tc 1.835 0 Td (patients )Tj -0.035 Tc 9.9195 0 0 10 376.24 364.09 Tm (in )Tj 0.0157 Tc 10 0 0 10 386.3 364.09 Tm (our )Tj 0.0111 Tc 1.58 0 Td (series )Tj 0.0105 Tc 2.557 0 Td (were )Tj 0.0198 Tc 2.199 0 Td (older )Tj 0.0143 Tc 2.363 0 Td (but )Tj 0.0112 Tc 1.534 0 Td (not )Tj 0 Tc 1.529 0 Td (immuno\255)Tj 0.0005 Tc -19.346 -1.104 Td (compromised )Tj -0.02 Tc 5.76 0 Td (and )Tj 0.0065 Tc 1.728 0 Td (only )Tj 0.0087 Tc 2.064 0 Td (one )Tj 0.0005 Tc 1.737 0 Td (had )Tj 0.0043 Tc 1.729 0 Td (underlying )Tj 0 Tc 4.646 0 Td (chronic )Tj 0.008 Tc 3.264 0 Td (chest )Tj -0.0007 Tc -20.927 -1.056 Td (disease. )Tj 0.0026 Tc 0.917 -1.105 Td (Bacteraemic )Tj /T1_3 1 Tf -0.034 Tc 10.7 0 0 10.7 372.09 331.44 Tm (Haemophilus )Tj /T1_0 1 Tf 0.0041 Tc 10 0 0 10 429.14 331.44 Tm (pneumonia )Tj -0.002 Tc 4.74 0 Td (caused )Tj 0.0176 Tc 3.035 0 Td (by )Tj -0.007 Tc 1.297 0 Td (peni\255)Tj 0.0008 Tc -20.94 -1.103 Td (cillinase )Tj -0.0015 Tc 3.756 0 Td (producing )Tj 0.0115 Tc 4.448 0 Td (species )Tj 0.0221 Tc 3.318 0 Td (is )Tj 0.0108 Tc 1.063 0 Td (rare )Tj -0.035 Tc 9.9195 0 0 10 456.4 320.41 Tm (in )Tj 0.005 Tc 10 0 0 10 467.9 320.41 Tm (adults )Tj -0.0282 Tc 2.866 0 Td ([9]. )Tj -0.0023 Tc 1.793 0 Td (In )Tj 0.0157 Tc 1.245 0 Td (our )Tj 0.0015 Tc -21.652 -1.104 Td (series )Tj -0.0043 Tc 2.892 0 Td (two )Tj 0.0033 Tc 2.116 0 Td (patients )Tj 0.0005 Tc 3.693 0 Td (had )Tj 0.006 Tc 2.066 0 Td (beta-lactamase )Tj 0.0045 Tc 6.577 0 Td (producing )Tj /T1_2 1 Tf 0 Tc 9.8 0 0 9.8 530.28 309.37 Tm (H)Tj 0.063 0.067 0.063 rg 0.78 0 Td (. )Tj 0.188 g /T1_3 1 Tf -0.0257 Tc 10.7 0 0 10.7 309.95 298.81 Tm (inf/uenzae )Tj /T1_0 1 Tf 0.004 Tc 10 0 0 10 355.19 298.81 Tm (resistant )Tj 0.0413 Tc 3.695 0 Td (to )Tj -0.0015 Tc 1.192 0 Td (ampicillin. )Tj 0.0341 Tc -8.49 -1.105 Td (For )Tj 0.0127 Tc 1.926 0 Td (patient )Tj 0.008 Tc 3.266 0 Td (No. )Tj 0 Tc 1.766 0 Td (2 )Tj 0.0152 Tc 1.108 0 Td (the )Tj 0.0015 Tc 1.769 0 Td (delay )Tj -0.035 Tc 9.9195 0 0 10 445.36 287.76 Tm (in )Tj 0.0076 Tc 10 0 0 10 458.74 287.76 Tm (starting )Tj 0.0022 Tc 3.556 0 Td (appropriate )Tj 0.0018 Tc -18.432 -1.055 Td (antibacterial )Tj -0.0029 Tc 5.48 0 Td (therapy )Tj 0.0011 Tc 3.508 0 Td (probably )Tj 0.0216 Tc 4.07 0 Td (led )Tj 0.0413 Tc 1.734 0 Td (to )Tj -0.0088 Tc 1.344 0 Td (the )Tj -0.0017 Tc 1.721 0 Td (deve)Tj 0.286 0.286 0.282 rg 0 Tc 1.921 0 Td (l)Tj 0.188 g 0.0095 Tc 0.238 0 Td (opment )Tj 0.05 Tc 10.5727 0 0 10 309.98 266.16 Tm (of )Tj 0.0281 Tc 10 0 0 10 323.42 266.16 Tm (an )Tj 0.0026 Tc 1.487 0 Td (empy)Tj 0.286 0.286 0.282 rg 0 Tc 2.256 0 Td (e)Tj 0.188 g -0.0156 Tc 0.441 0 Td (ma)Tj 0.286 0.286 0.282 rg 0 Tc 1.229 0 Td (. )Tj 0.188 g -0.0023 Tc 0.782 0 Td (In )Tj -0.0055 Tc 1.397 0 Td (view )Tj 0.05 Tc 10.5727 0 0 10 423.74 266.16 Tm (of )Tj 0.012 Tc 10 0 0 10 437.75 266.16 Tm (her )Tj 0.032 Tc 1.779 0 Td (poor )Tj 0.0016 Tc 2.388 0 Td (clinical )Tj 0.0022 Tc 3.456 0 Td (condi\255)Tj -0.0052 Tc -20.392 -1.103 Td (tion )Tj 0.001 Tc 1.962 0 Td (intravenous )Tj 0.0143 Tc 5.095 0 Td (rather )Tj -0.0126 Tc 2.831 0 Td (than )Tj 0.0011 Tc 2.104 0 Td (oral )Tj 0.0054 Tc 1.968 0 Td (co-trimoxazole )Tj 0.0004 Tc 6.537 0 Td (would )Tj -0.0034 Tc -20.496 -1.104 Td (have )Tj -0.0015 Tc 2.45 0 Td (been )Tj -0.0109 Tc 2.493 0 Td (more )Tj 0.007 Tc 2.584 0 Td (appropriate )Tj -0.0029 Tc 5.192 0 Td (therapy )Tj 0.0118 Tc 3.544 0 Td (along )Tj -0.0145 Tc 2.841 0 Td (with )Tj 0.0021 Tc 2.291 0 Td (sur\255)Tj 0.0107 Tc -21.45 -1.057 Td (gical )Tj 0.002 Tc 2.591 0 Td (drainage. )Tj 0.0033 Tc 4.42 0 Td (During )Tj 0.0152 Tc 3.507 0 Td (the )Tj 0.0124 Tc 1.86 0 Td (same )Tj 0.0096 Tc 2.704 0 Td (period )Tj -0.0002 Tc 3.252 0 Td (about )Tj -0.0168 Tc 2.903 0 Td (11% )Tj 0.05 Tc 10.5727 0 0 10 309.5 222.49 Tm (of )Tj -0.0075 Tc 10 0 0 10 325.3 222.49 Tm (sputum )Tj -0.0004 Tc 3.654 0 Td (isolates )Tj 0.05 Tc 10.5727 0 0 10 398.3 222.49 Tm (of )Tj /T1_2 1 Tf 0 Tc 9.4 0 0 9.4 413.65 222.49 Tm (H)Tj 0.286 0.286 0.282 rg 0.863 0 Td (. )Tj 0.188 g /T1_3 1 Tf -0.0307 Tc 10.7 0 0 10.7 427.55 222.49 Tm (inf/uenzae )Tj /T1_0 1 Tf 0.0049 Tc 10 0 0 10 475.22 222.49 Tm (produced )Tj 0.0074 Tc 4.415 0 Td (beta\255)Tj 0.0007 Tc -20.985 -1.056 Td (lactamase. )Tj 0.016 Tc 0.916 -1.104 Td (Four )Tj 0.0101 Tc 2.214 0 Td (patients )Tj -0.0055 Tc 3.549 0 Td (were )Tj 0.0056 Tc 2.295 0 Td (clinically )Tj 0.0071 Tc 4.13 0 Td (in )Tj 0.0233 Tc 1.146 0 Td (shock )Tj 0.05 Tc 10.1194 0 0 10 479.42 200.89 Tm (at )Tj -0.0023 Tc 10 0 0 10 490.58 200.89 Tm (presentation )Tj 0.004 Tc -18.108 -1.104 Td (and )Tj 0.0028 Tc 2.027 0 Td (because )Tj 0.05 Tc 10.5727 0 0 10 367.1 189.85 Tm (of )Tj 0.0111 Tc 10 0 0 10 381.58 189.85 Tm (their )Tj 0.0085 Tc 2.44 0 Td (age )Tj -0.0235 Tc 2.025 0 Td (had )Tj 0 Tc 1.959 0 Td (a )Tj 0.032 Tc 1.02 0 Td (poor )Tj 0.0071 Tc 2.448 0 Td (prognosis )Tj -0.0282 Tc 4.534 0 Td ([5\). )Tj 0.0049 Tc -21.629 -1.105 Td (However, )Tj 0.01 Tc 4.471 0 Td (prompt )Tj -0.0006 Tc 3.501 0 Td (resuscitation )Tj 0.028 Tc 5.607 0 Td (and )Tj -0.0018 Tc 2.064 0 Td (antibiotic )Tj -0.0109 Tc 4.376 0 Td (therapy )Tj 0.0108 Tc -20.072 -1.104 Td (allowed )Tj 0.0056 Tc 3.656 0 Td (three )Tj -0.035 Tc 9.7344 0 0 10 370.54 167.76 Tm (to )Tj -0.0214 Tc 10 0 0 10 382.57 167.76 Tm (be )Tj 0.0039 Tc 1.334 0 Td (discharged, )Tj 0.0152 Tc 5.095 0 Td (the )Tj -0.0124 Tc 1.671 0 Td (fourth )Tj -0.003 Tc 2.882 0 Td (dying )Tj -0.0064 Tc 2.743 0 Td (three )Tj 0.0163 Tc -21.079 -1.103 Td (days )Tj 0.0046 Tc 2.257 0 Td (later )Tj 0.05 Tc 10.0163 0 0 10 353.18 156.73 Tm (of )Tj 0.006 Tc 10 0 0 10 365.27 156.73 Tm (heart )Tj -0.0062 Tc 2.39 0 Td (failure. )Tj -0.035 Tc 9.8048 0 0 10 318.17 146.16 Tm (In )Tj -0.0002 Tc 10 0 0 10 330.22 146.16 Tm (this )Tj 0.0032 Tc 1.818 0 Td (limited )Tj 0.0062 Tc 3.223 0 Td (retrospective )Tj 0.0048 Tc 5.555 0 Td (study )Tj 0.0394 Tc 2.557 0 Td (we )Tj 0.0032 Tc 1.529 0 Td (identified )Tj 0.0217 Tc 4.173 0 Td (eight )Tj 0.0075 Tc -20.975 -1.103 Td (adult )Tj 0.0033 Tc 2.508 0 Td (patients )Tj 0.0015 Tc 3.597 0 Td (with )Tj /T1_3 1 Tf 0 Tc 10.7 0 0 10.7 393.21 135.13 Tm (H)Tj 0.286 0.286 0.282 rg 0.7 0 Td (. )Tj 0.188 g -0.0257 Tc 0.67 0 Td (influenzae )Tj /T1_0 1 Tf 0.0023 Tc 10 0 0 10 454.57 135.13 Tm (bacteraemia, )Tj -0.0121 Tc 5.604 0 Td (five )Tj 0.05 Tc 10.5727 0 0 10 530.78 135.13 Tm (of )Tj -0.0155 Tc 10 0 0 10 309.11 124.08 Tm (whom )Tj -0.0235 Tc 3.216 0 Td (had )Tj 0.0101 Tc 2.067 0 Td (pneumonia )Tj 0.0284 Tc 5.172 0 Td (on )Tj 0.0084 Tc 1.68 0 Td (clinical )Tj 0.004 Tc 3.648 0 Td (and )Tj -0.0008 Tc 2.169 0 Td (radiographic )Tj 0.002 Tc -18.009 -1.104 Td (criteria. )Tj 0.0009 Tc 3.702 0 Td (Prognosis )Tj 0.0053 Tc 4.506 0 Td (appears )Tj -0.0068 Tc 3.698 0 Td (good, )Tj -0.0145 Tc 2.839 0 Td (with )Tj 0.0016 Tc 2.339 0 Td (seven )Tj 0.0033 Tc 2.848 0 Td (patients )Tj 0.0035 Tc -19.936 -1.104 Td (surviving, )Tj 0.01 Tc 4.565 0 Td (despite )Tj -0.0017 Tc 3.454 0 Td (four )Tj -0.0006 Tc 2.22 0 Td (being )Tj 0.0051 Tc 2.724 0 Td (elderly )Tj 0.004 Tc 3.361 0 Td (and )Tj -0.0043 Tc 2.024 0 Td (two )Tj -0.0056 Tc 2.017 0 Td (having )Tj -0.0005 Tc -20.361 -1.104 Td (ampicillin )Tj 0.004 Tc 4.473 0 Td (resistant )Tj 0.0044 Tc 3.689 0 Td (isolates. )Tj ET endstream endobj 3 0 obj <>stream Hd͊zy8 >sRhF^#y QG#Oç==o/ϧ;c_mӷKv|~_oo~y>}~W=|z>{O݇q~?>Ï?o+~ߒ~;%zΏx߽w;>lp?(O?{wٸ^ PZUuTGu^5P5FjFDMԤU PjVjUmFmک]uPuNNE]E5|| _#_k55|| _#_k55|| _#_k55|| _#_k5Z||-_+_kZ||-_+_kZ||-_+_kZ||-_+_ku:||_'_uu:||_'_uu:||_'_uu:||_'_uz||=_/_z||=_/_z||=_/_z||=_/_ || ߀o77 || ߀o77 || ߀o77 || ߀o77 KG#(~? ?G#(~? ?G#(~? ?G#(~? ?z $߄o77MM&|| $߄o77MM&|| $߄o77MM&|| $߄o77MM&||3,ߌo77f||3,ߌo77f||3,ߌo77f||3,ߌo77f|| "߂oȷ[--|| "߂oȷ[--|| "߂oȷ[--|| "߂oȷ[--||+*ߊoŷʷ[V||+*ߊoŷʷ[V||+*ߊoŷʷ[V||+*ߊoŷʷ[V|| &߆o÷ɷmm6|| &߆o÷ɷmm6|| &߆o÷ɷmm6|| &߆o÷ɷmm6|ۯ\t;]~~߅ww;]~~߅ww;]~~߅ww;]~~߅w߁w;;|C߁w;;|C߁w;;|C߁w;;|C߉w;;NN|'S߉w;;NN|'S߉w;;NN|'S߉w;;NN|'S ߅w]..|K ߅w]..|K ߅w]..|K ߅w]..|?|x>stream jP ftypjp2 jp2 jpxbjpx rreq@ .-jp2hihdrcolrjp2cOQ)R \#B@HHPHHPHHPHHP((( vfPCBA$T Ma]RҾei9z=Qې6N_q`9*YZaV $%O B^ a9TIF@Wa9! Xi Ԙ4Ø = )q #x8NegՔ%}'{u;ZE~HKmԀ (SF,"S74gcSbj+sfbpp>D9 \' Q׼o=$Znѵ8NoN冁&} wd MfL '~i'%sZLLWfw7K'؉^'JG"Ŏh)WVkH4~"BKw` Zy}1Hd.XR2x=f0_ۂ0d]vISޱ/r. - ?470`>q ys@}/ ѷZhHK= `z̟5oh> ҄ `4IQ(q~@ 'UpOpoR >uN44kU>~d\Tu`.[hM:3)hi+('g3tҺ.ݛ<$E[H*%˰6 D󌱗5h`$ us 2!Fcp_7yA-FB )j'Æaz RӘڀ ?S˜`aP.ȟ65~ 6o|0='vҲutf|a}B>H %eMap,tM_+`-g=HC>)tҡ9,MA%NHh&;roxYN#$?4y [@=ZfۖykeI)N3 k~ u1Dcg~lG#P 'bɶW /x=N*)'7Cg$ mV/v c (rpK^Rev[&ܧXp@坾g!vcVj2YdFDxKGFn|7$R}ʼ`$hrIbǢp0k̗p~q9 nTp`a~K7A],)]Osf%5EWgID.V%,`ҋ/OF .2;8^I[g. U_]Ŕ m|vax`5Gvu,Qnh^-%G_gI9fhG>ΠdPMe?`Į>/Z3Tvp)VxS&:~q6E̛!A.Q?Ie~53Q.![t#*@x$nJm\Gv֞p>4D!VsMϹqpqCYݣ9+6QVp,V"6.97edT#Pcʀ?0ˍ %Cc^:h`cxoT^6aQL$b띠 Z5`=Y{mV*A\hm#"ߕbU~*窽hrD۽kb>y1ѐ~/hr& #T*`+,Lv < #wX*B1XBK - 3j &}EwQ޽=lV86 U+ ITO@1cרUVPs9X)ҝPH*yNdGAj}MRU˄N (v 2 R#zc(\\Ԏ]„օc>d I0sgۭlr%徫q|~/s{)НI+=E]O݁4Q=ϞiqDW5Ad]EjճU_6W6Y8Lr}ല"И[MZɯ״16aѠW:|H"m50W?#kT К]c=eJ KVy! +wN(F8a6+i)y R:^"tݾ2 NudhqM?`im֘BX%0`BrDP~ı(1XwO8ITx5Cix7?Y-ل9Y8W6E75%4^C xg#[mwN{CkȚ5M?Ȍ\D0((=qܳ.RyȊRBqLYi@ܙ 3fc߃Ad4;FHR Z=Qx]neu\,wl:+L$u2Jxu֦_2A04mHsͫtڮU3Kqo)&_:/)n.T12@Dx6iT)R,ԳG[abҭĖb8tÈ} c5e.U,HOjt'pK'YVC/xȣ'y>(} UI 4¡aeCr YMKHbL1a7@?4&e.NZx71b >TG@S5.zA$U}`&"aH_8z v4UhN*f}x:~]qlcǼC\㨉ĔJpkwhQiѾm_X&<&VՑa+%$0Z*HgC)8kħwŞ Bg.#`OoV@~IoތV:*3_0YC] țEw  tb{yQOoOă9ܗfpʘ?&Z@ʯp'lD>y}uӡy}T]x9veq\c,:%4$Ax߆*uKIf0bBkc]G.e 7J5ye0N!UCR]aѝt(‡Vr|l;q !T0Ŷ*YsGg[JP7=SM0<~PuCCdor,%ē=A7pyN7tݧfc3`xeFf$ysٗGb a<J e-۸ }gƑ[=z*U }{q3"WSңq"֘KR2̯r :SLrmG[>M aW]XIgҝ1(>Ud5 fvF SbN5?g`IQ7?qAAl)[po(1Nzu`qq*f ˩rfGNs;ڷQe+2 e?ƖkřĜy¸01{ma;.#G+0ZꚿaQN,>P&|uM^7zqP sÛnr_71M8qZQ(5=@,CI$aˊ#`-$A&W!De"j,NcQ D8vK^4ڢ0&"aY Z*vbE>9/ KD&iW{}cP ![_HN-SB^Kit)6G.o?D?Ϲ*(^9($-AwǕ+cggζa|: R?67qR`, QP ጄ4X n<48-U礼~5 @hh=f$vV\N@pQ8h,O_wF?݉FlfW:vl W%OygGt9֬G~ ^G!xyޟ%e Tי<&Qvm_ߴ!7;?ߧFޘke$IAJ] ~Ѕ2*8ⱙhC)J<᨜zs5T3Ր4Cʝe9KD.1FPnຼg"yȅ54q`j埮 ϕһXXzNપ!V{q(m85p(LTӕ}a2Pn,X!J+=B=\;m+},F4i;"tOJǿGWEW(]怏Ų)=fHW9`(knaʮQ>'Y=\M'~Ił Io6/QRH$T1Drknu#qS;CJ!XBo;6l :/H90. $y-_]ה=֎uKv݇2dbu¯6f>!O:f҇㺙4 clQcK&1( (*'ʯ Iٿ*OaƈKKރ,~"a@0SJa_}zdHsmsQ$A>)/ʾ6$OOuK8fn\V\<j΃Iρ  M%a?.nC$ U7g e/M?r(CьeU/.1>!<6JpSuC}h腗eli1d.EG9R&Ap?[FLՀs,KHZlg m} dFicËhU)J(/a[ )p:7-4{M&e5)PւO]iU#/HB"J]Ml] &B +ojpC_u'~lF{݇km:wݿm~T8]0|OaxT.VFgk fPsj)pK<_E(4LMg~iyT{aަ>U?f)7nso׬}\m9U6ϥ-1BpzF̓:5TgWtkNy`֝.o=Elwn'DȮ6_;`eZBԞD$FsI/f*qFR i_c :p%g(2dcz?fCʿ/e]])%ZP\mRJzeVS?F&|` I%{!/󶃤,sn<@asі a8ok-mJ)d*s2B1M{>OP )X (/]QΏfHt[GkjtZJlJ?? 5|? 5V1bA+WRpwz垕?>ceR;ma1 |篴8+48+uWOmf|[Pͺ$d/Jbq'E11`u5$^49*96%P1'rZVu)r/ i2ǭ 쳛]VO"ZFSږEy^BpPшNTDx4lȴC^wOləI6 w-txv48zwBKXs܉䳃,/)E|Ir5{e1"(` 0h!c{aHmi}f@f^1DdA"qJ O_pwˆrS${Oqh^O_Uw1dsUcyd_XNYF8QVwl%2ځYxlz&`~9%>A60=B8lxwoF _ތoQNlf+C+PkU@ !\ 1|1%:XÐ_8,]a f6G1-gO7-vCa4ZR]:>>κoY6JlBl"V>8qUHTd@ 8xha@'/hθC^q7^4rՖ#pO4x/,YG(b3/@ka~1[$qG9Hԉ_坴07,?&N- ?,YPya/ vȂ'K1U(S2$h@|n!Mܐ/{u u,n `*D *Ǖ~Af*PY]jæTG9<H{{. PU{`=h_}Tlӹク  ťP!X]O2%Sav|OP1%Z0n%bJHǕ'Uk%c_k{9ܦD=G MŁF\upd!RuPݍO'M?OVap'76Tt^ؐe-_RKAȳE)Z% -X3QCrT $sG&6A0,dY9f6Kΐv_X9Gl阋$kΝW"攖JA=ѩKWf>5· i/ܨC8ySxj&Re& fa0ֳoѼ[ W&!rL3+U ͤ,F)S˕ C}Nca\M&׈l38`Qֱ6,=5uy֖dw>Qj,ο\l}I2]^.S cYj[tcΰkP2Yc3b S^`-i>F3 ="d?ApPۤg_~`jsZ2fDPi0ƩY)Cix[q`{F Yy{2AdūE!>1Ña6`mEq0-t9ƎCӌf۱B1"@[4vC~[t]{&Vi1@P٦+aҸl?òAHb=ΜDm;W';8_t4,H] FY&.`.lLN+kPbToZOE#jV^s^#WUZqX{[; kc*c>7 TA>kb)ϑ g(U߬(5Y&0I֙O@r-9%˹ Kѿ zeY:`[6ؠJXH8;cߗ٢2~tB!s\p= K_Gֽ-v'JJ=v-Uc`c%hm_̛lj~=Ceh~UYV?=LǪ >t19LxsT&NV =ESY33]&%}S}F#; ~Wj.m:0Ʀ^sZ-; )n _pN^hThU5RZkdW\mʗ*dm@oϪES[cUZHet<>Ij9n X.I~Mh+j]=Ceϙ+TO̜V\]~ mTLz|d8: IO`w煏bhy2Bf;awރCSYzpY8#Vp;ǘr]#+/P'ss+-zkn$G<.L9{@8Mi.4@9_IxfoU.{&!`"װux(RQQ5Zx1bݕkk ;X:㣝mź _;q:'Z~تҎ,igBFEC ${7Dr~7}o?/oʞ+WXܿj~=Gܫʀz΍@F|0U.TcxՍ\6[+׼KEZ9ltQPR_]4gSMSNrQ)ƣ;>G05Yb,AN'n0*b-(ڙHׂ=Ŧbt8{EHw#hGqEWsOX3ش. FKQ {ޚAL岤yJp=u!ճO`hֽ:(ԅ0bS&5եۋW"k8RM#CTj2uQG},#TaF:8QŽZ~ ݥ-gki;WQle%t/b쁟7GUR] Qĺpb&1m{t[uP0n O]!ۦi1]/rE長^B hEeun/䕔_"Gx Xz/ Nw x=U`lhi4f|3=B?}cANWTMVꇯP*h{Z*ZʨrGϰ[uev(=} ߣ- ^j$-)5Rlqwvc`>SpL_6AxŌp8{;ү(s›|εQ,z<^9rŅ֔ FcH?xq ym0 #W$ɜ76 IAI2kǘ)<&"a6 9˪*3GCPAef+xƂ́J\gTVXr4VoF c`k SFIe l4?#l m::撻 AYD,8GJOrs,bXr%C*Dy2HOW4zbٳUWlR>;~+,#g"ޕ96^E E :q@d~c\HXXJY#Y Lb6>u;QCL6A %߽Ɍ쇞}jh' rr3J(pkm6%`!T BmWǥF|JrҔ&5ϫf؋pF<`ޑVz=sB?MԲKq57'W[9( }Em<ڴA'%@ # )l'S4 Nzhva3v{PT5O},ՖDmr꿀-})S rg,!E⩜ڲxd lL;Urjc;n~[]5tek6}Gh͏e" n p0)itttw7Cs=fMckч*,luLPӢڗhMtm4xUG0ww!HmўϾr: f(xI]=]G,i֑7F37wy1HZyN"vR5'*5w9ڨc=MY)~z;l~[?tc}JE͜0@N>4hpD4f.[Zc@FGa'CdFmI]UkH|MJVC\#W87}ĥRnĀ&׊r=z_uvAŒM/`6 VKp{4.1"=>T~c"6O8Ĉ8ƃPg#$\#I$ՈNd-|~#uwelS~;N#dUel;S?.-9ݤ9ށK=kڟLɊHcc A/jN?@wU2bN0 RX)wg;L'R\Чb7Gy/vӢ =m(7&86cWIN /UՒ_Lz/~KuU8v|щGlY2y}[fG>I\vCwo3ծ.m2ίR8Z D? jAۖj t S4RN!%jsQV"k MP}JBH/V;|W%gWfn;%H4(yM,E֛\$_Z3=+0sJ?ĤR6a(7Yӯ)*Q]HTJQEg7 ^^չQ,ԑi1Wpfm2O {}.pM ͕}TrF$$nd^8 l(KN;s$+ZK[NnP?`ɛF7ِZBSԯMl(=ę Cxf"a1"t`vUc'ßĒVXKS욧:ܻD :m ĕ: 'nO;eX'ͺA>PpŵbL_ζ*gWa!Xn,8fE2(K7 /Zqy!/r)/}rz>=HpQp+ QoiZL\6բ`õ%V)z߻s2jD*' (U="Һ 7\$RkW" D-ǹlY)c${sƝ? hd"o8ʣowq k?DEݪR,/€V@qUԴOs7Eʌ麅Oa@$ LJ"wE&Sb:4  7@8w{@(3JF`Pey{4 ͭ ɲ(';'__ݻkhvѡmU_f>ENTdՒPqc|YBNSm{m^i*gc=y2*ydrˊNCBG1vRd)Zߕu)}s% sOKx\lGrU_J&3蝙ҥh, Tym;iUdo;f>5 KQ1BY)@CN'7I$*@I+7kNp+ngΝ<ѝs8[m$AEM#&(bp+A7X6>:ڧ;8u' f6_ m@jgps3dEb;'5]QFC j cRv%UB\e_q 2NJIWE7r=-gЊvSϰcE~?ņ +sWyWn"x.h$'| 5F}1m-(+f m "ho"{VGq@(nzSoZ M6N ;L쑋IKB;psv#z%?='!M,[$u֌=85Y{d|GzaT^drblc;Ž&e1]|V_(z5YuvY|_忖[;nh˥ B>~$2;x:@.]T[/!vrI4tnGBODZ!p̰ݜ (.MԼ?֑Fn|C!rȶ^: K+Azbm^;M&sqBm],?&=8:tkli_j&n"}ET4[_$5e!!XTEW^='˾uv,Vr9lQz#@u 7{vɤSCJc:T;JF tMXUe^$`([lT0Ijb_ '}qמ"v {>P8*?S+ !f I좃0mUh|6p-iDE G ]3w8nm~R'e9VVqOCX?8Q c" cYio˰2lRmp_њ$[/\f>AA PhɄފ=Z+Ҹ0p] nE llz6&C$XH,4N ^N7bcU.YAˈ>5Q7~R, =@ Y[~Q#і!?Ro%/;lhgdr !8x\9Bvpnkz dG,ACWumO] =3-g?F7[־j}{$Ml_ڟ?Oj:'7D=wS]O&5j \w=]ow*o}Aj7߂i _ñu뻃?G\t__(⼣3oxV~Vm%Wֽj\.tw4+onot˩#1,} `$.Y\'5M>O|Ep/JX#7ѺOI`C'ΘJw1]-pIT6{ϱ+=q/τ{8ĿK=qYۗmMC͟ɹҍGe2w&q Rن&_e3xݠ!,tCQ LSyd9)k˄R!Eu+HqYѢw}n~aSi™5 щN d[ w}FNU^ cW?}盒)IiWzʯ: (G*ZC!l=Ќ~(44vGSFG$]vqɧPa}#9dT)Ԙfrm5Gty|wZn9͊a(ݚm'[\Qh_4vݠ˳?ڛT'9]xB%H >vS^ ļ ;Mmp<;Qb]d 5sMXckoj#8=YvNT c^_V`GOG{ŀZ%^D*X{rw]s2[Pv af4ף@+IXiK M{S8UW1Nʈ=KFHjVkNp޳L*J2Ku1F$ |U=g,_.(ض 90~\]\r_3o۝!-o™w"q+MS#.d#l+M4fʲ_4xhATH<MDK"['ޠCԍ >zÆz ÉOG XO )j~5g%]{~Ž b9>|(ˤ=4_vCP\F-Ce$[owN;&В%^ Y M>n}*zdbjv$ &ո$5AT)1Lu$k]z5#_#w70G@qW}Jͫnʖs}^X벣QeH-qkv.;}vke0W?ڌ>s2U\̛Wp y& Y|)/BƕL14U'W{)AAr'36m1x{,|4H&;Ri7|>?tRz4۝s=%qA"~5Gүa.A:OC?љ;Kp؇WBth/ִxKA`A[E$1äA=Fs/uPB`Di`.vyDODQg5*+vȟ{4:FhLy0N,)2Kv>rXtaL|~ E.@.Pc6]6g IOP%ۘ,a :.{q5pixl*ẙ3W6i*Ƣ bs1CgoՃEU }Yr $xl/>ޭ} <h"yo~>ޞ"Y}`sD„@g*/8{ExKiz@HYu?]K)VUNyA`S;<۳U %'|6X_МY8FzL| -iҾ _Ε UI& m?PM^nCL5Un>W'`h IL` JPdh?sxi8@s9f1ļLx98*e =Smn5Tn9R bc5NnΚ-4`UuNGq:b/G:F l\].h2VU"c; d}s1mkˊP 쳠jt}az4GmEU-0p?9E8GgMX!dv|1fXGAVJR!2\ZS9,Fh0scTC$s=6t;NcL5ER}[ٱI|UPI\UCyqw e'FySsbuW >d`Rn*|-i \/Ù ".QSKԃNoȤʭ'q>9 i .R;u&2i -dAmQC8 A /Tlк[*99|Q&G֯n(52{۶X0DsR2oj4Ka߆,dÝ?QGyZJc+`)Cj$1TRVXu3gTP8Ok6 ui4cF&-ߗ%"=PXꃒ֨xlg;(IJ@L7On]?y #7G`LŪaDd/{J!CJ43fe7l!P; $= bݗDyRK,x2QcBw?)K%X!vM{886aXRA9iOѺxP^1\q\B>5MFu0rrAGW[\nBaHޡ 5r=a$&=@8q'%rbāK MTX$tڇ;??P(YkD|  7( /$bxjCij#$o>F=U0.,JTI 3;*kApI*VQÇMGjx3]CdAir%fTJR-Qģ{ڤ;ƥߦsLB! iSFFG'0xGڍ&0+AQΟ>ՍiPʯTh:iqjX#1%ӹwxn 8[ێAH-QɆ+[[v7ne!Aey̝JSȢJ nuR#'frD`*&q!4^PSv7_rѦD箠s@޶<)Ft W1sXW8f>I(m"~@KO$lk \(A_{ BYosy[lM~N#V4F} hKlWzFNbNzn lgωatД&T\:ṅX<ƺ*ś:b9cjUtW#STC[}=Lz єږDT/r " `Lw:lW0â peZ-!«"~02~2_0/ ie\"bQy,%ѽ|CY\L\" ݕc+v Zrw "szR^_-y9Y{Szr102v&F4@>$FPr(\0Girџ||>(o(I0L5PL?q"<g/4n?Q0k4&سŮƣۣepw\&$0F<~ 5O3_lIeOCoq2+ D-~aOp9To&jw%,j,/52$;j:-0wf׳sRwi˻{ b3-u~qp[7@l<.y0y %p ox K@_c=TH V;+X_ջME. K~P`j&=EImmid.n/"ڑSƭxɣ˕%!eޒTzu`.ߥ} o8xNڮ*a,J#ܹ["FR"PDU& Vd5W5E$X*t^mGD,|B>£!Zy~v %KUF~l_=Yv?GO,+z@" ؕ%ntD]Ԩ }Hݩws4;bG5Bl bJg*ǵTFbĶe- 2]kaiZ6qHxo>#sw8jk5LxJ=ڋ3p鬰sle\۔EZn ʑRM51 IU<;?7Գx0~P$(ʆcw൹V{xo??u{!΂5@7 1XpjA<X9p"xY$BZGsd*C6^.5Qd̈́ 0 a\yL~%*ʼ^Nl(c^ .22iA.co RY}1A|4V4-*pyeq2_)jmO| í6~`׀I┘ϙcKp"xZV"/>GUOM ³rI In$T#$lUXjc"zQZdF)r @%  EQ|ar3zdݯC@AVt*鎡mv}N|BU`>x| %V tG)@r@mZQRR(0frULnI'^$0 \>3V_̾ HB?ɦSF~% LݬwǯA;r"M8hxN~ݱ*NڻV$3].1j"dhi/tX*dNƭ '*4Du2^rހ l,^5M G!R/HH\w#ŭHdh3g[_ѣoLǓ7?.]Բ$lDPr]zEFËFSL.8R~Y鎗!(MDbLLw񓟺7ca-.AyXHl`oKr?` .|M+QA+[Xֲ9>ּ@c"槴=:<T9 ~D o e2 C|hb2 OS M`zvWC!+ tLf)a|Yp |'2D=^K2iG4%SB۔(gYi@` CMG}gN\d#Uz Uᴩ<#8d?p]upQv?~b`zt f+2y*{)棶pFxg'GdqRJo Jv|Gֺ}- a 1xZ icv_9;qpk"|u;>}gbgT U Dv/cKcQr[`K;%Oe VR1;QK[r:bQ7L.&oғ֠xpu^R_ac\8wxIzz9:|ey.%Q(@oI7%a(-&Uh_klOi3y( Q⛴m?I2 h,0+gחh(;X]>o;| Io}B3"5UAs١i]VQZ ZIy٢n"^{gDgk3p*$sU#E^p k rɳz@aX*i^YQv|u0xՔ!|Y¹[L V$/8AZBF|п́sL38#<$)S6F'Q2X_?o? $xUuJ #!GK?_L@;y U"x $AA̭'45+P#OӤʢz5w`ڏ)G.F1ŵQxziidhKy[nWx!X<*3FZRG?eAMυtӦ|5Di.F?+*fIՄT,=B#:kpX27bw8Qw3W-3Io ֦I}δ\caQNVY3;O-Y/ &5K0 T+ %;y:^^'ϻP")WA^d&ڲ1|zcD>wi z) jl&4V}mZ1KF0[:5$g;\q K͛gD$ qSCClZ3D){v8+b`b7$RwR̐جi@* P;p L +X* JgQ~XC>e47Ug:']K$N\`ļdUΩie(8/|O(ʦGG஋ڍ  Yߠ32*q\/)˪H$GT"!T΢T]#v;ϗl^ QiLHKAփL"=e?lN2t3w|bv/ɒ^$"bc욁HbWhc$Ǻ#d+B> 6󂕩A&HiӦKO43ΠSR[w0ƀD䏜MKh'C].||a7A׹6Bp A3P9T%GtW6#Qzp)qVB=؅(.tC1$p#%UQFx^h3-\<pU"o@2#=|v;`at+-e Q7ftG,ᑼ)CTQCߩ\_oD8C=z*b߲ۑ/Q(wTۭ<N4QZNmXdY ݌]6|>A_i 1,|mr$b)dgnZCx؉~wE6UnHZʖsCh0o,X8BRl\͏J:p!I M!8}lXS+Yk5Urwun0-NZ6g [Cl;R6UEhXû83۪Lr7QdUkÒ>vp׬j:Fs&*sH(|2N5ޞɺ`FW^1_3f Q9R%0Eٴ?> IJ+G"(M߶2EЂ&\-@"Boz6˫8sDs|L2;RX܉)s_OXkBث &HR99e}@LIVKN+ rǢ8~%;(RN E$9_(P=J1.O9/ʹ8,zXnzmHJ'VII+M>y"֢~d .sYkAL<c^]Zufs& {`逃 *2ی=e@3ғ{ύMHma/}pL"@ת_fr{_3rK/Neq7#oe\ԐE'* Y,8 [@$amj}b2=: Bv \~)SYKH bx7 [SZ)\p Q"㌦$R YKGo:r=uv^tu 5 [)|YOgX:`abq"BԇxvrQGcRG$r蝹nr0ȓvctIfitNbMV#Kz{+ŊΡѻ6*޼ҤVf/m'׭U)5nP.5m(ӘzptVg &!(q{ c\¥lTm#G-ƿTZI9ad9]Wf))s)2~udfN5ΦPGVRH=q.x`f|Cmi"Hk=)>e^=xLˈ;|:S7"L쎂 6b ݔKnvR2oHߥ c ̮ȡC;?-:$=:y9aY0@Hn>Z;mTXM0L"똍A9PiOq`4:URAֱboČ) e2H4ֈ  :3 :n 7͂ >0A9nfG6 KĖi~I]{Ti <EN:fͬNS  iMyTYLB5d>` Wq%\ldE.nG݇'ZT9m8Ȕ*;C0pbKZuGnvnxS̈́\[(@b1 \d3멛le+kJ\*uĶ)$ITeɛI6⣐ Q ʖK,,g.sRx9w nGPrjZ_MC#^)$9zi4\ue#=ݖ_-x<#\ڗfL%v1D.4GBFq!E=iHǽ)峚A+yP=b.ޮH&5@(-Sɫl:X) o1V)l_?8';zg30Ħ".Jx,0&CnhYH ? 4瞰ER:$m-zg"ne#mY~չ bQUHPD!>cb]cvZS4ڪ<H;8XrEqc =54(T9B;/p-.6<:x-)pGKpݩp>L`4'f}ZĂ>3)>qYzM֑WCMAoTs9gE>Gԋz m:t!#7GtsOJ&E޲f%u.\!Azz9ImDi5ːGgzx%(Z+D FKLl]o91swI5֎zڜ#uq`gSu$rAz7^ ltZ^d~e[CB2㷼B8jTp JUAt޿ l?lMqL.YPٙ+ȯ,To3Y_dW+Y^_QNgGYBaD6!դ;~!qb.r@n8:ҒthH{$ʴ\5fTVF9l,:#oٽM٨R [6=)gk>ɇ(_rEUGmf!ӊ#v0ڳq_'e*n} RJz*U.R$JJa(6pJO#Jvܲ3([4/G)?f9k!#p_Vd; 0hXԧ ȽRH>;*5HE3q9erwh-| t6ELF-e%ˉѡ$uC I''Xi߁¹*bK]fR{nb ܿhMź%ܴ- #KD:mYv|ja5NU:}nWi4bk!5GA.w;L0NEDu"~|Ee,n=݅0 apq}n92}68c~o~#zn3eLCGD&E;#±[Cцo.ܨڥ<i)c=˴ɓ[&iXzܢu|)[ :xfAqYVRkN&{{=QA^nъg#p/^,Q1ث|I=u6Qv4ˎ27pt4{2J`磁U7-W}XJphkOcl5 ^BAI4Pթ~ .d&ˎ$VwP2!?nJ}^{mTG[օN @A.'Q˜I2#Ayo:Y9j FaVY +Wٵ _1wk)D[oD}o"gX BM"*~UwIwvF"dDދw}]UxkFF6 aGB4A)!w1@{4{{IzSճle4`1[]t=E"uAaT̰0;t?~\A ?bXSe38KwJVLHe3]qWs&U']ڞYf!#mz8 (z T@?ׄXݠK \2c ҧAuӴf>-Ue! 6wL+;4H]g} a?xW7w?2v/GQ&"wau.G4h`|$iq5J5 չZ` oN HhEZ?y #Ů+|M {xnL^BO?%~"ÀR&%IeʩB M^o8 Oyhb N)'f.!؇ARڱ)Kɇ 3;R`ui+Q))SZ:G봾uзfl95NN-1q' =O!-2CǑ/ÎJCtkKɽEptt7QxQ58>PL01iz`j~^PڮOO8 ilֱ}Mڱ^D^$<~iB` e9bs}god'ySޕqyv)nl.+6=1X~#\FJhAoUW\uRˤYz2I~;Y*qbQB]Gkٶ9 ]/I},k)Ŗp-8A`{VS2AOt*0q`Fx*ؙ30.CEz&#`u;R _Ut ܸ"6e^iE6h_,6e`"(G@(E˰ȓ%wP@/xh_E@_\ NeIfc mo'K.w=Zp޲-3=pWN穣B{ )Ejw߃~bCHnN &i3ܱϑx&yr4 zt(%& !jݜBǂˊ&.k`\Ab;kMJN^Hb X.>9 K' FF]il^y7 XpQ{l\H򈓚+q1-TyG6Uqq1|TdPޱ㛱eZ8Tu34dih"濲v6B)$fM)"Spg;̓k)H?zd޲C7 Rb_[.Oæ 3FsѣX@[8\AmO9$n}]MDM익D+?Om](#^E_YXٕ1%~7rBqM7"V&9@0V?羾0˺r-w't&EGtRn(4/Ąc¸؊k$6PΪWp@AC$)B\2=^nC%-gCLLBcK4"sdVrY'O8ػCƑ |ƛ3G\@y9`Xq9>W.To2jwV8 '!^O'=M#r#e;~BQX7?PڍN0MT&w!N[\X+<, J6K=>z1O%&X|N[it0c~Դ\[KWĩSpQ boz[-`G`( 4dg佨_?UV~[ܿWz\sGꕧ{Sgyejo5%-CZۮ㕵hnP,MAv1ϯn_Ks[>nWiz٫GsW-%yhmVnyk߁hw*|ugZ۩jko}PjGhEru]_945O)nh>4Zols os{:Ct:/t:/ڏtOOt?޿џ V>ת랖E:_tҼCQx굷kV5#VRLiEuIiRͩ+u~_I[-]^ud6+X:k)Re; uMn]-tzڻin?_?_zخzr_ҭ:۵_i?_L2޳[NA$IOI=yյ}{Yv]u~=v k5qvEwqa׵;Khu~򪺎~O6vo7A۠k-]{m{Sj{OtZwonn趸kkKh@SOΓvjy;2h|m_\·c%#KDn7βg"U9W36ᚍ raKd3Rj_Fnś"eԯ:gQXsnL'SSk7-8M1BuptԶY PΪ=3"u;vՃdaДIm㛪p;;1(t!K|k4ˏd- pFYKxN '"e'lӑI ijuC^$?v>{!wjPX@ߞg?H~~ഖhi9E>"g˳ie9!Q-2BgQнSusꎇ4BSլjxtVٛ8)~4Em^B"ݓ0-7֕s7Egh {!f bC0A/YѺtg|oX)^茞NR-b++tJ:9Z} )iw۫*Mo^iX_~trz+lkT2sxdcDPU@ C=H~eʚ *iR-8DhL{G9^jΩږY{jJ1#n\:1QP 6խ~Pss_ooi4V\HKhڃRr2X,&b MDAxG4CR%*ZZ1Jn@`xRd?V$hnrZPRv~fZ\< 䫎s*R2A5(V^q\3$JNMd(,D'4 dž4N %0SPSSZcMW? 4Bݜ &*^kOp]ޕڀwqHQkG)Q|tM.bjb\(аU2ԣg3iG@&IovaC`U&~?_uV80` `_7XJnc1jAB]`c38:!9˹]׷_ɉt3R1(|/%ې"V[H7%s7䚌dxUr}ֻ~&F0ms)(^߂&<-x? om@;}?s*+/‡YV_h9duaϔN L9!-y*EQAnfE+ ڿщ(阸d^LScՆO$2ySwOMFG2joe4Ok:iZ+=*Raxw(ڥsf8#t6{B%~WjsK~=c᭳[ J:u߱D nLX63˳pVS*M#u d>|FHDVtoն Lu#o+93(th SC0 x m guC'!JۻPq;k&t3Eq$ZтIS_idϡ=Acmj 5 ?If\Jv!s]6MaN1ÿ)-TwĬ.Tlw^Y<Myd ;P| S?נN$ QKlMT2<r5CDe';G}e hrb`^)!gs%Ѕ?e*lʔчX JCl3$ @ Ew㑝*xNcRUzhW<m++P"b;>i_esyB"C;`߂$LsJz hHF7N-`cOd: GZq^!C+l ;fPʷ=AJ2x"PkV]bH `ؿK&˜ HTɑa< ?uVHl!o4[&nMRڒ|z DU!{*߽X*'mʼK~H(K~ݓbټj7\0C<!"I/o|CuPDf7DI4p:"xPeg rڒ0vQ*EbOlOG/~DNϭLo\ ú!3$#zy6Gi eU<}͎ݦRp <1i߅RÕM*7ؕdB#MU= WZm%. R*ءѨ q9%O'ds [0WKM^^$/T+Dcs=ԉm9o%ĎYfFUWSWa9zXg9G5@zthX7Iɩ:]G8sï<\GPզ:vŁ睪g/ʴBg) ͑sؐh⮁9\A{XAˆ IQ6_P{?Iߣƺ|a`yhPO4bW~^hQf<0K]x QbcxڝP#bɯ.QJ[C)F!:l-9m80a?:UfdI_vEϭyT^BgL&̤Tί/.gj?6#E(Ef~T7߻[˴m/6 ʡ`t6V RD<ugQG%Jy%Gdt!I Q7FD:UK`bq~H]lCɱkR{8$W8H Ux: "_o˜Q@xq4GxF(iSf5\ Ȍqqg`?JoEc3{ >0t^AR~`G`[[V0 ~gkC&[;xD'G]L&@33]H\ZgЗ:^Rv+i۞۾חNߝOnEHZB?ݻtE8S*Cuzsyi Sy sUL*a+8#qլt^n~0_ĘwQiPm*p;Fsh PCWO_/Ў7F2BPCvLJ *6Ú(`Nl F:-c *o" >&rA6rOƫi4o F|ǜzd#ΎebQP;Lx}d"~o^ Ol@;v] ȁse U_cT,kY+]Rz;wz^T]9iϫ٤uX!4|HX_|jaeٓxyw̐.I¤ݺ9sqHO!6#4ÉF 2uAo}w2 htGI.n !"ޯ# LlM#8yEq;b&@r%kZc01'LjT}Ze~Qݬ DėQO|kŎʘO)(29ޣȿx4)&t>4e)A&5ŅOl}> ùrG%ǬEr =J%8㹯aZѴ=6{S[hw}Vܡ!%J]#v1켡)Ԕ]8-%Nǽ kÁNjgغi3OipIL\{vfB5DίBPvh>qjElHv>()J|8+]Iޡ|vT1)0 (ڬ;Ѷu\><ۋF//(IdO3g_7vR }HrrD9-$Gn| *If)*HK\;59Vm,Y+<ڝW/KaJnQLnEUaXD:ꅖbgTㅳQ[3)+)S,kﳴtFšF;8[u7H P4띯֓+7VQ{1rF઻`n^=LL9U)קls>Oš|Y˵~J ojgv|HECR…EEBdҳEpWKwX[>!pAI)}$1(2JH1H.6FW#toHGp?!8cq0971 EI.! MXRoY{<D-x*5xeU븙drfJCJW3GR쩭Pg+T]y9O)~3)WeA!e0IB9-q\[#J R?I%G,"8$N#JevУ$!X+ ngƜ6n}5Ux&@Ҋ>E L5N?~=Bѩlj䁐8ͥ mBaRam({SR8>cwP72c S_#=%rVTUPݕ$L1T,"0։ 迬}nOvoE皝)P4Ʊ얐 0Pŭ} v=Fi  'Mudhtz-nV6cf)^zR7Ҝ@8;S C`P#U1ozč/GpM^'y+UI$x!\%ȲϪoKUJ';KV鈖}guIajrsqzH ﱀ|\qCkfD !~ClY!wtS.PC킐}4Fk3LJ,\ _\/]_STK*2"`b;D0L6˯{̢d N\ ~1GkP[t g،MK5 h1MC&'uBWE3x!XGYpdo- r3;HG۪=C}z^XKK$ Ϲa:ȧق3[ac.&qk<'r'ְk]j/6Ёp#v#*=c5!g>>%F/%hcg/OVf(۰ Azq=ҳq#:"GtG#| ҰB)>@6_0 cwQ*-oC)Y{429$ y@Fdbt2&9`CQ͒U /f<by 42F;Οŏk*w (uX>M ('N%GBSC9cg[vvk R!EXf"9(qvI]JztQ?P?*t3š̞eWY-QW跲(mk@9Ls?t i7HKZ7IekkTnuy:DLNʒ~0 UNeS=E` ֌_eRK_nU]BW<rA5؜o]B'B!R4Hy3}%w *TB5ā4CEdP@O\i꿏 (Z4/~,F,sn4Hz!'⥀3+.5KtC4K# Nʠ W CG1w0|zZv4V媸{@lq2˸t4n56õX8J!dx5and$I%ݔ"o5̟Ֆ&O,Iwn8G3ϓ_KʨFD\뼉&V0d#א}lFfD%3I{& U؟zc}"ϔȧЪg$k;IS\\/D:*^0C{gK}#[nlS 2a\f< ƛ7p=bJ.d=Q'{r0Nc,6 ]x6>; (yYGC* !VcgCd@;2)ʰ"bP{uЯxZA`x1a1ȗPb5- u)ye6V?-$31";K-|(!@(C ^sFlRh]B7g${t\0bĿAo O_y@q2瀇W* Jy#b/ ҆aå͛5vA h4$kPɋ|fEY^uȴ lSv<"0f|hlQ03>hbE=BBYCRFǿ'Xըs7Vr{#Kn)1j>w4$N 7yh (׳VIDfgtrۃͮ s+ɫ1pє|Cc8|Ӑ+NV]5''(*/SEd 4z٫n7T[;{6K1#y]CoښlwK94$dQЀP CX2s/Y@$M [by^hK$Q>"SiM1~ŬHhв]2[kKW;ƦdN#=ȧbw9ə ȓ1R:v33(t`GI5-Љ"| r5qM0쨐|~wfeJT57TX|IY2>(ن.Љ LZĶmү,;ؼK`yԛUٷw~ݴxݹOzh?˺`谄zųs{+h <UP lJÄR/\[xct{[Oa"فM4̜ fk@ɜ]5 -,m Hh3›cam&Bc'if N..d_"XM#>qea<Jx ô],vho"2+-~P'Hr&Dб;H+46t PF&&0[j~. c.<}Iѷ'=HB/Ti\=tk z֧LY[ِi6wo"x-Ȗ;.S)$Ve_aL9DpX!э/3\d䍳u6hnf2nSp]8eI`CTjyPQ#|ŰM0'4r;uE]ފZ  z HFz5v1{3$o+!HS|R!+1=Pv 3t1|; X7\6j+vhdDrGZ4$8!x^g37mk'ZzOOF8B - aj{&Dkx6[A2M)OHye4{py4=OmmT.g{%Nzo$~ }n6m҈x.{b玍.,4yk\f 4iV3mR$넭QՅMМהǷhIac< \#pg4Eu. RHa%)A6[$wQ,k$~o+8JV׸epZ\+h\4ZQ5t0X4 CYr1->j] [Dy ֯HWlO|1Sd<{XU_c#sp#꜈#-iK|Uţxܚ2S5'5!y;r>t0REc E;'k#,00Vc[:H*yI<_of\1uV_3!WA?;x$("1<41xw<'ðȬSZG-IC >alឥBSU`,$~{0l?U.[k<; j{UB=2X6H?7&ezt0"ǕŽ3c LWVn}2 V&TDc( K.ZR)zxN7)Jf ilI$WQsǾ)36ۥqFQ r3`|D: vT»:ڏh5'zԽк@_9f?jnNs>&$vNZ uDuD%j/Oʻ\sup$REXO,V!2ً\Avf3z8&CEjEZ/5f .̙S+f o^U {J;6W@`_ !Ya׹gU 8ODZC-~ HCza^\ ~V'R!v# 27#! I =;cvHQF<0=[4a[3A5'C!6`3B&=I -mMo7%%SN&T3+c$J"#,z>G& 7G(ڡf%boX\M8n8LDlE_B Xl1L4H֖.7P[x ޣ./d?'6AhK'Y,>#I>4V5ìp?.OXÂmI:_U"&=ޚ+1,;"I[R$OO%BxsHR1sU'Bҝ6NǷur@+i.i=JԔd8v⭫2oT{U 1RUѾk+]9{QVa)Zda?sg,0^cx:V:_5#B~BiݱlZ\uiJ NRկC$nttw߃/ZqAtuoVkεK[a=+0J*-mB9>J须}΁v2%,̕_x(hAh'- 7YTF%)"N '^ hݱ;m4(+S@qu4x.;m?I7^N إ8^=羭~N3i5 2ϮX k ;RjEwilRyC ڗ%wD.<.Pv'1Ɍb'NwsWh[nX5;g&!n6M/=+BNGBܧ2M7_Yd;g3*V'71:#/{d/">5˰_Ij֧P&M[9 yxf g$+|14vɳ73/oƒ&((R-wmHd5yp օYF9?.З@:! 9,"fȥAC,Hv9'EEm?VЧ5m&yf 0УUaP.Yl.p~+)\!-V[X4jNse_x d29)|oꪊvv_ ,ݲK3̢>:yQxE%hNgqR.]P2.A <~io ǐM]ퟏ}~ED5Z3V!9bK#@`so^ VS}Ř:6bfW*!!څgqߐJr)_5L]n <,W5DgWhKrXG?L39&m` ?ݰHTO[ exxnR3ds4qxT逹 2\.G:F姢!6(t&ڇd~ u, B(BK488|?6Vh6s0gQNoPP7t5kyBRVO@]>+ ;&{db"v`*l?0fxJ.e4 F@[OT)aOik} D3:5oz"] I96`?AAr;F~ sv_jH=@w;Os\:]ٿobl߃n݇t?E{[7}ԟ:{ֿ:jjOSs;#[:;t'ۏO} ow= 7vm;:3_o6=7o;o]z+tG]I~e-6_l/i {:Wyнg:iOj4>zԭ~t{'tk퍻Z^v.o{hη=kZ{׫gj붾ۭ٭X:lZ[lm C[]hVmVtWt;3^ڿzڛk[c[~}G[wt5Vͱ략(VuZzޡߵ9ۛcK[{u;ֿ.ۻG_l{ۏnmmڻTF&ڛgk붮ۛolu_6.~u5Qlm흿v;g{[=vZ{Gim7=WjzھÂenR{ M J ' j* e`$d`;܀_:6ŒNsɖ7|x> - 2%ByJQ-1#AfMLDN>SsƢSj&pm?c!o  >_2R]Rfru4M=[0yΓrI*e3ͣ5@(#/* YqX2[3fyMnfJ?VcQ"t_;Xwl{flȁ!dj 9]+, =NfM##eh1늝 TVNZ~9VOvf/#BfP X KB>o&ωTyL ' C*c#wL̄L$iLVnb#n>xUf P4b+c )0c.$suc}g)Bw߉CA_A1"lB蟙swWzc*{ٸ.;>:u2h]sDvSǃwJyYLM}r^ Ek7M:; 巜zS>: >D[Kx;LO Ki5@#$-eZOD|O 1LM{f/6ajl< P |JlMfqd W推t{ܭҭ2-'!җd /z@m֛uB'bj.=g $WC] _ #C]K j qSMO#\|7b3"fXc/"%K{_$(ƺ^ScP76c.qʬr7UR*#kzPpʡuעϿ pdokhh\"ڀ_^//PT[oǤMCA` I=2QۏU 1y12S7~~%XMҊ}gC݋u@KGY=V/l^CA2VØS9Hd6yX GѧJ@-\"\Vɲ؄ o6/xh&X`b'x YƯ_\>>ߴ,Vgrdf?.T{N,3(O m wpPOفFQ=~ L:GS];:Y:(4E"<{oW;,Sp6r+qLv)b+ 47 DTtUg\X'*&$HDr :TF1Vk-P[r7y%sӟ UFVѮ\æ Aϳ ڊBfM2}\=ϕd\M^H1es^3\W*l -6NEz i.`;L|¬?TY!7. лa.~7@vX0U˦!i.[0/$|'zx׈bJ)xdRF4rPp+Q=e 3'zD2/"D{j$ti!ݨ4-@ #碗oOC H1Ku[T~1^&˖o Gh3w_qhRY$Tk 7j*œ,0%R% Ru?t'aWtd%3¯;|rz!DLHf)[H4/v(v$r"p%1KԒiCl d#+MU& ݹ-BcƬc_;dT1=xAuN%fu4cczjʓqC ^DGDUxY(I{ f9,ɐV ^z V [xѸ%VW&F!Зs#.#H:3~Iҩfʭ*%ghV{QmG-3:Ѕ͏TX$P6 ^2h֝IKʲ.12eGSa\M&d:/2{4;U:6ݘr2D|<.@PU8^`(%SLM/s]BC{ 2HfC 9Aty0ք?<P[F<[7Mxg:?r왑Dm& KM;h7r Q Fwj :Eev;k ;xcβNyF c M4+h/ o[Q7Y4T#ޑΒnai\G6FJĩ342~!]!pg~N< j%n&l(Gi~x\WrMR,xiC1(IP#CDq\u\Foȯڗ78΋[Yx@e{}Q=~%eRܾM~("o.;;kҊo"1F]5 6$ܢ/@O+U`9-^.RQNz@ _Q[%ݕ2weI.!>< nāu:+Q'x#Mèa]"9MX%7D_RB[ynDNm(2_ Axw~#P|+&éڤY򣚟aZ,s9~BvF /s#7&~ݱ ZН͛=S0P7s(&}m|v 2?IwU3s?HŬdb vzٱ㺲dfWxzVSȧn&o vq,j_>!oHi21MkcKo)i+S;+ q"=jtPB4EX@U+<<< ݰ& wx3Y,^ U/tC Bt\{M7b׆6Hn%/ yPh(FꈻxLˡr3*SFM}{`mP!w`S>[rRv` A!Yy!"-)/ Ku9>$ǥ¾OJwŻ$EZ@|yk|Z@MYa4EqKG\rQ5f(fZm} qO Nk*$8Mk1H15ePnMp:!9I6j| X%hj먋a>]]ɊoDTº8}l,gzx "86LJ$gt=jdKJ.`ţ:pirpvy348A#peT=B6-%}Ů x*}聴tٔxD?!Z m|)Mn[լgNv;O_3nU%A7>xQ6W_QnUm̋}06gSo k Xy]u)5 ivoaSPVGp21"z_ÔB(ͷm7Є1}qW{,q.qNXOBL\C )Tɧ~ jQ=O-yeŠ4;(%ZsGog.p {oXԗMFUAnXQ /'g|(I0 _AoAq#^MErhY@9_%oxؿ vTR\p'QUzoW"5PrF}Цҽ%$紷Y[ߥUˊ?8HY,X31XΫ))6.-tCRw+bmz^ AN2?Lp`W{m5)KKAf$,2T>,1SFߛ5XOM1._ h_ lY`ssq1 βTی+ua Y'7&49B u;jNyςN6{]*u { ')֒؏v3M}VKR V0GS# \eVQFT fHfƂnp{NwG/Go2ƹyu+2Pvu /(;v6c9{NywR)l_kGD?oe ;PbGl#1>n.XS[{tg ަ(#(Mr@cY M.Eޱ~f>̡"( *pu *&|7:?4ۗG Ǽw!F \,XT mM/dDUgzT^P ^'zB Fw1? do`O@hv6R@[0D`d/UA~zT* 1EޭRs:a k"~HzW5͖2߆`0Rvۈ*^lmƘd;^^Oiil ~D^O);Ԝ_oZCP-Ca5ݙ{p B<[$vnICʯaGz;Yvg.B>wֵgi}s?Q5CWLNS } iՠ+ac>Q>f_E@R!wҝ*~9<zxޣZFB ghiT҅tAƚ_>L;D/L^?56t=p\Gd8 ![Z$}HvK4X{HnwN0`CT>[B/rjfދAcoA'q/L8A5!{>Dcq[ YC O,Ω¼R__쯦{?7gvg-38zWuBи JK!խ\Ꮮbf^r&R6ߛ^߃A(Qb>iAU[0e>Ԭ}SZGZaezۅ ;UNG (qnEw"D4!H97wXj'?ćF7yGAL`;I_єK[}`Ӽqd (xAmPW6Y ^LncPzXH,8R_)l @z=ײW ZA*'{V0t3BΩvRu#KbE9c"Ml\V6c-KU{-?@qjDVN!y?/oQF ݐH߇cO(eJ#Ty*r2t_Eםtqx&b B* --g|W:ʠqZ'w9s 91)ש.6Cm1YH WirSGղΩڦa{[Hj˩in]o&Mc&,Qt;mūgU/*rSFiϬ ?aʂ\e!?ᒎ)(`'$##QɗOgzopv(=AG& md!䪂y,4^cŞt{ϳ8Oе-t۝4 }pPx T ۍCY×k SS[Y-TܭOuUSɶyۍםQ oc[x/ve Ki]GNU M^ mkm)S+)>fO؁#BZ]G5 zc/hwl7Mbk[0C (+$<\{y*>~m^tJNjvA$x2г OJ!3T0k؉i1ʈ)YPs+ G]].7>_21 F#B dc d 9mɖneʭۨ OmnQ黛)BYY+dE芝21,}=\>HW^ޛ-H1DxeNIrͨv z~֣21VL_T(5d,9~NӄZwRPc{a@wθȵsPZ,Hc<5p rO9ZҗpLLHׄXyA2Zkk!>T͹k]%v:"#γ ֦\ъ1,MeκoC2}̉@*-#y,!Ս\DwpaOj4rn罺j=3Y}*.XDL<%=)WfPPpV HX۴pYv-`ɍs_\9NAV)pP@)a{U|q $x::,"@KZ{ jni :y+9g GPan i+:J>14E;I)9"52&Ʀ#VaQX['3;y!OQK)&}SA# L ơSKN1t|c>_aW_,ΜPVަ^R h*l |$@fHm5bLGkԘU2V!i(K?$ 0T*@y2;JB:8i:llP9&o$Lb=Ɵ$,r ? ^Ҭ m<,7ݧ)R!ǜBj{e %fo&5wحw f@ a֐Y{CS&g|[!lj1l`.@>OQ"e}PIW0F7[ !Mmr'2%OG&YG'I O{WC6Us_]L뵃y?Ha6Ly0zDnMMO4.^M>ICoN WV&{^924鑕0QO0ú='9E՘pqv80ڻk-zgS*?eC0pFŒ^+mn&LRθ5x5}~uJCJv~خy5[#1k.Wď٩FwkPj* XYon+Fٹ!Re=Fl #eW&+"U3G $,,4-i O2A^%Ń0I\όPHHa{LLN S>ePC>IrߜA mlj4{B+@m$w{.ynzX/QcΘ٣Yq'`1j{7SJLДJ)dIh=̓>>t/ٚnTTEVӏ*Ęe)NKT @Bk!0N;-+$}:9FQX}ҝe(37!Ic"G~qAl),&^9gn ExrĔ!2)w^\߾Dz$5ZC,75s4BwK]?:4᫹렙 #ȌɼvMΛkE#BpC,JmrˤWkr|RGMޒ3jއ[#)fM"B*qYbG/4o老nAT^L]A yqBVBwy7G^Z=Q+i1"\u#=e~xZ/q7j6!'`O!֑sc&F(#jڣB"svX'c%CQ~fG u]A zrA[{lF$(n<-CE뼰Q2đ*;-4E8HMEJ13ŮyK"MUNcq:20xbhyZ#KmTG~`qeT7= /CYP-0@ eaAJ'MmV|ĬKJdT^ɍ({Lu¼YmsIoB-΂Xg׉*!~zg۽`nr~/eЩи{6ȷ{wǩ* %u<?R+OΒWԟK\# (+h6 \#iySϬAݠk|*9&!N8~sk1Q\P\B.8)b'ũxw羥XlCl)tQS!go+$b_?4ԃELlp04F*?kʈG4Y9BK.YM$cI 31=x]}} @oZ*q^LIp) UueTeBEـ5I=eM ђw&XxekÐ{K ƗTjas cЙ?o@ Ŀr{>h 6JjBmؽƕDX1eXwX:qɴGrWGXqNJ7z԰sHpj%_l U `Umz)L$9.N2Z3ؚ;ZJ9q ރDWbH=睩H W7X6~5%/ G@b;S#_'0f?owK Q6|Kl$)WLLKnw&>+qbGRļ3"XνanLyb~H*z B%dk lBQ,[4E[bh$T ު[rR }GIcS,wb mOaI}'B*Փe~&ʄfЋټh h5j"ieh$Z뼠'AtVx:Qj*fr%/(?\MFO_I*^l+샬&8}6ޖGgfigXrUOMyD3elSEIX,>Xe( A]n1v+Y1j zfh Dsр >y)0#wS^VqxqXp2@3)௨<]U9:±Q1OIŖ4'"g/RsV9L+\tZ_ :9k_ ]#)O_PIÕ:"b$n f\ϔxZPfP"tVm]Jɱ&"عR0\OW.I!+#ҏ3u {B:bMMZQq5+Fp_V}: 5Fbv}wu.d86L>t~iۼ#C={\L)m VESe\;}ŝQ%&uʐkap_5%>ocf"ѹ>d:'U܅QS2'8"L`p?=J}(\җ3SVwsrT*Ywr\]>nzpSՆѝO#&1ۊp?; k4odY\%6pr23ȋ<>^Mr^Q:!MuwV-פ:jgƍA\yzۥOA pH7SR.qf8Nbcu9̒<? gܚgi]2kh.^0U\!M؟@ůOLm$@%[pqy"*)b<Z4 e WҠ2>Xz3nDg^ZbE㱶 _nn%ץ'w'TP '06rI:8;tbiIV,̿IU =pč %#XRsu|+<~a;\q]..~@Xrа< a]##uެ5?Xr<59 2OOY~2Gzv_⳶o)NL1U7~ɀNpY0mݲ-* L^qǏ"O0= *e93O}8*~*p˱yLN |a7je40W{ c/Tgn`pK)q~J[k[xCSp>g8m3CT/maT丏۱ GcK lqUW1< #Phީ]s ЖՊ$;^Bx#͸hc0T2:̌RD߻x`.G?s7 aq q< ƃ^f&t@? ki.Fh29g(Fc#$?IO))Js87'Jr.[lc, ZЭ?Dn>9tR1kY,?I0 V.$+H.?M1vsc0<:FVG""n⎡Z:55[cYB7JxV_ھ>JdC)[z:3Eeў3GEqiOTہ"!1Ҝ w>@D7ti} `/$NL^BTZz>s, CȸxsMb҉t P1gliOjn\++ 3xRJl{]pmq{~@"';y5υ/_ }m=">90^]tR./R˪U)Ԓf"ҌHVw =fyl7Eɱi7|0 e5}ue$̌Y,Єv3[/z7nU+#En*oOuOblK\^qip BQsfQLWoUhp֘wzl`7lF(@Bx(Y9;,Xnia\u=';#+5V&7G?(Opa4Q5f^i N Y¸:9%(H|c]N[?+Y4Nx 9m&a%cVRZWFJrISMJD2=rGМ(H=w^ uBT# ޖJuEс XM9!F' |C8Z4坙yQ\)ZF6k8> fiwlr>zƄgj@|Z׬iN ѡwfi&DH,Ȑ9(^>=ж'BqhD~fo *;g/ѫ)IJS:zqB;e>āM.m4| &iu$Y!;D EHc s?v{"!/DUOyYsk%cnf^%h[?/ ̛p'2I3%hOF \` {i l1HG#*J`5d kշgbFz&6F՘!Ui neI4BM[Qժkuqņ>ϵ ?q9&ݍo}!+{,j=qc͸dVJR=܅f jEʋ endstream endobj 5 0 obj <>/Filter/JBIG2Decode/Height 1752/ImageMask true/Length 19707/Name/X/Subtype/Image/Type/XObject/Width 1240>>stream -88QǙ5֝$_!Î[殄Kp& l׍GC{~ pm?e/kTuB !NnzF;dtҊ+ΚOe;qv/uFyÌ@ T5Dܿi)oHH@ΕgnMM_8"˕Barھ0DǪ 0QHOwdY0*]*o;H0B.r&w Lyj:6 Je5%@b2>t 'QcF0oǧYaF S u(9Mt3p u!1RɫK@ʣ.=hc!@e+ 5=W=2qWR fA_PY \EŽ)9|'H=?R_q{v T&F*i㮻r.O%'4l6eAeӂ\pd~+n9 mcDz*!MM}1LP@R򌾥'Q䘃S{EoUG yov< VCڥ'z[g0Qc^]˽$2k`XIՏPFi H09rxuA(WّqX29%8g;8jҁ%137\dT];.ABEcMXQ|a &Xe\Q? kPRyy+ f#3L66XoyDآOp<4r&q@֑":GҲ'撖7ѪBFSg G|Bݭ>\5W!Yg59~eB):~ԟn#5gLb {p?}h1v|r)8O8-8.5~>g k_qS.`_o5VTqUg7V{RCաm#9yi,υ<.Vs&Z0T*l$l΍42I:*Idb ulCvмmwhb1rqKTR „-v3{j8y'r>_4KI8: @K=Mhc }4&r 12X_&FL 8FgZ%5ΉQ͋jSg=>Pu(x!rKoAr1|QE<=avʊ 4l``>+ž{Ǚ@0K0}!G f>Czg-Dʒt̵%g&hzNdroCzulޜj-]:Xs#%UugI-6.9jpQJq q ,0%;^-Iίzb@p.R֊5gA6SI7WZ[d6Fϓ#¹2K,P:/u!v2q+dSus FW9x;S0$! ja#Cᢶm5%w"?-:&[w[ۼ`a 5"{7 y zX*w3m.4 8K.vPauѲ<7!Vm5G`piVSixfSMGAѥqyG;C)w]K r2lD-'^WlevJEcNJ 3]( e9P-WSrcGL>Q& i`4'Yjb;JEdN5vQfQX QomaG:ͮӰu8#]TnS5T>$WO2*ul͕#Qh7y[){C W{>d Koɷo(kdik2!V}"՘;cVByͧS%C+c AjܭdH8[Wbo0#'aBW?  F`lr6nq=A6rO^X|73)z1b=)X|˦e+܀@V#q^jۖEY(U+Ȳ 3 Ivs?4Yk%{.Nfa@~'}$|FhMa=1/)|A #09X^E}V~Tk 4zpԑr6B=FùMRppA|i1M+z~ݦV0 dВ0ȁ~>[|~e I=SMPL?Wj8&i`fn@Mc|u"lI:]}:J d֌yRt qiA<օS9~#H3]ګk@PQ8,CԢɄJ#"| p>;F͒ScrBzXٚuq`ME Յ$e>ǶA`w][RT}Ah,Ekeaz~Mw/ǵ}B7LEݡ9Xu%lrPV/~ό}_zT͸L6xP,ѫ}-S%U8vnIuΐ G3P a\AIҏr*MV0)QYYK$7KLZ&Cz^xgfRM-*VU םB/[p#ic'Ea?ZW9֤u!O;C4, I%)*Q˵2ldq%R#C#j2uvn%y$ɓvD|ۖ]kյQoӳ|gCpRU*>n=Q"8* }htCl#~mjjy7(++܃S֞Bd<C=yn[$%yQպhviQ&ad/`^9SM0HLRXuI2O_s<:A#6gݭ hWМ'tq5f+j[Fz<02 SG[$`kD"|:BNFC*3 qk܆QnB~6/T14~`[vET!lqY69AmOMvgcƭǾck2|IUXzHPܯHzNw.!PYse/^ "y Ơ*l?hSd$>Pgu>up :5|S@f+j^^*FDcψJT|xaBLygdwPi_ENwǟYc)DV_ܤNQؠ(s$DjPF^Ϯ9/ !z5.V=ÕV0/;(ة}+nTI}{(vU oqTJ5LfqH*hg 8uU'VkUm\i:5V77Cpo)?UuZNjGk-0 گKT#ff~ L5?!ok#-{+23}{z)EwjX~{O¿-'x9Y!~U%*6rW"'IӞ>Q<-I^4Ugsr 3D\kflqq#;J絊, ӑ%YIkV*lߑr xn :(vN]`P0 osnFؘve۳. -2l3=*,JGC f,ͭ9FmBW"[q͐d&WI0- G O:.0TV,# lwu'YS&>}vxNOve-v?YFAU遐HXb_ R {GnsE%y 3]FK$+Y]θ;MJ67`b72JSW8םNT3·3t9_ FLec@>1"²RG9'uJEr4U18y5Rټ>: 3fsQc:_A#ST̎.hRtB݅ 'νGfӅv?|7pKi2$0w?71N[AD&z{l3/>@JAsh^1*2kݺ:"jB}>PG@DԺO0V%;ਜC^kg^󖦑9ͧ2dh]_ J-X7*OHk4ټz}r.Rqi "m,BpxIy:z}+e3e4$#*w(dZRn&I4zi D7,n߿}S(*c!;`"o&ic$MMxH0OMmc;P GGAsE ZFk3doNnH3 / -pq^GBRQby I/x}p*aw%ROGɖgKn Kxd<;̹D$ztsQӅi^Oٍa) c?( "Ȣ1樺#[3En^: ڔС DGhO1@,C&^@XmpgCUma ar|-Mfr}#Ĝ@py ZF7u89pHWiףIoKTZ#f;}/fv,,ֆjEs8 /Uǣ iI2@i(a}'RX a Y@iN̙1̸?? 4B=c9ywʕ$yd'}l'GRrkAl JM ! n Ieq 3fD8CI:wMNt &k &)mb1O,f[T ݸ DSI,( s-`A]E) 0ksjӃb² `%B%k*aUG6o o`LTDJj2n,SA&^bX1d8>vO0X)Pa`hFrϗ݁ rB?,z^Q54eՒR(L(IѢ؈)[,jZ,@vKZޚq~Jxa"@քidE9[X8DAqA5$Jq\D࿎JNM/9 AVdvZC&1/4rN%W&B< 1˝+Uus $nCào :Sz6uK,KM@u*kYM{* Ɉ;w?(%U W#9nhZ\͂֋1xG }좤ѳc5~"|zflGK<7ǚ?GIdj`bgӇ ~4 {2,v& M?Hy CcWQ\#/cC|6J`;`M]ѐ[]?NJhx9)4@ C?*Om3g $?k!*jhV.BzG$y(sT7SSSvKg\XG57Rt籥8gn斻YA ͙j)6A)a)}mVae$.%i0pɜ|odڳ\Uh<cAnTh/*.KAv_ vA*$!= CeNC},6$" eİp #,ya߀uck#o\1~rUS:hMq<&@&FhG&9U,l=͜ ;)p?n6)~[YgS}eI1M]I(E@lwɠ?]M=P m}]9'B"Xp㳢ŞbwuOdU(^*m %]Q!fw%ͽ'uWWTe)A2wpŔ[GY4x3<_4w_A%DYg}Ȏy"'6@Y%7MKV@KvͰ(T SwbJXL,P{pWKǡf ÆKt~6 QC"zXmg+,SMfsw4 ~E'.%@=zc|OF«  q Y_$c|hY+.dD{+>Fb_dtcUW(%~EtZzjѩUOvtR&an9"vQ kf{YNk6U醑tE#dZ3TE2n\8eL3Ѿ =P}z?E191WD N#|k;k,J{%W$Uտ}}vf.XggxƳ>`o[o26A{R^0]q^&ukƻ8"UYNJvhF!NCtjPApJi%a$ljb ى&qKjKa";eEqTil6^nq=iISk, ܺxv0ÀSk342L qDPRڵyy2o]n]]vDL}_ Z"ky2=~&F8tɶQ.@.7cq2p8!C=7-=y{3,v ~"1nLu6v^[MQ$'P2{QDZa${Y@~xHJz '+S/V*"櫈ɋJ{ߕJaf$듁2Mi@ɮҦW}|(92Li"$"V)"H('4t8F.jtdM AHpp?k;CЉ#~k‡1ʤ;nMSwOQKMآ ?˅+dݨ46c[mJtNtLn|["zVrra-6IB:!Se2TR(a\/-y؀X7UpuX0naX(O(0`wG-,YwW>%êMbNsBڟy*hڥo+^T⻨T% hCA3;)ӯ_iU*=Ijeiѯq;&f5|UDdR~`%'\ۍ✟r?NRyBBzzžp~thqiڳ._>0K4xa]i_8b,-NUytjY Po"-%Sá^6h y~Dھ3澿`  =A.:[E09χC=uDG`ŗ;ZyRN/^.w HĖ ,AFS{ l1R;;4!sc{I7#2ڼ-rn.ԎX'KaMW: 4Mg8LO3vwr&O#SXqۥRGn7ƹۙyؕLZ}ChB3_9"+U{9b/Q*wdҡmWYSSҤe4FbTsux.ǐY?EA(|x!kd"FSF*Ylw_R{^b%c`OߢOND^el5)M\9XG4oչ\QT'΍1܊zQ ϨXS8}- !?̫\| c/1>\z]7tj'өp %| "2'@`R_$IrtY5/^͎I5}Ki$ypHwĽ&zX{vuLƇAx;@ɓma=QWgp3N% 8.dVI\6-fH3ØGx"dHLOg&5A&[cGmt96.Z"uh yI9ѽ3YaA_FoUyhn* /[UJH,UϦ dB [.G_^G0H897;f%di;jbД]֡*|_.nN⹜%IG>d =:oCZS7B@d#.^pR} cp)2Myc6GzDԻn k\[_IuS%pS{Vݝz 9+զZ!!o\Cbԫ?+5(Ad z.jH=wΒ%&O-Jݘ'Kknǖl2 vwlؒ5E9aE\awL͎]a/qiͺ| ^l>IUcr0Љ96C\ωpO`PGwfƣe؏{37iTE;*c^n|#Eur?aua !t&hV71ֱ={`wQH7ʟ+r7,~Q3aG7z>R¨ ݊ ߢ jcg旄wD0_RW: cP=VJ;$!&٭29ZR@ȐbJ|pJoKjSL9o:]ڽOS[G&jQ>SBuvĮPksNX-BƝ炚TemI-7!Ϡ"YS=;F\Uz2c#v/c|亩W%aGU9`R @acxaO2[eDiMxj`?TX6(NCŇQ[?-W&hҫj\^Uw|L/";vZl؎Ja 'Xrp}~!?Akgċ8?օYgI S4ܠSV2m:10Ks2fSTr M_@ %>'EvP1 ]]nor؝~ǣQѓ<8( l63V-1,(l}1ޖĤL)ja|VH(.yP55v9g'ŸPS[OQԭ2,0NTxgyD}Qs9#Ø;O"إ_8TS!dyC4}Y3"e1>c*i>'iު=[|ɓs+o,u{(؏+'ln2Q홹{8i=huK}QQ-EJUUc=;p<5=("ROκ`C?lsJ%kYg{[`Muj=_]4?N`Bf^wex?%eHF՝ [_/b@𠹆WVgL,# 퀴ƌ)<@zVj-'%,Nz`S_iYI.u>g0@  *oXR.ʮ#~/!Wӊ YGݖ8^2ûҞr P N anYA cIנT"Uv hᚷ+fmiW-wyim×,qVDȞ^h3e'% ~NkWQjdQ9wHՁ6 , 4Z|Um!h R5JOo88wV aH=p~]LFM)czLXw٦E`~ 7|̙K?%Ԯ OF-LpzQk2:Tҷz"mS,F߰1z5%h10Þ^WBۗ)7훋Ι$3pwqkhв΁{Wn3ùdvLR6.JةKMx+@@CB8h9J#ͬKU+葒_fweœr{Ov`l=ľA#NShR e3"cըUcͲUFȼ ȢÜ@?˫ybRB ucGAG*2 gÜHG\GbU崩:4L@R|5ѬLw3G7>7ބc>0Ȍ8-4^E;ıO׀J˧lxXXO⡁ȁ˛+=U'&z$Ur`T=%!Mķrg2"w<ĶB^ " w?\u267zL3 yhl2Wυ]DѠ20.s+.!Q7:bL>\M U:uX/|l.?KKNwzOD*@w>9MxdR! 3 9NK4|vп2^<^],|%;,/4`iZGaRy/06j8O5#/3!1(nwԳ;ZDN5->K7}ٻGw@c!ѵ-tY? g29N lJzM"+lQ#c vɨT+,8!`_йgF}k$U'_B;1*%c暊E-"~~SZN$,Rw݉D־J: :M?+hgL>f=R4VQ,"ʜ{{&U 3G$OM*.F,r;ȪێIl0G|AvIvR,ϱ\'֦^H{_/>0 Bl!3vpQjn6lBD}#Jc_=J^R[hƚgC'f䁭U6'RjKm[}aCMYbQ™[,-KFRߵ)kmw&aʛ%xj&K6>sjR,$Y X|AO=mzV6$ZkhiH֌:+$\C2nzImsLz&?vlS`Q5ى EL!͏$. 7Ⱦ3\-1k(]\+t(ݗ|ݬU"򿿞~1\4plex"ARReɖ܈?Zr -/5:x ئD7'w-ZT]YFi+Ɋ9ԻG))i[q%Y!Fk~_o GJff3Q;~lOm%ɋ|>g=>͹Љ2XUP&j ϑWTQ;g9xRO41o[^&*RUDO ,+?wŭ&iG?2!{RtE6iGd Xk^Z7SMFmt݅{Z,AE*kMC~mԍ P-jJfP_sbw87Kھ*yJMei qUNA1:0'ZSΤ9b̧[FZ~aZ,vɌ@L|,) D.]}./uлS%+ U.C;AI˩/nr3>ܳR S ]ndCX"؟ɟ4גA6&cb{D=Tmamd">ҮPE}*$%4 ~ߝ4ݏU.c_pL6PQ'@z,}I$4},XW]}3ǥ3zZ߃q[X'}@ne诋n H=<k.E(Wlzn!ZjM,gFqnN츧5"(=jJ~PJAJggM6"`x G7a,aĄkFnO">+o[Y3i ?@zL/Qeuͼ`S۴ h,u%_.БVU3Vh[| c"#M+[fزw( OBkox.OH6vP=#ccA<3[wv&bh{g?>P:GYmᣬyY;/]}oֳZ961:k8D0*4Jc[fЀ[%[Y0E4~*B$ʻhr'mnI&}뾩^dUw[,6氄A3BEdTf{PVX X ^+}qF"@fD׻M>J8lIbFoI߱ sH_y"|A} x/'Lb!hLqtU e?>D&$ΎH#J Vx{˧UGBܶE00s-/ ˜Ȣ$-6%W/g6XifzT30)P꧊%ZʼnIYňfm2j j /$c>V;Oޕ-쨬|Y12 oυ38/d0EkPnC^]tr}VN*K{/VijiGzRdrp y]}`\ZkLb (Bꬖ2( ¤H#Y%g59Wepp(`{敾/1l^ +v4@8c/vD-l|DcwyaVq*;W9ej;Y[&^/&LԔ`$Kg#ko0^1E 7=lG;6@eDkRN&$ 4^J*>u$K8€?L+ZzƦ@1978/sE\ ɯ^rRAfۍS''">g5Mџ3kZto*/^Fa50_sϱ)Eze<ĖY eit<5 q #ָCֶ_ Ԫ[Kh]NZOh{Or]-(^e=4cMw.&flXG C{z~^n h՚Xp.&w[ڔ MX/eR}?Q ߴf;,'b3 ^;L'+W9N.b@!j;iw~E]\CJ eL0k=DWV纐DYE\'pk4YO8ת ୼}|zVA`?e$jk>|iaPŋK=j)YH]Q5\@n߁O p}Tn S\-n/āN'#u1L.*)c Fͧ1W&CaVeVlsT ׅfv䏻@\Z(!q8~ʹL @OF7\L8ö9yx"Q‘;my[pG}muep601zbgAo.Fn xo -K.; r񻀅L7g }Z-Yg,wSO,ef_[xc@QxC i% 8>,J)4JMPhXö լv k~愙l<;q,1u En{`-|TM l5mtdsGTSX 7D+o6irG8J}Dݽ7 2~nȟfL%/dV~Xok4Ӿe'`} ZQ,ĤӍ"e`2=QYQ;J/G?]GfIi : Y6'ǥh\B vN$Ɠ Uȃ[^KK*Φꟷ  .t"Dtn6l#B7m\7<*ӬsﰶHZ ux2T[ J$&镒c5ByKf;鞥.mvI#Z=p@F7PD'`_;΁J$/EF̟Wqװ[<PO[kf(>u1$sX/˯pxі2jKs/͓XflD1io! z'ԒjfrU/j^|:A47%_\IV C֚ C9=a |àa^JE}.jm d#vVzG U[rZEmZ1{8AS̃:%L&J:@.I3V6 KH6/hr*P)U&q?zh,DS+ ꕸ9~t!rA*7DhD`_AkO,wՒK86Zke@^/b6dBit>6a)CwB^4 J(% }6#ulp#Gdg/uU lqv+kݨhXSz@qP͵,-طMZf ɤP7KOr{# ~GWܥ/ T/4r8VȻL n\?i ٶ0C[s?s~qWFSeRKxꚋ!G,M-ѬSq`:%HBн{;!M7zURD~|m.%#^%uG߯#i1JcLl{b502 nr`:JT,2>RNA[6e܋ZNܚzR*|baTa2@Dҧ"b%"4BFr=h |-UuӉ^8>qw'f{A'uJ Mǁ_TZ~G:,!(#je )6 ͷS~ vgP,_N˙u[_R [!XNbID}Lqe}dgmD?v[#X ?]`k0gtufOI&牄, t_{K endstream endobj 6 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ .-jp2hihdrllcolrjp2cOQ)llllR \#B@HHPHHPHHPHHP((( Ϸ]PT[}l~,smLմnzHbR}ھ٩{bN}em%A5|B8ҺE? dm{m'>m_h'ڗ^3E}|Ekc2(6ҷ> 2MjMD2Q)- )[`NY-ݭ$&< jjFşhVgxGW"|mc1ǵʛڢ4OuSIӑbE-"O֣2" 4*g^2Xs)veh,KUjHT ~Yr*SK3OO fSG0f `dϓ|{F$nUz fPʟZ` L%KMm!-\IjΜ+ obЧj U ;.;{~dυ,9Q- n^.e(W@#e4kyxڎ J8I#o䑕HxedOj)XݏD}0ۅXj+M |cՉ/ /;n{TA<*Y}m,cKO>I"|"=oWT=>*AٟD<¨lwtA_ v(Eޞ3pDpZK ("z yL9@y Bf\VDS |5nyҀMAS+DGTe-0m3RR1>&WeO:F;wfHwP-ӾƓs,[S7 ^K5i42f,48&O@]_okPS~MLOl8Oi }rX*FH\-}X7WJihZ; '_W?i?vT_qT5iiS]\4HΒ%b[3 ~&aI1ۣ)_8u7HEn;U}4Wg]*΍pIԼ\Og}`V b0U;:h5YIi\*]3\u #"2<\xli<.RӅPF,| S{T0r1ow믣Rl!Dz Yε|GUL [BFxU,tN>ӿ5ُ>L#,.´J|99Һmmj I2YO~|N ܘ9| A^4CO.$2PI*sT'ѷ-{tu5Dsi Bߓ)Z'g͠^(6zIkBݕ%<|53j[K-s~ 6ˇ> HS$N]jᙄ7lұk]:.ޝ<9o^P33b묑6>=yn#ŵCS┠#TFE]i?-]FoJ֭AϣAlW52 ˍ}їbs8)} tԄ: \H.xȶx> aIY_gQEb&Ė%&գ7CiDsh|-|<ϋWflnsuɤjMa.idž.qH-l`a1⇕)ZvQH/ֱ7FbJQU=W2Y ;j q Ji+NR HjS?z=:")Ɓ+`nH̔VҶ82ˑP CMLE[23?fV",J=r6}DWB=5 H&-uzO|-.ZTq>nS r;;cy2q*]ngڏQ|&Lyy;|}fmOh ܰ `M4M̸bdɰJSt8 DŘ8y̸C"ٴqf}wиP?ϜG*ovrM 09̸3tvԸO*jd3 ̸O24̸}nG99ǥsiX9.XXǑU{?}OX|G}X9.&X b|3b{b|>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdrcolrjp2cOQ/R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ |!@:  h h !|!|!@> &  # ^#ݞ $*B'(OȀ  endstream endobj 8 0 obj <>stream h2T0P02P0U02T0W0475R0Q04210=+ endstream endobj 9 0 obj <>/ProcSet[/PDF/Text/ImageB]/XObject<>>>/Rotate 0/Type/Page>> endobj 10 0 obj <>stream q 0.196 0.196 0.196 rg 595.1999969 0 0 840.9600067 0 0 cm /Im0 Do Q BT 0.227 g /T1_0 1 Tf 0.0414 Tc 3 Tr 7.5001 0 0 7.5001 184.77 769.68 Tm (BACTERAEMIC )Tj ET BT /Suspect <>BDC /T1_1 1 Tf -0.0018 Tc 8 0 0 8 246.31 769.68 Tm (HAEMOPH/LUS )Tj EMC /Suspect <>BDC 0.0155 Tc 7.381 0 Td (INFLUENZA\243 )Tj EMC /Suspect <>BDC /T1_0 1 Tf 0.0442 Tc 7.5001 0 0 7.5001 357.57 769.68 Tm (PNEUMONIA )Tj EMC ET BT /T1_0 1 Tf -0.012 Tc 8.6 0 0 8.6 523.1 769.68 Tm (931 )Tj /T1_1 1 Tf 0.025 Tc 7.9001 0 0 7.9001 112.44 747.12 Tm (Acknowledgements: )Tj /T1_0 1 Tf 0.0007 Tc 8 0 0 8 183.81 747.12 Tm (We )Tj -0.0279 Tc 2.103 0 Td (wish )Tj 0.161 g 0.05 Tc 8.1489 0 0 8 220.3 747.12 Tm (to )Tj ET BT /Suspect <>BDC 0.227 g /T1_0 1 Tf -0.0144 Tc 8 0 0 8 232.3 747.12 Tm (thank )Tj EMC ET BT /T1_0 1 Tf -0.0088 Tc 8 0 0 8 254.86 747.12 Tm (the )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0189 Tc 8 0 0 8 269.732 747.12 Tm (Bac\255)Tj EMC ET BT /T1_0 1 Tf -0.0006 Tc 8 0 0 8 103.66 737.528 Tm (teriology )Tj 0.0046 Tc 3.958 0 Td (Department )Tj 0.05 Tc 8.3469 0 0 8 175.6 737.53 Tm (of )Tj ET BT /Suspect <>BDC 0.161 g /T1_0 1 Tf 0.0212 Tc 8 0 0 8 184.78 737.53 Tm (the )Tj EMC ET BT 0.227 g /T1_0 1 Tf -0.013 Tc 8 0 0 8 197.796 737.53 Tm (North )Tj ET BT /Suspect <>BDC 0.161 g /T1_0 1 Tf 0.0031 Tc 8 0 0 8 218.74 737.53 Tm (Staffordshire )Tj EMC /Suspect <>BDC -0.014 Tc 5.592 0 Td (Hospi\255)Tj EMC ET BT 0.227 g /T1_0 1 Tf 0.0395 Tc 7.6 0 0 7.6 103.66 728.41 Tm (tal )Tj 0.0374 Tc 8 0 0 8 114.63 728.41 Tm (for )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0231 Tc 8 0 0 8 127.182 728.41 Tm (their )Tj EMC ET BT 0.161 g /T1_0 1 Tf -0.012 Tc 8 0 0 8 145.43 728.41 Tm (help )Tj 0.227 g -0.035 Tc 7.9356 0 0 8 162.18 728.41 Tm (in )Tj -0.0048 Tc 8 0 0 8 171.77 728.41 Tm (identifying )Tj -0.0055 Tc 4.75 0 Td (pat)Tj 0.333 0.337 0.329 rg 0 Tc 1.19 0 Td (i)Tj 0.227 g -0.0098 Tc 0.299 0 Td (ents. )Tj 0.161 g 0.0469 Tc 8.6 0 0 8.6 150.2 701.53 Tm (References )Tj 0.227 g 0.0147 Tc 9 0 0 9 56.33 679.92 Tm (1. )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.05 Tc 8.6506 0 0 8.6 66.56 679.92 Tm (Smith )Tj EMC ET BT /T1_0 1 Tf 0.0291 Tc 8.6 0 0 8.6 92.55 679.92 Tm (CB, )Tj 0.161 g 0.0397 Tc 2.512 0 Td (Golden )Tj 0.227 g 0.05 Tc 8.6693 0 0 8.6 148.71 679.92 Tm (CA, )Tj 0.0373 Tc 8.6 0 0 8.6 171.32 679.92 Tm (Kanner )Tj 0.161 g -0.0084 Tc 3.572 0 Td (RE, )Tj 0.0116 Tc 2.512 0 Td (Renzetti )Tj 0.227 g 0.021 Tc 4.356 0 Td (AD. )Tj 0 Tc 2.223 0 Td (-)Tj 0.161 g /T1_1 1 Tf 0.0083 Tc 8.9 0 0 8.9 55.76 668.89 Tm (Haemophilus )Tj ET BT /Suspect <>BDC 0.227 g /T1_1 1 Tf 0.0071 Tc 8.9 0 0 8.9 108.8485 668.89 Tm (influenzae )Tj EMC ET BT /T1_0 1 Tf 0.0096 Tc 8.6 0 0 8.6 150.15 668.89 Tm (and )Tj 0.161 g /T1_1 1 Tf 0.0029 Tc 8.9 0 0 8.9 167.12 668.89 Tm (Haemophilus )Tj ET BT /Suspect <>BDC 0.227 g /T1_1 1 Tf 0.0108 Tc 8.9 0 0 8.9 219.1761 668.89 Tm (parmnfluenzae )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 8.8796 0 0 8.6 277.37 668.89 Tm (in )Tj 0.0435 Tc 8.6 0 0 8.6 55.6 658.33 Tm (chronic )Tj 0.027 Tc 4.019 0 Td (obstructive )Tj 0.032 Tc 5.48 0 Td (pulmonary )Tj 0.016 Tc 5.348 0 Td (disease. )Tj /T1_1 1 Tf 0.0176 Tc 8.9 0 0 8.9 218.01 658.33 Tm (Lancet, )Tj /T1_0 1 Tf 0.0135 Tc 8.6 0 0 8.6 253.14 658.33 Tm (1976, )Tj 0.0053 Tc 9.3 0 0 9.3 279.28 658.33 Tm (i, )Tj 0.0382 Tc 8.6 0 0 8.6 56.34 648.24 Tm (1253-1255. )Tj 0.0156 Tc 9 0 0 9 55.63 637.68 Tm (2. )Tj 0.161 g 0.0272 Tc 8.6 0 0 8.6 67.11 637.68 Tm (Quintillani )Tj 0.0351 Tc 4.862 0 Td (R, )Tj 0.0281 Tc 1.284 0 Td (Hymans )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0032 Tc 9 0 0 9 152.12 637.68 Tm (PJ. )Tj EMC ET BT 0.227 g /T1_0 1 Tf 0 Tc 9 0 0 9 165.017 637.68 Tm (-)Tj 0.161 g 0.041 Tc 8.6 0 0 8.6 172.25 637.68 Tm (The )Tj 0.227 g 0.0206 Tc 1.951 0 Td (association )Tj 0.05 Tc 10.0163 0 0 8.6 230.78 637.68 Tm (of )Tj 0.0211 Tc 8.6 0 0 8.6 240.97 637.68 Tm (bacteraemic )Tj /T1_1 1 Tf 0.0083 Tc 8.9 0 0 8.9 55.28 628.09 Tm (Haemophilus )Tj 0.161 g 0.0071 Tc 6.073 0 Td (influenzae )Tj /T1_0 1 Tf 0.0322 Tc 8.6 0 0 8.6 151.21 628.09 Tm (pneumonia )Tj 0.227 g 0.0205 Tc 5.349 0 Td (in )Tj 0.0162 Tc 1.449 0 Td (adults )Tj ET BT /Suspect <>BDC 0.161 g /T1_0 1 Tf 0.0234 Tc 8.6 0 0 8.6 236.6338 628.09 Tm (with )Tj EMC ET BT 0.227 g /T1_0 1 Tf 0.0127 Tc 8.6 0 0 8.6 258.2198 628.09 Tm (typable )Tj 0.0179 Tc -23.565 -1.117 Td (strains. )Tj /T1_1 1 Tf 0.05 Tc 9.0617 0 0 9 87.98 618.48 Tm (Am )Tj /T1_2 1 Tf 0 Tc 8.6 0 0 8.6 102.64 618.48 Tm (J )Tj /T1_1 1 Tf -0.0052 Tc 8.9 0 0 8.9 110.49 618.48 Tm (Med, )Tj /T1_0 1 Tf -0.0005 Tc 8.6 0 0 8.6 133.14 618.48 Tm (1971, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.034 Tc 8.6 0 0 8.6 155.8784 618.48 Tm (50, )Tj EMC ET BT /T1_0 1 Tf 0.0158 Tc 8.6 0 0 8.6 170.3092 618.48 Tm (781)Tj 0.333 0.337 0.329 rg 0 Tc 1.562 0 Td (-)Tj 0.227 g 0.0202 Tc 0.559 0 Td (786. )Tj 0.05 Tc 8.8062 0 0 8.6 55.1 608.41 Tm (3. )Tj 0.161 g 0.0206 Tc 8.6 0 0 8.6 68.11 608.41 Tm (Levin )Tj 0.05 Tc 8.7798 0 0 8.6 94.52 608.41 Tm (DC)Tj 0.333 0.337 0.329 rg 0 Tc 8.6 0 0 8.6 106.91 608.41 Tm (, )Tj ET BT /Suspect <>BDC 0.227 g /T1_0 1 Tf 0.0241 Tc 8.6 0 0 8.6 115.037 608.41 Tm (Schwartz )Tj EMC ET BT /T1_0 1 Tf 0.0228 Tc 8.6 0 0 8.6 153.5564 608.41 Tm (MI. )Tj 0.161 g 0.0144 Tc 2.233 0 Td (Matthay )Tj -0.0085 Tc 4.13 0 Td (RA, )Tj 0.0197 Tc 2.343 0 Td (La )Tj 0.0216 Tc 1.731 0 Td (Force )Tj 0.0262 Tc 3.014 0 Td (FM. )Tj 0.227 g 0 Tc -24.9 -1.117 Td (-)Tj 0.161 g 0.0336 Tc 0.788 0 Td (Bacteraemic )Tj /T1_1 1 Tf 0.0029 Tc 8.9 0 0 8.9 110 598.8 Tm (Haemophilus )Tj 0.227 g 0.0071 Tc 5.642 0 Td (influenzae )Tj /T1_0 1 Tf 0.0252 Tc 8.6 0 0 8.6 199.69 598.8 Tm (pneumonia )Tj 0.05 Tc 8.8796 0 0 8.6 241.85 598.8 Tm (in )Tj -0.0003 Tc 8.6 0 0 8.6 251.91 598.8 Tm (adults. )Tj 0.161 g 0 Tc 3.022 0 Td (A )Tj 0.0252 Tc -25.896 -1.115 Td (report )Tj 0.227 g 0.05 Tc 9.4598 0 0 8.6 80.55 589.21 Tm (of )Tj 8.845 0 0 8.6 91.63 589.21 Tm (24 )Tj 0.0364 Tc 8.6 0 0 8.6 104.08 589.21 Tm (cases )Tj 0.0375 Tc 2.678 0 Td (and )Tj 0.161 g 0 Tc 1.953 0 Td (a )Tj 0.0258 Tc 0.791 0 Td (review )Tj 0.227 g 0.05 Tc 9.4598 0 0 8.6 178.95 589.21 Tm (of )Tj 0.0051 Tc 8.6 0 0 8.6 190.54 589.21 Tm (the )Tj 0.0169 Tc 1.669 0 Td (literature)Tj 0.333 0.337 0.329 rg 0 Tc 3.783 0 Td (. )Tj 0.227 g /T1_1 1 Tf 0.05 Tc 9.0617 0 0 8.9 242.54 589.21 Tm (Am )Tj /T1_2 1 Tf 0 Tc 8.6 0 0 8.6 257.68 589.21 Tm (J )Tj 0.161 g /T1_1 1 Tf -0.0052 Tc 8.9 0 0 8.9 265.53 589.21 Tm (Med, )Tj 0.227 g /T1_0 1 Tf 0.0135 Tc 8.6 0 0 8.6 55.86 579.12 Tm (1977, )Tj 0.0292 Tc 2.701 0 Td (62, )Tj 0.049 Tc 1.681 0 Td (219-224. )Tj 0.0467 Tc -4.52 -1.115 Td (4. )Tj 0.0356 Tc 1.398 0 Td (Ashworth )Tj ET BT /Suspect <>BDC 0.161 g /T1_0 1 Tf 0 Tc 8.6 0 0 8.6 104.5962 569.531 Tm (M)Tj 0.333 0.337 0.329 rg 0.883 0 Td (, )Tj EMC ET BT 0.161 g /T1_0 1 Tf 0.0225 Tc 8.6 0 0 8.6 117.0834 569.531 Tm (Ross )Tj 0.227 g 0 Tc 2.338 0 Td (G)Tj 0.333 0.337 0.329 rg 0.777 0 Td (, )Tj 0.227 g /T1_3 1 Tf 0.0156 Tc 8.2 0 0 8.2 148.14 569.53 Tm (Loehry )Tj /T1_0 1 Tf 0 Tc 8.6 0 0 8.6 176.55 569.53 Tm (C)Tj 0.333 0.337 0.329 rg 0.715 0 Td (. )Tj 0.227 g 0.456 0 Td (-)Tj 0.161 g 0.0345 Tc 0.843 0 Td (Lobar )Tj 0.227 g 0.05 Tc 8.7609 0 0 8.6 217.45 569.53 Tm (pn)Tj 0.333 0.337 0.329 rg 0 Tc 8.6 0 0 8.6 226.47 569.53 Tm (e)Tj 0.161 g 0.037 Tc 0.457 0 Td (umonia )Tj 0.227 g 0.0297 Tc 3.395 0 Td (caused )Tj 0.0143 Tc -23.766 -1.173 Td (by )Tj /T1_1 1 Tf 0.002 Tc 8.9 0 0 8.9 66.8 559.44 Tm (Haem)Tj 0.333 0.337 0.329 rg 0 Tc 2.464 0 Td (o)Tj 0.227 g 0.0241 Tc 0.419 0 Td (philus )Tj 0.0071 Tc 2.812 0 Td (injluenzae )Tj /T1_0 1 Tf 0.0228 Tc 8.6 0 0 8.6 157.42 559.44 Tm (type )Tj 0.05 Tc 8.6404 0 0 8.6 175.16 559.44 Tm (B. )Tj /T1_1 1 Tf 0.0035 Tc 8.9 0 0 8.9 186.31 559.44 Tm (Brit )Tj /T1_2 1 Tf 0 Tc 8.6 0 0 8.6 202 559.44 Tm (J )Tj 0.161 g /T1_1 1 Tf 0.0323 Tc 8.9 0 0 8.9 209.36 559.44 Tm (Dis )Tj 0.227 g 0.0146 Tc 1.644 0 Td (Chest, )Tj /T1_0 1 Tf 0.0135 Tc 8.6 0 0 8.6 250.26 559.44 Tm (1985, )Tj 0.0292 Tc 2.592 0 Td (79, )Tj -0.0263 Tc -25.285 -1.115 Td (95)Tj 0.333 0.337 0.329 rg 0 Tc 1.06 0 Td (-)Tj 0.227 g 0.0293 Tc 0.502 0 Td (97. )Tj 0.05 Tc 8.7752 0 0 8.6 54.6 539.76 Tm (5. )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0436 Tc 8.6 0 0 8.6 67.16 539.76 Tm (BTS )Tj EMC ET BT /T1_0 1 Tf 0.0375 Tc 8.6 0 0 8.6 90.1478 539.76 Tm (and )Tj ET BT /Suspect <>BDC 0.161 g /T1_0 1 Tf 0.0141 Tc 8.6 0 0 8.6 108.9216 539.76 Tm (PHLS. )Tj EMC ET BT 0.227 g /T1_0 1 Tf 0 Tc 8.6 0 0 8.6 138.1444 539.76 Tm (-)Tj 0.0269 Tc 1.229 0 Td (Community)Tj 0.333 0.337 0.329 rg 0 Tc 5.022 0 Td (-)Tj 0.227 g 0.0206 Tc 0.336 0 Td (acquired )Tj 0.0322 Tc 4.198 0 Td (pneumonia )Tj 0.0205 Tc 5.349 0 Td (in )Tj 0.0162 Tc -25.788 -1.115 Td (adults )Tj 0.05 Tc 8.8796 0 0 8.6 79.13 530.17 Tm (in )Tj 8.6039 0 0 8.6 88.28 530.17 Tm (Briti)Tj 0.333 0.337 0.329 rg 0 Tc 8.6 0 0 8.6 105 530.17 Tm (s)Tj 0.227 g 0.348 0 Td (h )Tj 0.0239 Tc 0.893 0 Td (hospitals )Tj 0.0205 Tc 4.067 0 Td (in )Tj 0.161 g 0.0352 Tc (1982-1983: )Tj 0.227 g 0 Tc 6.36 0 Td (a )Tj 0.0302 Tc 0.722 0 Td (survey )Tj 0.05 Tc 9.4598 0 0 8.6 237.99 530.17 Tm (of )Tj 0.0132 Tc 8.6 0 0 8.6 248.55 530.17 Tm (aetiology, )Tj 0.0249 Tc -22.541 -1.172 Td (mortality, )Tj 0.0245 Tc 4.413 0 Td (prognosti)Tj 0.333 0.337 0.329 rg 0 Tc 4.008 0 Td (c )Tj 0.227 g 0.0159 Tc 0.78 0 Td (fact)Tj 0.333 0.337 0.329 rg 0 Tc 1.508 0 Td (o)Tj 0.227 g 0.05 Tc 8.7081 0 0 8.6 151.19 520.09 Tm (rs )Tj 0.0375 Tc 8.6 0 0 8.6 160.71 520.09 Tm (and )Tj 0.0347 Tc 1.787 0 Td (outcome)Tj 0.333 0.337 0.329 rg 0 Tc 3.672 0 Td (. )Tj 0.161 g /T1_1 1 Tf 0.0138 Tc 8.9 0 0 8.9 211.56 520.09 Tm (Quart )Tj 0.227 g /T1_2 1 Tf 0 Tc 8.6 0 0 8.6 235.6 520.09 Tm (J )Tj /T1_1 1 Tf -0.0052 Tc 8.9 0 0 8.9 242.49 520.09 Tm (Med, )Tj /T1_0 1 Tf -0.0005 Tc 8.6 0 0 8.6 264.18 520.09 Tm (1987, )Tj 0.0013 Tc -24.313 -1.116 Td (62, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0405 Tc 8.6 0 0 8.6 69.777 510.4924 Tm (195-220. )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 8.6665 0 0 8.6 54.61 500.41 Tm (6. )Tj 0.0365 Tc 8.6 0 0 8.6 66.69 500.41 Tm (Woo)Tj 0.333 0.337 0.329 rg 0 Tc 2.059 0 Td (d)Tj 0.227 g 0.0424 Tc 0.455 0 Td (head )Tj 0.05 Tc 8.6135 0 0 8.6 110.36 500.41 Tm (MA, )Tj 0.161 g 0.0293 Tc 8.6 0 0 8.6 131.96 500.41 Tm (Macfarlane )Tj /T1_3 1 Tf 0.0327 Tc 9.4 0 0 9.4 175.42 500.41 Tm (IT.)Tj 0.333 0.337 0.329 rg 0 Tc 1.449 0 Td (-)Tj 0.227 g /T1_1 1 Tf 0.0029 Tc 8.9 0 0 8.9 196.4 500.41 Tm (Haemophilus )Tj 0.161 g 0.0049 Tc 5.642 0 Td (influ)Tj 0.333 0.337 0.329 rg 0 Tc 1.891 0 Td (e)Tj 0.227 g 0.024 Tc 0.381 0 Td (nzae )Tj /T1_0 1 Tf 0.0391 Tc 8.6 0 0 8.6 54.25 490.33 Tm (pneumonia )Tj /T1_3 1 Tf 0.05 Tc 9.14 0 0 8.8 97.26 490.33 Tm (in )Tj /T1_0 1 Tf 0.0159 Tc 8.6 0 0 8.6 107.05 490.33 Tm (previously )Tj -0.0066 Tc 4.733 0 Td (fit )Tj 0.009 Tc 1.228 0 Td (adults. )Tj /T1_1 1 Tf 0.026 Tc 8.9 0 0 8.9 183.9 490.33 Tm (Eur )Tj /T1_2 1 Tf 0 Tc 8.6 0 0 8.6 199.6 490.33 Tm (J )Tj /T1_1 1 Tf 0.0183 Tc 8.9 0 0 8.9 206.47 490.33 Tm (Respir )Tj 0.0101 Tc 2.913 0 Td (Dis, )Tj /T1_0 1 Tf 0.0135 Tc 8.6 0 0 8.6 250.26 490.33 Tm (1987, )Tj ET BT /Suspect <>BDC 0.161 g /T1_0 1 Tf 0.0013 Tc 8.6 0 0 8.6 272.5512 490.33 Tm (70, )Tj EMC /Suspect <>BDC 0.227 g 0.05 Tc 8.707 0 0 8.6 54.19 480.72 Tm (218-220. )Tj EMC ET BT /T1_0 1 Tf 8.6666 0 0 8.6 54.15 470.65 Tm (7. )Tj 0.161 g 0.0326 Tc 8.6 0 0 8.6 72.89 470.65 Tm (Tillotson )Tj 0.0213 Tc 4.523 0 Td (JR, )Tj 0.227 g 0.0282 Tc 2.065 0 Td (Lerner )Tj 0.05 Tc 8.7 0 0 8.6 159.82 470.65 Tm (AM)Tj 0.333 0.337 0.329 rg 0 Tc 8.6 0 0 8.6 174.54 470.65 Tm (. )Tj 0.227 g 0.847 0 Td (-)Tj /T1_1 1 Tf 0.0083 Tc 8.9 0 0 8.9 192.56 470.65 Tm (Haemophilus )Tj 0.0011 Tc 6.127 0 Td (influenzae )Tj /T1_0 1 Tf 0.0146 Tc 8.6 0 0 8.6 306.73 746.17 Tm (bronchopneumonia )Tj /T1_3 1 Tf 0.0282 Tc 9.4 0 0 9.4 376.62 746.17 Tm (in )Tj /T1_0 1 Tf -0.0003 Tc 8.6 0 0 8.6 385.83 746.17 Tm (adults. )Tj /T1_1 1 Tf 0.0194 Tc 8.9 0 0 8.9 410.54 746.17 Tm (Arch )Tj 0.161 g /T1_2 1 Tf 0.0219 Tc 7.6 0 0 7.6 430.02 746.17 Tm (lnJ )Tj /T1_1 1 Tf 0.0128 Tc 8.9 0 0 8.9 442.17 746.17 Tm (Med, )Tj 0.227 g /T1_0 1 Tf 0.0135 Tc 8.6 0 0 8.6 463.38 746.17 Tm (1968, )Tj 0.0172 Tc 2.567 0 Td (121, )Tj 0.161 g 0.0424 Tc 2.04 0 Td (482-432)Tj 0.333 0.337 0.329 rg 0 Tc 3.612 0 Td (. )Tj 0.227 g 0.0107 Tc -26.452 -1.117 Td (8. )Tj 0.161 g 0.0256 Tc 1.402 0 Td (Goldstein )Tj 0.227 g -0.0099 Tc 4.414 0 Td (E, )Tj 0.161 g 0.028 Tc 1.229 0 Td (Daly )Tj 0.227 g -0.035 Tc 8.2153 0 0 8.6 387.8 736.56 Tm (K, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0279 Tc 8.6 0 0 8.6 398.72 736.56 Tm (Seamans )Tj EMC ET BT /T1_0 1 Tf 0 Tc 8.6 0 0 8.6 433.8338 736.56 Tm (C)Tj 0.333 0.337 0.329 rg 0.771 0 Td (. )Tj 0.161 g 0.512 0 Td (-)Tj 0.0209 Tc 0.956 0 Td (Haemophilus )Tj ET BT /Suspect <>BDC 0.227 g /T1_0 1 Tf 0.0387 Tc 8.6 0 0 8.6 503.5368 736.56 Tm (pneumo)Tj 0.333 0.337 0.329 rg 0 Tc 3.448 0 Td (\255)Tj EMC ET BT 0.227 g /T1_0 1 Tf 0.0335 Tc 8.6 0 0 8.6 306.2356 726.4808 Tm (nia )Tj 0.0163 Tc 1.777 0 Td (as )Tj 0 Tc 1.34 0 Td (a )Tj 0.0366 Tc 0.894 0 Td (cause )Tj 0.05 Tc 9.4598 0 0 8.6 364.71 726.48 Tm (of )Tj 0.0198 Tc 8.6 0 0 8.6 376.71 726.48 Tm (adult )Tj 0.161 g 0.0256 Tc 2.523 0 Td (pneumonia. )Tj ET BT /Suspect <>BDC 0.227 g /T1_2 1 Tf 0.05 Tc 8.2179 0 0 7.6 444.53 726.48 Tm (Ann )Tj EMC ET BT /T1_2 1 Tf 0.0437 Tc 7.6 0 0 7.6 463.19 726.48 Tm ([nJ )Tj /T1_1 1 Tf -0.0052 Tc 8.9 0 0 8.9 477.69 726.48 Tm (Med, )Tj /T1_0 1 Tf 0.0135 Tc 8.6 0 0 8.6 500.82 726.48 Tm (1967, )Tj 0.0013 Tc 2.757 0 Td (66, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.05 Tc 9.0382 0 0 8.6 306.14 716.89 Tm (35-40)Tj 0.333 0.337 0.329 rg 0 Tc 8.6 0 0 8.6 329.1 716.89 Tm (. )Tj EMC ET BT 0.227 g /T1_3 1 Tf -0.035 Tc 8.0813 0 0 9.2 306.14 706.8 Tm (9. )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0235 Tc 8.6 0 0 8.6 320 706.8 Tm (Stratton )Tj EMC ET BT /T1_0 1 Tf 0.0301 Tc 8.6 0 0 8.6 351.7512 706.8 Tm (CW, )Tj 0.161 g 0.05 Tc 8.6085 0 0 8.6 371.96 706.8 Tm (Bradf)Tj 0.333 0.337 0.329 rg 0 Tc 8.6 0 0 8.6 392.56 706.8 Tm (o)Tj 0.227 g 0.0045 Tc 0.51 0 Td (rd )Tj 0.161 g 0.0283 Tc 1.336 0 Td (Hawley )Tj 0.0438 Tc 3.628 0 Td (H, )Tj 0.0331 Tc 1.451 0 Td (Horsman )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.05 Tc 8.6459 0 0 8.6 488.57 706.8 Tm (TA, )Tj EMC ET BT /T1_0 1 Tf 8.8147 0 0 8.6 506.32 706.8 Tm (Tu )Tj 0.227 g /T1_3 1 Tf 0.0154 Tc 9.2 0 0 9.2 520.12 706.8 Tm (KK, )Tj /T1_0 1 Tf 0.027 Tc 8.6 0 0 8.6 306.22 696.73 Tm (Ackley )Tj 0.0385 Tc 3.293 0 Td (A, )Tj 0.161 g 0.0133 Tc (Fernando )Tj 0.227 g -0.035 Tc 9.4579 0 0 9.7 381.64 696.73 Tm (NK, )Tj 0.161 g 0.0249 Tc 8.6 0 0 8.6 399.33 696.73 Tm (Weinstein )Tj 0.0436 Tc 4.52 0 Td (M.)Tj 0.333 0.337 0.329 rg 0 Tc 1.556 0 Td (-)Tj 0.161 g /T1_1 1 Tf 0.0137 Tc 8.9 0 0 8.9 456.56 696.73 Tm (Haemophilus )Tj ET BT /Suspect <>BDC 0.227 g /T1_1 1 Tf -0.0023 Tc 8.9 0 0 8.9 507.2544 696.73 Tm (influen\255)Tj EMC ET BT /T1_1 1 Tf 0.0032 Tc 8.9 0 0 8.9 306.328 687.118 Tm (zae )Tj /T1_0 1 Tf 0.0322 Tc 8.6 0 0 8.6 323.05 687.12 Tm (pneumonia )Tj 0.161 g /T1_3 1 Tf 0.0282 Tc 9.4 0 0 9.4 368.46 687.12 Tm (in )Tj 0.227 g /T1_0 1 Tf 0.0162 Tc 8.6 0 0 8.6 380.55 687.12 Tm (adults)Tj 0.333 0.337 0.329 rg 0 Tc 2.557 0 Td (. )Tj 0.161 g 0.026 Tc 0.853 0 Td (Report )Tj 0.227 g 0.05 Tc 9.4598 0 0 8.6 439.59 687.12 Tm (of )Tj 0.0155 Tc 8.6 0 0 8.6 453.03 687.12 Tm (five )Tj 0.0224 Tc 2.234 0 Td (cases )Tj 0.0297 Tc 2.791 0 Td (caused )Tj -0.035 Tc 8.541 0 0 8.6 526.57 687.12 Tm (by )Tj 0.0166 Tc 8.6 0 0 8.6 306.15 677.05 Tm (ampicillin )Tj 0.0236 Tc 4.753 0 Td (resistant )Tj 0.0179 Tc 4.006 0 Td (strains. )Tj /T1_1 1 Tf 0.05 Tc 9.4102 0 0 8.9 411.5 677.05 Tm (Am )Tj 0.0355 Tc 8.9 0 0 8.9 428.23 677.05 Tm (Rev )Tj 0.161 g 0.0291 Tc 2.049 0 Td (Respir )Tj 0.227 g 0.0101 Tc 3.183 0 Td (Dis, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0135 Tc 8.6 0 0 8.6 495.06 677.05 Tm (1980, )Tj EMC ET BT /T1_0 1 Tf -0.0014 Tc 8.6 0 0 8.6 520.0172 677.05 Tm (121, )Tj 0.05 Tc 8.6696 0 0 8.6 305.64 667.44 Tm (595-598)Tj 0.333 0.337 0.329 rg 0 Tc 8.6 0 0 8.6 337.74 667.44 Tm (. )Tj 0.227 g /T1_1 1 Tf 0.05 Tc 9.116 0 0 8.9 305.37 637.68 Tm (La )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0.0053 Tc 8.9 0 0 8.9 318.65 637.68 Tm (bacteriemie )Tj EMC ET BT /T1_1 1 Tf 0.0045 Tc 8.9 0 0 8.9 364.2625 637.68 Tm (avec )Tj -0.035 Tc 8.1011 0 0 8.9 384.56 637.68 Tm (Ia )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0.015 Tc 8.9 0 0 8.9 394.38 637.68 Tm (pneumonie )Tj EMC /Suspect <>BDC 0.161 g 0 Tc 13.8 0 0 13.8 437.67 637.68 Tm (a )Tj EMC ET BT 0.227 g /T1_0 1 Tf 0.0312 Tc 8.6 0 0 8.6 445.43 637.68 Tm (haemophilus )Tj 0.0016 Tc 5.853 0 Td (influertzae. )Tj 0.161 g /T1_1 1 Tf -0.0301 Tc 8.9 0 0 8.9 305.85 628.09 Tm (M.B)Tj 0.333 0.337 0.329 rg 0 Tc 1.761 0 Td (. )Tj 0.161 g 0.0149 Tc 0.51 0 Td (Allen, )Tj 0 Tc 2.798 0 Td (K)Tj 0.333 0.337 0.329 rg 0.737 0 Td (. )Tj ET BT /Suspect <>BDC 0.227 g /T1_1 1 Tf 0.0154 Tc 8.9 0 0 8.9 362.4718 628.09 Tm (Pr)Tj 0.333 0.337 0.329 rg 0 Tc 1.009 0 Td (o)Tj 0.227 g -0.0232 Tc 0.543 0 Td (wse. )Tj EMC /Suspect <>BDC /T1_0 1 Tf 0.0229 Tc 8.6 0 0 8.6 305.72 618 Tm (RESUME: )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 8.8013 0 0 8.6 350.83 618 Tm (La )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0209 Tc 8.6 0 0 8.6 366.25 618 Tm (bacteriemie )Tj EMC ET BT /T1_0 1 Tf 0.0296 Tc 8.6 0 0 8.6 414.152 618 Tm (accompagnant )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.035 Tc 8.5916 0 0 8.6 472.74 618 Tm (Ia )Tj EMC ET BT 0.161 g /T1_0 1 Tf 0.0322 Tc 8.6 0 0 8.6 484.81 618 Tm (pneumonic )Tj ET BT /Suspect <>BDC 0.227 g /T1_0 1 Tf 0 Tc 13.4 0 0 13.4 530.74 618 Tm (a )Tj EMC ET BT /T1_0 1 Tf 0.0209 Tc 8.6 0 0 8.6 305.72 608.41 Tm (Haemophilus )Tj 0.0414 Tc 5.799 0 Td (est )Tj 0.0037 Tc 1.46 0 Td (rare)Tj 0.333 0.337 0.329 rg 0 Tc 1.599 0 Td (. )Tj ET BT /Suspect <>BDC 0.161 g /T1_0 1 Tf 0.0266 Tc 8.6 0 0 8.6 386.8352 608.41 Tm (Pour )Tj EMC /Suspect <>BDC 0.227 g 0.0289 Tc 2.172 0 Td (determiner )Tj EMC ET BT /T1_0 1 Tf 0.0437 Tc 8.6 0 0 8.6 447.233 608.41 Tm (son )Tj 0.0261 Tc 1.736 0 Td (incidence )Tj 0.05 Tc 8.9571 0 0 8.6 499.11 608.41 Tm (et )Tj 0.0161 Tc 8.6 0 0 8.6 507.72 608.41 Tm (ses )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0289 Tc 8.6 0 0 8.6 520.7232 608.41 Tm (car\255)Tj EMC /Suspect <>BDC 0.0245 Tc -25.006 -1.117 Td (actenstiques, )Tj EMC ET BT /T1_0 1 Tf 0.0226 Tc 8.6 0 0 8.6 355.1904 598.8038 Tm (nous )Tj 0.161 g 0.0198 Tc 2.223 0 Td (avons )Tj 0.227 g 0.0221 Tc 2.688 0 Td (revu )Tj 0.0392 Tc 2.114 0 Td (les )Tj 0.0277 Tc 1.45 0 Td (dossiers )Tj 0.0362 Tc 3.684 0 Td (des )Tj 0.02 Tc 1.685 0 Td (patients )Tj 0.0482 Tc 3.506 0 Td (chez )Tj 0.0364 Tc 2.177 0 Td (qui )Tj /T1_1 1 Tf 0 Tc 8.9 0 0 8.9 305.84 589.21 Tm (H)Tj 0.333 0.337 0.329 rg 0.685 0 Td (a)Tj 0.227 g -0.019 Tc 0.483 0 Td (em)Tj 0.333 0.337 0.329 rg -0.0091 Tc 1.188 0 Td (op)Tj 0.227 g 0.0207 Tc 1.027 0 Td (hil)Tj 0.333 0.337 0.329 rg -0.0119 Tc 1.13 0 Td (us )Tj /T1_0 1 Tf 0.0166 Tc 8.6 0 0 8.6 356.52 589.21 Tm (species )Tj 0 Tc 3.352 0 Td (a )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 8.6 0 0 8.6 392.081 589.21 Tm (c)Tj 0.227 g 0.509 0 Td (t)Tj 0.333 0.337 0.329 rg 0.271 0 Td (e )Tj EMC /Suspect <>BDC 0.0209 Tc 0.84 0 Td (isole )Tj EMC ET BT 0.227 g /T1_0 1 Tf 0.0137 Tc 8.6 0 0 8.6 426.1628 589.21 Tm (du )Tj 0.333 0.337 0.329 rg 0 Tc 1.391 0 Td (s)Tj 0.227 g -0.035 Tc 8.5624 0 0 8.6 441.99 589.21 Tm (an)Tj 0.333 0.337 0.329 rg 0 Tc 8.6 0 0 8.6 450.17 589.21 Tm [(g )-142(o)]TJ 0.227 g 1.459 0 Td (u )Tj 0.333 0.337 0.329 rg 0.828 0 Td (d)Tj 0.227 g 0.567 0 Td (u )Tj -0.035 Tc 8.5757 0 0 8.6 482.33 589.21 Tm (li)Tj 0.333 0.337 0.329 rg 0.0336 Tc 8.6 0 0 8.6 487.12 589.21 Tm (quide )Tj 0 Tc 2.69 0 Td (p)Tj 0.227 g 0.493 0 Td (l)Tj 0.333 0.337 0.329 rg 0.0222 Tc 0.277 0 Td (eural )Tj 0.0169 Tc -24.558 -1.173 Td (au )Tj 0.0259 Tc 1.341 0 Td (co)Tj 0.227 g 0 Tc 1.014 0 Td (u)Tj 0.333 0.337 0.329 rg 0.0039 Tc 0.501 0 Td (rs )Tj 0.05 Tc 9.3204 0 0 8.6 339.75 579.12 Tm (d')Tj 0.227 g 0.0053 Tc 8.6 0 0 8.6 347.52 579.12 Tm (un)Tj 0.333 0.337 0.329 rg 0 Tc 1.05 0 Td (e )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0231 Tc 8.6 0 0 8.6 363.3698 579.12 Tm (periode )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 9.2683 0 0 8.6 393.03 579.12 Tm (de )Tj 0.0419 Tc 8.6 0 0 8.6 404.56 579.12 Tm (cin)Tj 0.227 g 0 Tc 1.34 0 Td (q )Tj 0.333 0.337 0.329 rg 0.0372 Tc 0.892 0 Td (ans)Tj 0.439 0.439 0.435 rg 0 Tc 1.441 0 Td (. )Tj 0.227 g 0.64 0 Td (N)Tj 0.333 0.337 0.329 rg 0.0413 Tc 0.712 0 Td (ous )Tj 0.0375 Tc 1.841 0 Td (avo)Tj 0.227 g 0 Tc 1.516 0 Td (n)Tj 0.333 0.337 0.329 rg 0.545 0 Td (s )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0159 Tc 8.6 0 0 8.6 488.582 579.12 Tm (idc)Tj 0.227 g 0 Tc 1.179 0 Td (n)Tj 0.333 0.337 0.329 rg 0.0207 Tc 0.551 0 Td (lific )Tj EMC /Suspect <>BDC 0.227 g 0 Tc 2.072 0 Td (h)Tj 0.333 0.337 0.329 rg -0.035 Tc 8.4166 0 0 8.6 525.6 579.12 Tm (ui)Tj 0.227 g 0 Tc 8.6 0 0 8.6 532.5 579.12 Tm (1 )Tj EMC /Suspect <>BDC 0.333 0.337 0.329 rg 0.0196 Tc -26.364 -1.115 Td (patie)Tj 0.227 g 0 Tc 2.007 0 Td (n)Tj 0.333 0.337 0.329 rg -0.035 Tc 8.399 0 0 8.6 327.82 569.53 Tm (ts )Tj EMC ET BT /T1_0 1 Tf 0.0141 Tc 8.6 0 0 8.6 337.83 569.53 Tm (adultes )Tj 0.227 g -0.035 Tc 8.5624 0 0 8.6 367.59 569.53 Tm (av)Tj 0.333 0.337 0.329 rg 0.05 Tc 8.9059 0 0 8.6 375.27 569.53 Tm (ec )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0374 Tc 8.6 0 0 8.6 387.85 569.53 Tm (bac)Tj 0.227 g 0 Tc 1.448 0 Td (t)Tj 0.333 0.337 0.329 rg 0.0415 Tc 0.271 0 Td (&iemie )Tj EMC /Suspect <>BDC /T1_3 1 Tf -0.035 Tc 8.2732 0 0 8.7 434.17 569.53 Tm (II )Tj EMC ET BT 0.227 g /T1_1 1 Tf 0.038 Tc 8.9 0 0 8.9 443.03 569.53 Tm (fla)Tj 0.333 0.337 0.329 rg 0.0199 Tc 1.179 0 Td (emop)Tj 0.227 g 0 Tc 2.215 0 Td (h)Tj 0.333 0.337 0.329 rg 0.01 Tc 0.533 0 Td (ilus )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0.0011 Tc 8.9 0 0 8.9 495.2641 569.53 Tm (influenzae)Tj 0.439 0.439 0.435 rg 0 Tc 4.161 0 Td (; )Tj EMC ET BT 0.333 0.337 0.329 rg /T1_0 1 Tf 0.05 Tc 9.6007 0 0 8.6 305.19 559.44 Tm (ci)Tj 0.227 g 0 Tc 8.6 0 0 8.6 311.99 559.44 Tm (n)Tj 0.333 0.337 0.329 rg 0.494 0 Td (q )Tj 0.05 Tc 9.8847 0 0 8.6 324.39 559.44 Tm (d'e)Tj 0.227 g 0 Tc 8.6 0 0 8.6 336.47 559.44 Tm (n)Tj 0.333 0.337 0.329 rg 0.0328 Tc 0.501 0 Td (tre )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0139 Tc 8.6 0 0 8.6 354.1516 559.44 Tm (eux )Tj EMC ET BT /T1_0 1 Tf 0.0065 Tc 8.6 0 0 8.6 370.9474 559.44 Tm (avaie)Tj 0.227 g 0.05 Tc 8.7411 0 0 8.6 389.27 559.44 Tm (nl )Tj 0.333 0.337 0.329 rg 0.0044 Tc 8.6 0 0 8.6 400.8 559.44 Tm (une )Tj 0.0391 Tc 1.899 0 Td (pneumonic )Tj 0.05 Tc 8.8838 0 0 8.6 461.15 559.44 Tm (sur )Tj 0.0255 Tc 8.6 0 0 8.6 476.65 559.44 Tm (base )Tj 0.05 Tc 9.2683 0 0 8.6 495.75 559.44 Tm (de )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0217 Tc 8.6 0 0 8.6 508.24 559.44 Tm (critcres )Tj EMC ET BT /T1_0 1 Tf 0 Tc 8.6 0 0 8.6 305.2026 549.851 Tm (c)Tj 0.227 g 0.0388 Tc 0.448 0 Td (lin)Tj 0.333 0.337 0.329 rg -0.035 Tc 8.5969 0 0 8.6 319.13 549.85 Tm (iq)Tj 0.227 g 0 Tc 8.6 0 0 8.6 325.92 549.85 Tm (u)Tj 0.333 0.337 0.329 rg 0.025 Tc 0.492 0 Td (es )Tj 0 Tc 1.06 0 Td (e)Tj 0.227 g 0.566 0 Td [(t )80(r)]TJ 0.333 0.337 0.329 rg 0.0257 Tc 0.829 0 Td (adio)Tj 0.227 g 0 Tc 1.844 0 Td (l)Tj 0.333 0.337 0.329 rg 0.0098 Tc 0.222 0 Td (ogiq)Tj 0.227 g 0 Tc 1.851 0 Td (u)Tj 0.333 0.337 0.329 rg -0.0009 Tc 0.492 0 Td (es. )Tj 0.227 g 0 Tc 1.46 0 Td (U)Tj 0.333 0.337 0.329 rg 0.67 0 Td (n )Tj 0.227 g 0.0148 Tc 0.784 0 Td (pa)Tj 0.333 0.337 0.329 rg -0.0165 Tc 1.051 0 Td (lic)Tj 0.227 g 0.0077 Tc 1.012 0 Td (nt )Tj 0.333 0.337 0.329 rg 0.0305 Tc 1.048 0 Td (se)Tj 0.227 g -0.035 Tc 8.4166 0 0 8.6 448.8 549.85 Tm (ul)Tj 0.333 0.337 0.329 rg 0.05 Tc 8.8112 0 0 8.6 455.43 549.85 Tm (eme)Tj 0.227 g 8.7411 0 0 8.6 470.39 549.85 Tm (nl )Tj 0.333 0.337 0.329 rg 0.0075 Tc 8.6 0 0 8.6 479.91 549.85 Tm (avai)Tj 0.227 g 0 Tc 1.738 0 Td (t )Tj 0.333 0.337 0.329 rg 0.505 0 Td (u)Tj 0.227 g 0.557 0 Td (n )Tj 0.333 0.337 0.329 rg -0.0051 Tc 0.772 0 Td (fac)Tj 0.227 g 0 Tc 1.236 0 Td (t)Tj 0.333 0.337 0.329 rg 0.215 0 Td (e)Tj 0.227 g 0.513 0 Td (u)Tj 0.333 0.337 0.329 rg 0.501 0 Td (r )Tj 0.227 g 0.05 Tc 8.7873 0 0 8.6 305.29 540.24 Tm (pr)Tj 0.333 0.337 0.329 rg 0.0191 Tc 8.6 0 0 8.6 312.87 540.24 Tm (edisposan)Tj 0.227 g 0 Tc 4.133 0 Td (l)Tj 0.333 0.337 0.329 rg 0.328 0 Td (, )Tj 0.05 Tc 8.8775 0 0 8.6 356.07 540.24 Tm (en )Tj 0.227 g 0 Tc 8.6 0 0 8.6 367.62 540.24 Tm (I )Tj 0.333 0.337 0.329 rg 0.0319 Tc 0.386 0 Td ('occurrence )Tj 0.227 g -0.035 Tc 8.4613 0 0 8.6 416.16 540.24 Tm (un)Tj 0.333 0.337 0.329 rg 0 Tc 8.6 0 0 8.6 424.71 540.24 Tm [(e )-99(b)]TJ 0.227 g 1.405 0 Td (r)Tj 0.333 0.337 0.329 rg 0.05 Tc 8.6022 0 0 8.6 439.12 540.24 Tm (oncho)Tj 0.227 g 8.7609 0 0 8.6 461.77 540.24 Tm (pn)Tj 0.333 0.337 0.329 rg 0.0302 Tc 8.6 0 0 8.6 470.79 540.24 Tm (eumopathic )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0472 Tc 8.6 0 0 8.6 515.4412 540.24 Tm (chro)Tj 0.439 0.439 0.435 rg 0 Tc 1.951 0 Td (\255)Tj EMC ET BT 0.227 g /T1_0 1 Tf 0.0077 Tc 8.6 0 0 8.6 305.2658 530.1694 Tm (ni)Tj 0.333 0.337 0.329 rg 0.0371 Tc 0.829 0 Td (que )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0272 Tc 8.6 0 0 8.6 327.2732 530.1694 Tm (obslnlctive. )Tj EMC /Suspect <>BDC 0.227 g 0 Tc 5.251 0 Td (D)Tj 0.333 0.337 0.329 rg 0.014 Tc 0.72 0 Td (eux )Tj EMC ET BT /T1_0 1 Tf 0.0196 Tc 8.6 0 0 8.6 394.0866 530.1694 Tm (patie)Tj 0.227 g 0 Tc 2.007 0 Td (n)Tj 0.333 0.337 0.329 rg 0.0061 Tc 0.557 0 Td (ts )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0381 Tc 8.6 0 0 8.6 424.7112 530.1694 Tm (ava)Tj 0.227 g 0 Tc 1.453 0 Td (i)Tj 0.333 0.337 0.329 rg 0.0417 Tc 0.277 0 Td (ent )Tj EMC ET BT /T1_0 1 Tf 0.0362 Tc 8.6 0 0 8.6 453.0396 530.1694 Tm (des )Tj 0.0233 Tc 1.676 0 Td (isolcmcnts )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.019 Tc 8.6 0 0 8.6 508.329 530.1694 Tm (produ)Tj 0.227 g 0 Tc 2.391 0 Td (i)Tj 0.518 g 0.331 0 Td (\255)Tj EMC /Suspect <>BDC 0.333 0.337 0.329 rg 0.0298 Tc -26.346 -1.172 Td (snnt )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 9.2683 0 0 8.6 324.39 520.09 Tm (de )Tj ET BT /Suspect <>BDC 0.227 g /T1_0 1 Tf 0 Tc 8.6 0 0 8.6 338.34 520.09 Tm (I)Tj 0.333 0.337 0.329 rg 0.276 0 Td (a )Tj EMC /Suspect <>BDC 0.227 g 1.016 0 Td (b)Tj 0.333 0.337 0.329 rg 0.0423 Tc 0.491 0 Td (eta )Tj EMC ET BT /T1_0 1 Tf 0.0298 Tc 8.6 0 0 8.6 368.5776 520.09 Tm (lactamase; )Tj 0.05 Tc 8.6907 0 0 8.6 412.32 520.09 Tm (un )Tj 0 Tc 8.6 0 0 8.6 426.16 520.09 Tm (d)Tj 0.227 g 0.612 0 Td (')Tj 0.333 0.337 0.329 rg 0.28 0 Td (e)Tj 0.227 g 0.456 0 Td (n)Tj 0.333 0.337 0.329 rg 0.0328 Tc 0.557 0 Td (tre )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0419 Tc 8.6 0 0 8.6 456.8706 520.09 Tm (eux )Tj EMC ET BT /T1_0 1 Tf 0 Tc 8.6 0 0 8.6 475.1112 520.09 Tm (a )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.05 Tc 9.2683 0 0 8.6 483.75 520.09 Tm (de)Tj 0.227 g 0 Tc 8.6 0 0 8.6 492.46 520.09 Tm (v)Tj 0.333 0.337 0.329 rg 0.0295 Tc 0.494 0 Td (eloppe )Tj EMC ET BT /T1_0 1 Tf -0.035 Tc 8.4613 0 0 8.6 526.08 520.09 Tm (un )Tj 0.227 g 0.0352 Tc 8.6 0 0 8.6 305.19 510.49 Tm (empyemc )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0094 Tc 8.6 0 0 8.6 344.0706 510.49 Tm (apr)Tj 0.333 0.337 0.329 rg 0.025 Tc 1.284 0 Td (es )Tj EMC ET BT /T1_0 1 Tf -0.035 Tc 8.4613 0 0 8.6 366.72 510.49 Tm (un )Tj ET BT /Suspect <>BDC 0.227 g /T1_0 1 Tf 0.0201 Tc 8.6 0 0 8.6 379.13 510.49 Tm (ir)Tj 0.333 0.337 0.329 rg 0 Tc 0.612 0 Td (a)Tj 0.227 g -0.035 Tc 6.317 0 0 8.6 387.79 510.49 Tm (iL)Tj 0.333 0.337 0.329 rg 0 Tc 8.6 0 0 8.6 393.03 510.49 Tm (e)Tj 0.227 g 0.51 0 Td (m)Tj 0.333 0.337 0.329 rg 0.829 0 Td (e)Tj 0.227 g 0.456 0 Td (n)Tj 0.333 0.337 0.329 rg 0.553 0 Td (L )Tj EMC ET BT /T1_0 1 Tf 8.6 0 0 8.6 418.9418 510.49 Tm (a )Tj 0.227 g 0.897 0 Td (I )Tj 0.333 0.337 0.329 rg 0.0329 Tc 0.386 0 Td ('ampici)Tj 0.227 g 0.0194 Tc 3.129 0 Td (ll)Tj 0.333 0.337 0.329 rg 0 Tc 0.614 0 Td (i)Tj 0.227 g 0.286 0 Td (n)Tj 0.333 0.337 0.329 rg -0.0035 Tc 0.493 0 Td (e, )Tj 0.227 g 0.05 Tc 8.9089 0 0 8.6 478.47 510.49 Tm (ce )Tj 0.0364 Tc 8.6 0 0 8.6 490 510.49 Tm (qui )Tj 0 Tc 1.785 0 Td (a )Tj 0.161 g 0.0363 Tc 0.791 0 Td (requis )Tj 0.227 g 0.05 Tc 8.6907 0 0 8.6 305.28 500.41 Tm (un )Tj 0.0283 Tc 8.6 0 0 8.6 318.64 500.41 Tm (drainage )Tj 0.333 0.337 0.329 rg 0.0247 Tc 4.186 0 Td (chirurg)Tj 0.227 g 0 Tc 3.071 0 Td (i)Tj 0.333 0.337 0.329 rg 0.0146 Tc 0.222 0 Td (cal)Tj 0.227 g 0 Tc 1.272 0 Td (. )Tj ET BT /Suspect <>BDC 0.333 0.337 0.329 rg /T1_0 1 Tf 0.0413 Tc 8.6 0 0 8.6 400.7098 500.41 Tm (Quatte )Tj EMC ET BT /T1_0 1 Tf 0.0148 Tc 8.6 0 0 8.6 430.0874 500.41 Tm (pa)Tj 0.227 g -0.035 Tc 8.3616 0 0 8.6 438.7 500.41 Tm (ti)Tj 0.333 0.337 0.329 rg 0.0284 Tc 8.6 0 0 8.6 443.43 500.41 Tm (ents )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0146 Tc 8.6 0 0 8.6 463.124 500.41 Tm (cta)Tj 0.227 g 0.0087 Tc 1.285 0 Td (ient )Tj EMC /Suspect <>BDC 0.026 Tc 2.063 0 Td (ages )Tj EMC ET BT /T1_0 1 Tf 0.0148 Tc 8.6 0 0 8.6 512.5654 500.41 Tm (de )Tj -0.0266 Tc 1.559 0 Td (69 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0 Tc 13.4 0 0 13.4 305.14 490.81 Tm (a )Tj EMC /Suspect <>BDC 0.161 g 0.05 Tc 8.9862 0 0 8.6 313.28 490.81 Tm (80 )Tj EMC ET BT 0.227 g /T1_0 1 Tf 0.0093 Tc 8.6 0 0 8.6 326.79 490.81 Tm (ans )Tj 0.05 Tc 8.9571 0 0 8.6 342.63 490.81 Tm (et )Tj ET BT /Suspect <>BDC 0.333 0.337 0.329 rg /T1_0 1 Tf 0.0226 Tc 8.6 0 0 8.6 353.67 490.81 Tm (etaie)Tj 0.227 g 0.0077 Tc 1.963 0 Td (nt )Tj EMC ET BT 0.333 0.337 0.329 rg /T1_0 1 Tf 0.0256 Tc 8.6 0 0 8.6 381.5082 490.81 Tm (en )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0104 Tc 8.6 0 0 8.6 394.477 490.81 Tm (ctat )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 8.7805 0 0 8.6 411.76 490.81 Tm (de )Tj 0 Tc 8.6 0 0 8.6 424.24 490.81 Tm (c)Tj 0.227 g 0.51 0 Td (h)Tj 0.333 0.337 0.329 rg 0.05 Tc 8.8834 0 0 8.6 432.88 490.81 Tm (oc )Tj 0.0256 Tc 8.6 0 0 8.6 445.84 490.81 Tm (cl)Tj 0.227 g -0.0166 Tc 0.838 0 Td (ini)Tj 0.333 0.337 0.329 rg 0 Tc 1.003 0 Td (q)Tj 0.227 g 0.623 0 Td (u)Tj 0.333 0.337 0.329 rg 0.492 0 Td (e )Tj 0.227 g 0.0169 Tc 0.949 0 Td (au )Tj 0.0382 Tc 1.459 0 Td (moment )Tj 0.0137 Tc 3.9 0 Td (du )Tj 0.0174 Tc -25.619 -1.173 Td (diagnostic. )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0335 Tc 8.6 0 0 8.6 347.8258 480.7222 Tm (Sept )Tj EMC ET BT /T1_0 1 Tf 0.0362 Tc 8.6 0 0 8.6 366.6254 480.7222 Tm (des )Tj 0.0414 Tc 1.794 0 Td (huit )Tj 0.028 Tc 2.067 0 Td (patients )Tj 0.05 Tc 8.8578 0 0 8.6 430.96 480.72 Tm (on )Tj 0.0262 Tc 8.6 0 0 8.6 443.4 480.72 Tm (survecu. )Tj /T1_1 1 Tf -0.0009 Tc 8.9 0 0 8.9 305.34 471.12 Tm (Eur )Tj 0.161 g 0.0183 Tc 1.835 0 Td (Respir )Tj 0.227 g /T1_2 1 Tf -0.0251 Tc 8.6 0 0 8.6 347.92 471.12 Tm (J., )Tj /T1_1 1 Tf 0.0138 Tc 8.9 0 0 8.9 360.8 471.12 Tm (19)Tj 0.333 0.337 0.329 rg 0 Tc 0.978 0 Td (8)Tj 0.227 g -0.0342 Tc 0.539 0 Td (8, )Tj -0.0059 Tc 1.126 0 Td (1, )Tj 0.0291 Tc 1.089 0 Td (929-931. )Tj ET endstream endobj 11 0 obj <>/Filter/JBIG2Decode/Height 1752/ImageMask true/Length 14935/Name/X/Subtype/Image/Type/XObject/Width 1240>>stream 'zmm Ùa<Y#læ*7%M|`gZ 8U1 +| o`B& ϰ'DF4+ NݚTqxUmW _q=C #{>W6bi:׹0 cq- `T_0~3-:^ɿMd4`@R SXJ:ʣ%^e*b#ƣɳTY VMzOfX#TyF,ˇ]4a} üR8@zH+8mi4o"FA2fr'ܥO+ڋt/a/|1ٵ{+XQ->PWYڋT* @O@''Y%ÇZk͚ZUH=ꪭnr9B?n)M`.}ZeY"`^2Z9wY eE1AN`'Ä\jt*H)YcNz,v1Mد6QǨn (gD3ywXcj˾W fvq]'AiL3G tsTo!f23: ȯV/T];Pvh *v6ZY3mE֒.EDLڒ{>0~2p͑ߥzeL( ٷrC͡tYB%Z3db%͍U& y+~4y+LfJ{-jH005bR.Xgr*$4"Bo "=LYDa)##= ~E4proP8ijL*}!#rЇiv3@xnnw@ss2{Ix? Dt%񂢲(Iƹ;`hS2rӎ%Hߕ\ LU?'0?.(vf1(6Gf6cABz曆,8=}Wi|eUT~0RN$oBL\ˢ@v`@{M*x3t1kҰ|>4[8bɨݧytDZc2 dF4u8da3ҬO~g.w2镍djzJ Z \RnO 6<fN9V*$OD%%VXq4O Nnj~I܁%B(4=f1_~_i5kIdS䒷!aIK%@0=("-t`v bp59eS$*/Ϙ %4_7I瘄*#m^4'Xxc3vǾԾZsM#R&/,"ؖ| t{4O"8ԉfڄƤ]Թ'"qe&v{>~vwNDd>ɨiќAc}|q7D=i׸cId:TJӯ*26 s3ިt_):`ʾYimwbOCcȏvs>EuTGAPT{.a uyk.BWsQZĚzULs"&ϊR=cA"8:;0bsp "GeclkEIx 7Lz2g⢸s8y%MJ/Fr,~ ;^7 JVՔъNc+ uӅ,|C7eDDkE2m8ʓLx3wciǥ_4 m}:mj5 y쏳H9g\E싪EC`sMu{l/! 4A! פKvSa=QysIpk"hsfڨFz );$a_D$H`:ú'0kx0l}>H*k`ɶ;ʝ bZ~6[GQ[r2A)+Q}ﵐk^9$PI~E䐭WN?>;gB?s7S|LSqRll#/Wˁ9TӢ\ ,t&n)B\@ @$Ye]XR%Z˗ [|L.r/K3 %bL0YbCy3%ÿlǠFj#ɩaszg"cfs%ă&'Qn }:hX`\y8QK:<=N (U[ϫ#U9(nuRgC E ԹChЊ5'ݧ\lNC#:ުq<>.U@ %mZ2Rq+   ?n)AǽI3@<2Q2jd]Gp< oIHs%B+EM0Wc #Fw-j?]E*^cy!IpI靍ap035IfwMQhr⻴^ ƽٙu}н0,q?7j[xh4\$9HҊK&mGȐݞ{7fs4:Ub(pFzjJ7G`A <1&dsY鹐ѡH`-P-?IH4M yOu4O홶3[eKx.`]/ (l{tUg$]wF^1 /5νaGlҿ޶z΍>vKTT:fm ~3t͔x#gf.i+,.`az$Wy IDmE#0à 6\60Qp>jl[;f_8wT LIA4ڄ_u1L(ݢSCcUġEQڔA/i\=PN/Xг  -[) UVWIY9:x9J+ӣ߇e8Gwl*K8ՙ0,ʽ ,ʍ~>g< _ Io3.Xm2+mV86r!OO/x{!G/46 W|5w<$:%*Cx0-0пUE czK66.Ζd1Yf0ZLQH:R# 0+^6VOIT'UgG-o%‹IgI_U ߎ%鍦pYkó/O,236 “ .ޯa5ϛ,m+fM8\ 멮hv>eB>y W~kFtPyճV:xe)/L4™ v4@6CFy zUG01v:-2{bW^+H2bw7KeOz{'m:&EMr2RoCb-d݆-Ȕto[>o/k=~J<:%GL ~ͣubb$;1-stWzYFY[cABu$Al-n/"UJ+:r9DVz.5~$TfUMJ>^ lvu">TDXPǥ I"}/Ehsk( s ڇõxii/!z1vnE{M1P:ʾZ<≧¹gFY(@|ٶ;ykb\=@u)**:(p7SFfOt v+q5O('cONQd4D_tK+k[iU5(!=wT2";6Aj )y"w!י^B6nK|(AaX)ŦN0%1sZpю|ֈLދ9ԥVy NB7s`|}V? ӍrlfXd#Bj1ˍ$#"N&5075 .6]Ag:}[GO9G.p\xjB/eJ°zǒPɧ=Q 9eBnEsNNM az,GJR%,F1tzt/JnIZb8`-tCeiѳ{sr#+X̵Tr1Nō)ԏG5㡜ҽ4 ;567}d?eH(k,t#}WL> 7zu!^K~-5BT C1|@|,@~ucrG;ttP u>-J zPHwuGT ~\>n9m`.wQo+YJʾ-F}qr'I(Km/F u],6ëִT MӾ hfQ#.ۏ)0#ۭ"O+',LZ1Y|!Ic&%'- i—k[lrF`VxJ:'?Cw;7ʅe+!^XdmUFk8DpH_0r׋Dxڕm窘ojiD/`]cQ"RT H+A_`AZn=숼-,zl&r5P7 `srQ3JU bLrjF+V5KIv ]3 A,1܃|T+fid-`޷B ̅(W` oZ:USx_ԪEZ@Dhlj&y~:xq5e޿K.ݐ[YqHMM'xl(Z!e0bk=-9&~I=T_ԏtѿ*BQc? `1 hQ]]g)%Y|s#gHጛśFf9'ns-γ,{QH O (I e5~ > 55xޛ_Q/gG^'DOsj2:,](+kgfN|**5?e6v@@)6,P5"_" h^;#eӁIUsb`)B8?n4 _Aɯx2@MfG̯DJϫ\c eف/\4bw?,hӟ[d/3!ڭ%rOnZ/X%bA&y{[릸+wW_hG<reҳU ˵[OHy͞b)Ow.,ޛۼ 3*N ǯł6 FXϗS.Z&a<6vn"fk=9;HOӐb#?>EME@S;@Z^nR\j'VYv}Vآ^C=槍08ɯ6)ǖpIkQw^[Ȯg~z)U ot#YFNn&465RGIDo))M,S}o-_Sf9RL/OVau{z"R9Hl 'i"pZ ܋=) kduwQPQ92Z|ig$ mW3ڌ;!im^𭄕mbG3*]`,)TE 8X~$ \:BDF}<Td]wAU3S&/zŽX:R}m}w><9zQ|DI% , ,kI:w5Ɖil6N&+X|y?]Fe "934cwM-4?&( @>Z1u.[!{>ơ)Yr/؆  vo0,xb39`Q}y'璌 ,Isμ9am'4Kp3g@ R0mޞON *J7uY?{s8FCwz6%<U?#M߾3#2?("xTW_MM[6lu΄5D"E%c`ɛځ__P٘Im^k.cDO HǹțzZȜuV!Yr/Ŭ5v3=y@k&H\fL g LEZ ]pᘡC^v^-2݃:P"دanއ"TӦ~/74vհqf4h .Jȷ\ =A62+7 2=[TvURiH]vL /̹E$9z vg'˟1k2yɥZ`~6T3הu)*ߡNƝmJ%^u{Qt=19Q ! $h7Tzv^k2$+UŮBEm%3t]L<}cRnwNm -ɺY.m/%S͇ T-1':vBAe~;Zb!2Y!o7ej/%4B Ҡ&=!D7rŘ]=M41.t JI L\U2 7;K{MmF;ރh4 k3۷ U6@1{SvuGg>}`Bq(T' * LEɺd}bط{E*'J:$VjUw϶op~Gkg$eHs4G6Ena0/ v;0]A$5ĆIz3f-Zc5ޏȦQāv_"=ÈK1@:uTcS[&v:m:b`puxON 8`9x{f+6+(ve5"y;(vH>IIn0hUӷ.ɒune{#h FsuovvMK`( |3Y3DOW+ HPYXrᾄ)=H5j8ϟ]ѝC?-#"Ouu;V~%)EҨ1O6ecgm sbwlBE-́Qq'Bys]y̨xN$'Jw˭_3NALdCזS7iҼ95`L=3Vx =y)b]i|~Q@ v,$r*k2{@ӭK±/[0@ ZXclaՀjfB`37imɻ S [~y396E>8`f#VA8~]P`L;*٨*cx`OoVp{@DDvtst7Ư$[+O x6FP*pdĸUs8e' نAj_@w {)Qy)J+ %8۩س#$xbn ,iIw(+V|N0#=ae+ b 6.@4ᣚj<Nhʋɓ2ëGbiL` W9uws1gX/g|L|&6:[3㭂X]b«D2xiP\@FBXWR$PS1G8slTv QݾW&*ʶ%S E#8>̭hP|JұVzD1P#nʕoxcQ(Yw4'bVS|/*ub<ߧ;m@F5l4ͧE'T 08zzF*DX2Tᦓ5kt>I3뗀XI 9oX$قTXAb#tBr:LpϠXk;<2tigZfXc bjvݠgZl*f9_9@^C]! ^1t/W$pF>eqxwKPܯyoX(HjPf][c>5tnE|B;Pp3/z@-YE^8}@def!9d`P0)`RpR@k.$3p1sW/U(ɮ iDow_6c쨺RxȘot2d~ S@"?\Zo]A{hy-'p CѰ}G*}mot1`ó? $ b'Ћu.5[c*/Kf#ѺME.6d _ *c=V.9wd{#em(ΐc~]4;̦b=)ӏ.:j}XUXb ? TQ Oa+1tWva?bSH㴘 P8`6XzqIcOȑ%eDsFkIU$ne7%iV eAQ} g^ `您)s+W窻cWS\xs+-xf*5n<]֊Uy-`h' EDz.1!O02kgi&'#Z#A=}b+CdN3\#~&L{eض[ŧ&3-)Þ*j((jA#n٩rzi<"IQl-HL0d6VrdW[}8FxDQV"^`ä`/,JT"*Qs$s.3%%4aI5>֡{2Z&!ϮۥOCy7A_dJ)LH{2!QUH7U ڶ0OJ$;x,i*͆&*zZ)ܾEoPm9LKFi%̽^+uȉ#y.{ї5jXcs%;YGjjZ1:.D7A e}$(BtObʿm [WxkE3TP cqh _v^uF0,47+-Su!<_`LY++=7% }6s}aB]t~hsnkv64= #+tg.mE]pO$H;I̕@}!d3=9.kJ.ĩ-~m1^LTOTrXVфV#5uH{)Ro+P 0P)T5u.'a2xknjr3ol#jl 5p_t ր)t~(a`^z"&3XgKZۋ/| w*nQɱwx҄ k!5:A+FI|jFKd|w_i=*hi26 |"Zd(u˟urbnnhJ\ٳ4B6yHy nnGWR%),Ae1#'ȣ?5Aگ-,U(]ޕ{-!=M̠;:"i`.Q|z b]s 9z!;N|;E}XJ5"ŋq ס }.8&}FEϣA4zItM ]vs~wjQm7Z!l ZeP $~>stream h 0+ha1}+M< endstream endobj 13 0 obj <>stream h̐N0 _/PIڬH$@iR)8d,u,٤IA]@\l翭KA[PJJUJ$wP( FAQY0Jk*'Y6БNX OMkg,/N͑)W6[ 8X\kyG!k7ZŗdH;m菼Oe6i/ endstream endobj 14 0 obj <>stream h26Q0P06U07T06S4U ($敄$QER+JS+C* RKJA%vv@cM]KsAvv/! endstream endobj 15 0 obj <>stream 2012-10-24T09:27:56+01:00 2012-09-17T12:46:36+01:00 2012-10-24T09:27:56+01:00 Canon iR-ADV C2020L PDF application/pdf uuid:2a20f5e5-f08e-4827-b4d1-632bfcec4f4f uuid:9a1d5876-7b3e-483b-8eda-3f4e32267e5d Adobe Acrobat 10.14 Paper Capture Plug-in endstream endobj 16 0 obj <>stream h26W0Pw/+Q0L)61 )@HKRYZlg`ip endstream endobj 17 0 obj <>stream hḺ 0_MXN ZG %P9wWa*%&H=uM[ 1+*Jl# kQWr=w_a$$8;M@xݜ[Ły҇b? rp., endstream endobj 18 0 obj <>/Filter/FlateDecode/ID[<81F2F404A2008144801D205C526EC146>]/Info 38 0 R/Length 108/Root 40 0 R/Size 39/Type/XRef/W[1 3 1]>>stream hbb&Fm L 2i=ddw7A"~An4L< ~`&0&H:0{ |o 6 Y0bC2@a`b endstream endobj startxref 116 %%EOF